UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: September 30, 2024

 

     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to _____________

 

Commission File No. 001-40222

 

Airship AI Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

93-4974766

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

 

 

8210 154th Ave NE, Redmond, WA

 

98052

(Address of principal executive offices)

 

(Zip Code)

 

(877) 462-4250

(Registrant’s telephone number, including area code)

 

_____________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock

 

AISP

 

The Nasdaq Stock Market LLC

Warrant

 

AISPW

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒     No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒     No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes      No ☒

 

As of November 14, 2024, there were a total of 27,284,515 shares of the registrant’s common stock issued and outstanding.

 

 

 

 

Airship AI Holdings, Inc.

 

Quarterly Report on Form 10-Q

Quarterly Period Ended September 30, 2024

 

TABLE OF CONTENTS

 

PART I

Item 1.

Financial Statements (Unaudited).

 

3

 

Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023

 

3

 

 

Consolidated Statements of Operations for the three and nine months ended September 30, 2024 and 2023

 

4

 

 

Consolidated Statements of Changes in Stockholders’ Deficit

 

5

 

 

Consolidated Statements of Cash Flows for the nine months ended September 30, 2024 and 2023

 

6

 

 

Notes to the Financial Statements

 

7

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

30

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

37

 

Item 4.

Controls and Procedures

 

37

 

 

 

 

 

 

PART II

Item 1.

Legal Proceedings

 

38

 

Item 1A.

Risk Factors

 

38

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

38

 

Item 3.

Defaults Upon Senior Securities

 

38

 

Item 5.

Other Information

 

38

 

Item 6.

Exhibits

 

39

 

 

SIGNATURES

 

40

 

 

 
2

Table of Contents

  

PART I

 

ITEM 1. FINANCIAL STATEMENTS.

 

AIRSHIP AI HOLDINGS, INC.

CONSOLIDATED BALANCE SHEETS

As of September 30, 2024 and December 31, 2023

 

 

 

September 30,

2024

 

 

12/31/2023 (1)

 

ASSETS

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

Cash and cash equivalents

 

$6,515,688

 

 

$3,124,413

 

Accounts receivable, net of allowance for credit losses of $0

 

 

1,121,862

 

 

 

1,648,904

 

Prepaid expenses and other

 

 

373,498

 

 

 

18,368

 

Income tax receivable

 

 

-

 

 

 

7,230

 

Total current assets

 

 

8,011,048

 

 

 

4,798,915

 

 

 

 

 

 

 

 

 

 

PROPERTY AND EQUIPMENT, NET

 

 

-

 

 

 

1,861

 

 

 

 

 

 

 

 

 

 

OTHER ASSETS

 

 

 

 

 

 

 

 

Other assets

 

 

155,432

 

 

 

182,333

 

Operating lease right of use asset

 

 

929,890

 

 

 

1,104,804

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

$9,096,370

 

 

$6,087,913

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

 

Accounts payable - trade

 

$722,742

 

 

$2,908,472

 

Advances from founders

 

 

1,750,000

 

 

 

1,750,000

 

Accrued expenses

 

 

121,978

 

 

 

200,531

 

Senior Secured Convertible Promissory Notes

 

 

1,793,360

 

 

 

2,825,366

 

Current portion of operating lease liability

 

 

267,660

 

 

 

174,876

 

Deferred revenue- current portion

 

 

3,326,543

 

 

 

4,008,654

 

Total current liabilities

 

 

7,982,283

 

 

 

11,867,899

 

 

 

 

 

 

 

 

 

 

NON-CURRENT LIABILITIES:

 

 

 

 

 

 

 

 

Operating lease liability, net of current portion

 

 

718,393

 

 

 

943,702

 

Warrant liability

 

 

3,501,543

 

 

 

667,985

 

Earnout liability

 

 

6,229,390

 

 

 

5,133,428

 

Deferred revenue- non-current

 

 

3,585,344

 

 

 

4,962,126

 

Total liabilities

 

 

22,016,953

 

 

 

23,575,140

 

 

 

 

 

 

 

 

 

 

COMMITMENTS AND CONTINGENCIES (Note 9)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' DEFICIT:

 

 

 

 

 

 

 

 

Preferred stock - no par value, 5,000,000 shares authorized, 0 shares issued and outstanding as of September 30, 2024 and December 31, 2023

 

 

-

 

 

 

-

 

Common stock - $0.0001 par value, 200,000,000 shares authorized, 26,954,871 and 22,812,048 shares issued and outstanding as of September 30, 2024 and December 31, 2023

 

 

2,692

 

 

 

2,281

 

Additional paid in capital

 

 

11,845,413

 

 

 

-

 

Accumulated deficit

 

 

(24,765,218)

 

 

(17,476,700)

Accumulated other comprehensive loss

 

 

(3,470)

 

 

(12,808)

Total stockholders' deficit

 

 

(12,920,583)

 

 

(17,487,227)

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

 

$9,096,370

 

 

$6,087,913

 

 

(1)

Derived from the audited consolidated balance sheet.

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 
3

Table of Contents

  

AIRSHIP AI HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS)

For the three and nine months ended September 30, 2024 and 2023 

(Unaudited)

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

2024

 

 

September 30,

2023

 

 

September 30,

2024

 

 

September 30,

2023

 

NET REVENUES:

 

 

 

 

 

 

 

 

 

 

 

 

Product

 

$1,730,521

 

 

$910,441

 

 

$16,525,515

 

 

$4,415,386

 

Post contract support

 

 

1,137,128

 

 

 

1,473,915

 

 

 

3,318,180

 

 

 

3,677,585

 

 

 

 

2,867,649

 

 

 

2,384,356

 

 

 

19,843,695

 

 

 

8,092,971

 

COST OF NET REVENUES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of Sales

 

 

285,448

 

 

 

439,565

 

 

 

9,381,244

 

 

 

2,575,523

 

Post contract support

 

 

428,820

 

 

 

342,869

 

 

 

1,174,737

 

 

 

1,437,910

 

 

 

 

714,268

 

 

 

782,434

 

 

 

10,555,981

 

 

 

4,013,433

 

GROSS PROFIT

 

 

2,153,381

 

 

 

1,601,922

 

 

 

9,287,714

 

 

 

4,079,538

 

RESEARCH AND DEVELOPMENT EXPENSES

 

 

1,073,735

 

 

 

688,798

 

 

 

2,471,872

 

 

 

2,028,081

 

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

 

 

2,667,130

 

 

 

2,142,327

 

 

 

8,829,544

 

 

 

8,067,343

 

TOTAL OPERATING EXPENSES

 

 

3,740,865

 

 

 

2,831,125

 

 

 

11,301,416

 

 

 

10,095,424

 

OPERATING LOSS

 

 

(1,587,484)

 

 

(1,229,203)

 

 

(2,013,702)

 

 

(6,015,886)

OTHER INCOME (EXPENSE):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain (loss) from change in fair value of earnout liability

 

 

5,511,961

 

 

 

-

 

 

 

(1,095,962)

 

 

-

 

Gain (loss) from change in fair value of warrant liability

 

 

2,471,186

 

 

 

-

 

 

 

(2,833,558)

 

 

-

 

Gain (loss) from change in fair value of convertible debt

 

 

370,548

 

 

 

(400,921)

 

 

(141,636)

 

 

(400,921)

Loss on note conversion

 

 

(434,797)

 

 

-

 

 

 

(593,591)

 

 

-

 

Interest expense, net

 

 

(133,824)

 

 

(33,761)

 

 

(587,149)

 

 

(57,830)

Other income (expense)

 

 

16,366

 

 

 

(2,722)

 

 

(22,922)

 

 

(7,425)

Total other income (expense), net

 

 

7,801,440

 

 

 

(437,404)

 

 

(5,274,818)

 

 

(466,176)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME (LOSS) BEFORE PROVISON FOR INCOME TAXES

 

 

6,213,956

 

 

 

(1,666,607)

 

 

(7,288,520)

 

 

(6,482,062)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INCOME (LOSS)

 

 

6,213,956

 

 

 

(1,666,607)

 

 

(7,288,520)

 

 

(6,482,062)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OTHER COMPREHENSIVE INCOME (LOSS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation income (loss), net

 

 

354

 

 

 

(2,410)

 

 

9,338

 

 

 

40,141

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL COMPREHENSIVE INCOME (LOSS)

 

$6,214,310

 

 

$(1,669,017)

 

$(7,279,182)

 

$(6,441,921)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INCOME (LOSS) PER SHARE:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$0.25

 

 

$(0.07)

 

$(0.31)

 

$(0.28)

Diluted

 

$0.17

 

 

$(0.07)

 

$(0.31)

 

$(0.28)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

24,696,425

 

 

 

22,812,048

 

 

 

23,609,189

 

 

 

22,812,048

 

Diluted

 

 

35,445,694

 

 

 

22,812,048

 

 

 

23,609,189

 

 

 

22,812,048

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 
4

Table of Contents

  

AIRSHIP AI HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT 

(Unaudited)

 

 

 

 

 

 

Common

 

 

Additional

 

 

 

 

 

Other

 

 

Total

 

 

 

Common

 

 

Stock

 

 

Paid in

 

 

Accumulated

 

 

Comprehensive

 

 

Stockholders'

 

 

 

Stock

 

 

$

 

 

Capital

 

 

Deficit

 

 

Income (Loss)

 

 

Deficit

 

Balance as of January 1, 2023

 

 

22,812,048

 

 

$2,281

 

 

$1,963,727

 

 

$(10,314,313)

 

$(10,106)

 

$(8,358,411)

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

136,709

 

 

 

-

 

 

 

-

 

 

 

136,709

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,712,176)

 

 

-

 

 

 

(1,712,176)

Balance as of March 31, 2023

 

 

22,812,048

 

 

 

2,281

 

 

 

2,100,436

 

 

 

(12,026,489)

 

 

(10,106)

 

 

(9,933,878)

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

136,709

 

 

 

-

 

 

 

-

 

 

 

136,709

 

Stock based compensation- warrants

 

 

-

 

 

 

-

 

 

 

2,136,115

 

 

 

-

 

 

 

-

 

 

 

2,136,115

 

Foreign currency translation gain

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

42,551

 

 

 

42,551

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3,103,279)

 

 

-

 

 

 

(3,103,279)

Balance as of June 30, 2023

 

 

22,812,048

 

 

 

2,281

 

 

 

4,373,260

 

 

 

(15,129,768)

 

 

32,445

 

 

 

(10,721,782)

Stock-based compensation- stock option grants

 

 

-

 

 

 

-

 

 

 

164,110

 

 

 

-

 

 

 

-

 

 

 

164,110

 

Foreign currency translation gain

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,410)

 

 

(2,410)

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,666,607)

 

 

-

 

 

 

(1,666,607)

Balance as of September 30, 2023

 

 

22,812,048

 

 

 

2,281

 

 

 

4,537,370

 

 

 

(16,796,375)

 

 

30,035

 

 

 

(12,226,689)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of January 1, 2024

 

 

22,812,048

 

 

 

2,281

 

 

 

-

 

 

 

(17,476,700)

 

 

(12,808)

 

 

(17,487,227)

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

268,989

 

 

 

-

 

 

 

-

 

 

 

268,989

 

Issuance of common stock for prior period services

 

 

15,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of common stock for conversion of debt

 

 

169,204

 

 

 

17

 

 

 

835,593

 

 

 

-

 

 

 

-

 

 

 

835,610

 

Issuance of common stock for exercise of warrants

 

 

162,867

 

 

 

16

 

 

 

293,233

 

 

 

-

 

 

 

-

 

 

 

293,249

 

Foreign currency translation gain

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,239

 

 

 

3,239

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(31,964,469)

 

 

-

 

 

 

(31,964,469)

Balance as of March 31, 2024

 

 

23,159,119

 

 

 

2,314

 

 

 

1,397,815

 

 

 

(49,441,169)

 

 

(9,569)

 

 

(48,050,609)

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

261,636

 

 

 

-

 

 

 

-

 

 

 

261,636

 

Issuance of common stock for services

 

 

50,000

 

 

 

5

 

 

 

198,495

 

 

 

-

 

 

 

-

 

 

 

198,500

 

Issuance of common stock for exercise of warrants

 

 

100

 

 

 

-

 

 

 

800

 

 

 

-

 

 

 

-

 

 

 

800

 

Issuance of common stock for stock options exercise

 

 

294,448

 

 

 

29

 

 

 

146,944

 

 

 

-

 

 

 

-

 

 

 

146,973

 

Issuance of common stock for debt interest payment

 

 

232,360

 

 

 

23

 

 

 

1,008,400

 

 

 

-

 

 

 

-

 

 

 

1,008,423

 

Foreign currency translation gain

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

5,745

 

 

 

5,745

 

Net income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

18,461,995

 

 

 

-

 

 

 

18,461,995

 

Balance as of June 30, 2024

 

 

23,736,027

 

 

 

2,371

 

 

 

3,014,090

 

 

 

(30,979,174)

 

 

(3,824)

 

 

(27,966,537)

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

273,170

 

 

 

-

 

 

 

-

 

 

 

273,170

 

Stock based compensation- warrants

 

 

-

 

 

 

-

 

 

 

284,478

 

 

 

-

 

 

 

-

 

 

 

284,478

 

Issuance of common stock for stock options exercise

 

 

30,000

 

 

 

3

 

 

 

49,197

 

 

 

-

 

 

 

-

 

 

 

49,200

 

Issuance of common stock for conversion of debt

 

 

305,961

 

 

 

30

 

 

 

934,766

 

 

 

-

 

 

 

-

 

 

 

934,796

 

Issuance of common stock and warrants for offering, net

 

 

2,882,883

 

 

 

288

 

 

 

7,289,712

 

 

 

-

 

 

 

-

 

 

 

7,290,000

 

Foreign currency translation gain

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

354

 

 

 

354

 

Net income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

6,213,956

 

 

 

-

 

 

 

6,213,956

 

Balance as of September 30, 2024

 

 

26,954,871

 

 

$2,692

 

 

$11,845,413

 

 

$(24,765,218)

 

$(3,470)

 

$(12,920,583)

 

The shares of the Company’s common stock, prior to the merger, have been retroactively restated as shares

reflecting the exchange ratio of approximately 1.7581 established in the merger described in Note 1.

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 
5

Table of Contents

  

AIRSHIP AI HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS 

For the nine months ended September 30, 2024 and 2023 

(Unaudited)

 

 

 

Nine Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

2024

 

 

September 30,

2023

 

 

 

 

 

 

 

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

Net loss

 

$(7,288,520)

 

$(6,482,062)

Adjustments to reconcile net loss to net cash used in operating activities

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

1,861

 

 

 

11,160

 

Stock-based compensation

 

 

803,797

 

 

 

479,913

 

Stock-based compensation- warrants

 

 

284,478

 

 

 

2,136,115

 

Amortization of operating lease right of use asset

 

 

174,914

 

 

 

513,234

 

Accelerated amortization of ROU asset - lease termination

 

 

-

 

 

 

265,130

 

Gain from lease termination

 

 

-

 

 

 

(344,093)

Issuance of common stock for services

 

 

198,500

 

 

 

-

 

Noncash interest expense

 

 

520,758

 

 

 

-

 

Loss from change in fair value of warrant liability

 

 

2,833,558

 

 

 

-

 

Loss from change in fair value of earnout liability

 

 

1,095,962

 

 

 

-

 

Loss from change in fair value of convertible note

 

 

141,636

 

 

 

400,921

 

Loss on note conversions

 

 

593,591

 

 

 

-

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

527,042

 

 

 

104,814

 

Prepaid expenses and other

 

 

132,512

 

 

 

(295)

Other assets

 

 

26,901

 

 

 

(255,431)

Operating lease liability

 

 

(132,525)

 

 

(461,203)

Payroll and income tax receivable

 

 

7,230

 

 

 

960,383

 

Accounts payable - trade and accrued expenses

 

 

(2,261,087)

 

 

377,519

 

Accrued income tax expense

 

 

-

 

 

 

(10,000)

Deferred revenue

 

 

(2,058,893)

 

 

(220,144)

NET CASH USED IN OPERATING ACTIVITIES

 

 

(4,398,285)

 

 

(2,524,039)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

Issuance of common stock and warrants for offering, net

 

 

7,290,000

 

 

 

-

 

Proceeds from convertible promissory note

 

 

-

 

 

 

1,984,582

 

Proceeds from warrant exercise

 

 

294,049

 

 

 

-

 

Advances from founders, net

 

 

-

 

 

 

1,150,000

 

Proceeds from stock option exercises

 

 

196,173

 

 

 

-

 

Repayment of small business loan and line of credit

 

 

-

 

 

 

(424,540)

 

 

 

 

 

 

 

 

 

NET CASH PROVIDED BY FINANCING ACTIVITIES

 

 

7,780,222

 

 

 

2,710,042

 

 

 

 

 

 

 

 

 

 

NET INCREASE IN CASH AND CASH EQUIVALENTS

 

 

3,381,937

 

 

 

186,003

 

 

 

 

 

 

 

 

 

 

Effect from exchange rate on cash

 

 

9,338

 

 

 

(2,244)

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS, beginning of period

 

 

3,124,413

 

 

 

298,614

 

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS, end of period

 

$6,515,688

 

 

$482,373

 

 

 

 

 

 

 

 

 

 

Supplemental disclosures of cash flow information:

 

 

 

 

 

 

 

 

Interest paid

 

$-

 

 

$21,438

 

Taxes paid

 

$2,410

 

 

$17,247

 

 

 

 

 

 

 

 

 

 

Noncash investing and financing

 

 

 

 

 

 

 

 

Elimination of advances to founders in connection with contribution of Zeppelin by shareholders

 

$-

 

 

$1,100,000

 

Elimination of payables to founders in connection with contribution of Zeppelin by shareholders

 

$-

 

 

$1,100,000

 

Issuance of common stock for debt interest payment

 

$

487,642

 

 

$

-

 

Issuance of common stock for debt conversion

 

$1,770,340

 

 

$-

 

Recognition of warrant liability

 

$-

 

 

$15,418

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 
6

Table of Contents

  

AIRSHIP AI HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

1. Organization

 

Airship AI Holdings, Inc. (the “Company” or “Airship”) is a holding company incorporated in Delaware that executes business through its wholly owned subsidiary, Airship AI, Inc. (“Airship AI”). Prior to the formation of Super Simple AI, Inc. in 2022, the Company operated as Airship AI, Inc. (formerly known as JDL Digital Systems, Inc.). On March 7, 2023, Super Simple AI, Inc. changed its name to Airship AI Holdings, Inc. Super Simple AI, Inc. was formed in January 2022 through a share exchange with JDL Digital Systems, Inc. JDL Digital Systems, Inc. was incorporated under the laws of the State of Washington on June 30, 2003.

 

On December 21, 2023, the Company completed the merger contemplated by the Merger Agreement, dated as of June 27, 2023 and amended on September 22, 2023, by and among BYTE Acquisition Corp. (“BYTS”), BYTE Merger Sub, Inc., a Washington corporation and a direct, wholly-owned subsidiary of BYTS (“Merger Sub”), and Airship AI.

 

Effective December 21, 2023, Merger Sub merged with and into Airship AI with Airship AI as the surviving corporation. Thus, Airship AI became a wholly-owned subsidiary of the Company. In connection with the merger, Airship AI changed its name from “Airship AI Holdings, Inc.” to “Airship AI, Inc.” See Note 11 —Reverse Recapitalization for additional information.

 

Fair Value Transactions

 

As a result of the merger, the Company entered into the following transactions that were measured at fair value and vary quarterly with the share price and other items. Any change is non-cash and is recorded as a gain or loss in other income (expense). See Note 14– Fair Value Measurements for more information.

 

 

 

Liability as of

 

 

Liability as of

 

 

 

September 30, 2024

 

 

December 31, 2023

 

 

 

 

 

 

 

 

Earnout liability

 

$6,229,390

 

 

$5,133,428

 

Senior Secured Convertible Promissory Notes

 

 

1,793,360

 

 

 

2,825,366

 

Warrant liability (Public Warrants)

 

 

3,393,393

 

 

 

646,428

 

Warrant liability (Private Warrants)

 

 

108,150

 

 

 

21,557

 

Total liabilities measured at fair value

 

$11,524,293

 

 

$8,626,779

 

 

 

 

 

 

 

 

 

 

Other loss related to instruments recorded at fair value during the nine months ended September 30, 2024 and 2023

 

$(4,071,156)

 

$(400,921)

  

Common Stock and Warrant Offering

 

On September 3, 2024, the Company closed an $8 million public offering with net proceeds of approximately $7.3 million, after deducting the estimated offering expenses payable by the Company, including the placement agent fees. The offering consisted of 2,882,883 shares of its common stock and warrants to purchase up to an aggregate of 2,882,883 shares of its common stock at a combined public offering price of $2.775 per share and associated common stock warrant. The warrants have an exercise price of $2.65 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance. The warrants are classified as a component of permanent equity because they are freestanding financial instruments that are legally detachable and separately exercisable from the shares of common stock with which they were issued, do not embody an obligation for the Company to repurchase its shares, and permit the holders to receive a fixed numbers of shares of common stock upon exercise.

 

The Company intends to use the net proceeds from the offering for working capital and general corporate purposes, including cost of goods sold purchases, personnel and product development.

 

 
7

Table of Contents

 

Private Placement and Public Warrants

 

At the merger closing, the Company assumed 515,000 private placement warrants and 16,184,612 public warrants. On June 3, 2024, the Company permanently reduced the exercise price of such warrants from $11.50 per share to an exercise price of $7.80 per share. The purpose of this reduced exercise price was to potentially raise proceeds received from the exercise of such warrants, if any, for working capital and general corporate purposes. As of September 30, 2024, there were 515,000 private placement warrants and 16,159,012 public warrants outstanding. See Note 12– Private Placement and Public Warrants for more information.

 

Business

 

The Company is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources.

 

The Company solves these challenges by structuring “dark” or unstructured data at the edge, the location at which the data is generated and collected, and leveraging purpose-built AI models. Unstructured, or “dark” data, which is typically categorized as qualitative data, cannot be processed and analyzed via conventional data tools and methods. Conversely, structured data, typically categorized as quantitative data, is highly organized and easily decipherable by machine learning algorithms.

 

Structuring and then analyzing data using AI models at the edge, versus transmitting the data from the edge back to a central processing location for structuring and analysis, enables real-time decision making and data-driven operational efficiency.

 

The Company specializes in ingesting all available metadata from edge-based sensors used by government and law enforcement agencies around the world, including surveillance cameras (video), audio, telemetry, acoustic, seismic, and autonomous devices, along with large commercial corporations with fundamentally similar capabilities and requirements.

 

Data generated by these edge-based sensors, including video, can then be run through the Company’s trained AI models to detect objects present within the video frame. Once an object is detected, for example an automobile, additional identifying characteristics of the object can be extracted from the image including the license plate characters and the make, model, and color of the automobile. This process of analyzing, logging and categorizing ingested data is referred to as “structuring” the data.

 

Airship AI’s software allows customers to view structured data both in real-time as well as to conduct searches on the structured data at a later point in time. Real-time structured data use includes, for example, alarms on a specific license plate or a specific make, model or color of automobile. Non-real-time structured data use includes, for example, searching a database of video data that has been previously ingested and stored to find instances of a particular license plate being visible, along with other logged vehicle characteristics such as make, model and color of an automobile.

 

Additional edge deployed AI models enable similar object detection and recognition of common and custom trained objects, such as an aircraft, boat, person, animal, bag, or weapon. Airship AI’s models provide similar data points for these object types allowing analysts the ability to be notified in real-time of the detection of a specified object and similarly search for historically detected objects. Examples include detecting aircrafts and boats along with their respective tail numbers and hull registration numbers.

 

The Company’s AI modelling process starts with pre-trained AI models from its technology ecosystem partners which the Company then customizes using proprietary datasets tailored towards its customers’ unique workflow requirements. Where customers have pre-existing AI models or engines, the Company integrates those models or engines into its edge platform allowing customers to leverage proprietary models within the Airship AI software ecosystem.

 

 
8

Table of Contents

 

The Company’s primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where they need it, using a highly secure permissioned based architecture.

 

The Company employed fifty one employees as of September 30, 2024. The employees are headquartered in Redmond, WA and are supported by a growing team at its Customer Center of Excellence located in Charlotte, NC. The Company employed eight research and development personnel in Taiwan as of September 30, 2024.

 

2. Summary of Significant Accounting Policies

 

Basis of Presentation and Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany accounts and transactions have been eliminated. The preparation of these consolidated financial statements were prepared in conformity with U.S. generally accepted accounting principles (“GAAP”).

 

For periods prior to the merger, the reported share and per share amounts have been retroactively converted by the applicable exchange ratio with the exception of the authorized shares and shares reserved for issuance. See Note 11—Reverse Recapitalization for additional information.

 

Functional Currency

 

The Company’s  reporting  currency  is the U.S.  Dollar. The Company’s  functional currency for U.S. operations is  the U.S. Dollar. The operations of Zeppelin Worldwide, Inc. and its subsidiary, Zeppelin Taiwan, Ltd. (together “Zeppelin”) use the Taiwan Dollar as its functional currency. At each period end, Zeppelin’s balance sheet is translated into U.S. Dollars based upon the period end exchange rate, while their statements of operations and comprehensive loss and statements of cash flows are translated into U.S. Dollars based upon an average exchange rate during the period.

 

Cash and Cash Equivalents

 

The Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash equivalents. The Company maintains cash balances at various financial institutions. Balances at US banks are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk for cash on deposit.

 

Revenue Recognition and Deferred Revenue

 

The Company primarily generates revenue from sales of systems and products and the related post contract support to customers. The Company’s primary systems and products include Outpost AI, Acropolis and Airship Command. To date, the majority of the Company’s product revenue that has been recognized consists primarily of a bundled offering of hardware and software which delivers on premise solutions to its customers. Separate limited software subscription services have been delivered to customers including those customers that are able to operate in a cloud based environment. The transaction price recognized as revenue represents the amount the Company expects to be entitled to and is primarily comprised of product revenue, net of returns and variable consideration, including sales incentives provided to customers. Payment is typically due within 30 to 90 calendar days of the invoice date.

 

The Company recognizes revenue when promised goods or services are transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services by following a five-step process: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price, and (5) recognize revenue when or as the Company satisfies a performance obligation, as further described below.

 

 
9

Table of Contents

 

Product Revenue

 

Product revenue is derived primarily from sales of the Company’s system offerings, Outpost AI, Acropolis and Airship Command. The Company recognizes product revenue at a point in time when title transfers, when the products are shipped, or when control of the system is transferred to the customer, which usually is upon delivery of the system and when contractual performance obligations have been satisfied.

 

Post Contract Support Revenue

 

Post Contract Support (“PCS”) revenue is derived primarily from the Company’s support and software maintenance agreements (“SMA”). The Company’s PCS includes the right to receive, on a when and if available basis, future unspecified firmware upgrades and features as well as bug fixes, and email and telephone support. The Company allocates a portion of the transaction price to the PCS performance obligation based on a cost-plus methodology and recognizes the associated revenue on a straight-line basis over the estimated term of the support period. The Company’s support contracts are typically one to five years with an average of four years, payment is due within 30 to 90 calendars days of the invoice date and may include options to renew. For the three months ended September 30, 2024 and 2023, the Company recognized revenue of $95,120 and $60,367, respectively, related to one-year support contracts. For the three months ended September 30, 2024 and 2023, the Company recognized revenue of $1,042,008 and $1,413,548, respectively, related to multi-year support contracts. For the nine months ended September 30, 2024 and 2023, the Company recognized revenue of $234,717 and $141,582, respectively, related to one-year support contracts. For the nine months ended September 30, 2024 and 2023, the Company recognized revenue of $3,083,464 and $3,536,003 respectively, related to multi-year support contracts.

 

Other Services

 

The Company earns other service revenues from installation services, training and licensing which are short-term in nature and revenue for these services are recognized at the time of performance when the service is provided.

 

Contracts with Multiple Performance Obligations

 

The Company’s contracts with customers often contain multiple performance obligations that can include three separate obligations: (i) a hardware component (which may be bundled with hardware accessories) and the embedded firmware essential to the functionality of the hardware component delivered at the time of sale; (ii) the right to the Company’s downloadable free application and software solutions, and (iii) the right for the customer to receive post contract support (“PCS”) after the initial sale. The Company’s products and PCS offerings have significant standalone functionalities and capabilities. Accordingly, the products are distinct from the Company’s PCS services as customers can benefit from the products without the PCS services and such PCS services are separately identifiable within the contracts. The Company accounts for multiple agreements with a single customer as a single contract if the contractual terms and/or substance of those agreements indicate that they may be so closely related that they are, in effect, parts of a single contract. The amount of consideration the Company expects to receive in exchange for delivering on the contract is allocated to each performance obligation based on its relative standalone selling price.

 

The Company establishes the standalone selling price using the prices charged for a deliverable when sold separately. If the standalone selling price is not observable through past transactions, the Company estimates the standalone selling price based on its pricing model and offering type (products or PCS services).

 

The Company has elected the practical expedient to not assess whether a contract has a significant financing component as the Company’s standard payment terms are less than one year.

 

The Company sells its products primarily through a direct sales force. The Company considers revenue to be earned when all of the following criteria are met:

 

 

The Company has a contract with a customer that creates enforceable rights and obligations,

 

 

 

 

Promised performance obligations are identified,

 

 

 

 

The transaction price, or the amount the Company expects to receive, is determinable and

 

 

 

 

The Company has satisfied the performance obligations to the customer.

 

 
10

Table of Contents

 

Transfer of control is evidenced upon passage of title and risk of loss to the customer unless the Company is required to provide additional services.

 

The Company’s short-term and long-term deferred revenue balances totaled $3,326,543 and 3,585,344 as of September 30, 2024. The Company’s short-term and long-term deferred revenue balances totaled $4,008,654 and $4,962,126 as of December 31, 2023. Of the deferred revenue balance of $8,970,780 as of January 1, 2024, the Company recognized approximately $933,675 and $3,061,613 during the three and nine months ended September 30, 2024, respectively.

 

Accounts Receivable and Provision for Credit Losses

 

The Company generally sells its products to large governmental entities and large corporations in the United States. Accounts receivable are recorded at invoiced amounts and are non-interest bearing.

 

The Company adopted Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments — Credit Losses (codified as Accounting Standards Codification (“ASC”) 326) on January 1, 2023. ASC 326 adds to U.S. GAAP the current expected credit loss (“CECL”) model, a measurement model based on expected losses rather than incurred losses. Prior to the adoption of ASC 326, the Company evaluated receivables regularly and adjusted the allowance for doubtful accounts accordingly. The Company determined estimates of uncollectible accounts receivable based primarily on actual historical bad debt and sales return trends, customers financial condition and general economic conditions. Under the application of ASC 326, the Company’s historical credit loss experience provides the basis for the estimation of expected credit losses, as well as current economic and business conditions, and anticipated future economic events that may impact collectability. In developing its expected credit loss estimate, the Company evaluated the appropriate grouping of financial assets based upon its evaluation of risk characteristics, including consideration of the types of products and services sold. Account balances are written off against the allowance for expected credit losses after all means of collection have been exhausted and the potential for recovery is considered remote.

 

Occasionally certain long-standing customers, who routinely place large orders, will have unusually large receivables balances relative to the total gross receivables. Management monitors the payments for these large balances closely and very often requires payment of existing invoices before shipping new sales orders. As of September 30, 2024 and December 31, 2023, the Company did not have a reserve for credit losses as all accounts receivable are considered collectible. Accounts receivable balances as of September 30, 2024 and December 31, 2023 were $1,121,862 and $1,648,904, respectively.

 

Concentration of Credit and Sales Risk

 

The Company sells its product to commercial and government customers under agreements that are normally paid within 30 days of contract completion.    

 

For the nine months ended September 30, 2024, the Company had revenue from sixty eight customers and one customer represented 63% of total revenue, although such a high level of customer concentration is not typical. The primary reason for the high level of customer concentration for the nine months ended September 30, 2024 was due to one large order received in late 2023 which was fulfilled in the nine months ended September 30, 2024. As of September 30, 2024, five customers represent approximately 21%, 20%, 16%, 12% and 11% of outstanding account receivables. Due to the nature of the customers and timely payment history, customer concentration and credit risk in account receivables is estimated to be minimal.

 

For the nine months ended September 30, 2023, two customers represent approximately 49% and 16% of total revenue. As of December 31, 2023, three customers represent approximately 51%, 26% and 17% of outstanding account receivables. Due to the nature of the customers and timely payment history, customer concentration and credit risk in account receivables is estimated to be minimal.

 

 
11

Table of Contents

 

Inventory

 

The Company’s purchase of inventory, primarily computer servers, is undertaken to match purchase orders received from customers. Upon receipt of inventory, the Company generally configures the servers and loads proprietary software onto the servers before shipping out. The Company holds inventory for a short period of time and as of September 30, 2024 and December 31, 2023, it had no inventory in stock. Inventory value is primarily material costs and is valued at the lower of cost (first in, first out method) or net realizable value.

 

Long-Lived Assets

 

The Company reviews its long-lived assets for impairment annually or when changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets under certain circumstances are reported at the lower of carrying amount or fair value. Assets to be disposed of and assets not expected to provide any future service potential to the Company are recorded at the lower of carrying amount or fair value (less the projected cost associated with selling the asset). To the extent carrying values exceed fair values, an impairment loss is recognized in operating results. The Company recorded impairment losses of $0 for the nine months ended September 30, 2024 and 2023.

 

Research and Development Expenses

 

Research and development expenses consist of the cost of employees, consultants and contractors who design, engineer and develop new products and processes as well as materials, supplies and facilities used in producing prototypes.

 

The Company’s current research and development efforts are primarily focused on improving the Company’s products. The Company is also actively involved in identifying new applications. The Company’s current internal team along with outside consultants has considerable experience working with the application of the Company’s technologies and their applications. The Company engages third party experts as required to supplement the Company’s internal team. The Company believes that continued development of new and enhanced technologies is essential to the Company’s future success. The Company incurred research and development expenses of $1,073,735 and $688,798 for the three months ended September 30, 2024 and 2023, respectively, on development activities. The Company incurred research and development expenses of $2,471,872 and $2,028,081 for the nine months ended September 30, 2024 and 2023, respectively, on development activities.

 

Software Development Costs

 

Costs incurred in the development of software programs for the Company’s products are charged to operations as incurred until technological feasibility of the software has been established. Generally, technological feasibility is established when the software module performs its primary functions described in its original specifications, contains features required for it to be usable in a production environment, is completely documented and the related hardware portion of the product is complete. After technological feasibility is established, any additional costs are capitalized. Capitalization of software costs ceases when the software is substantially complete and is ready for its intended use. No software development costs have been capitalized as of September 30, 2024 and December 31, 2023.

 

Cost of Net Revenues

 

Cost of net revenues for products includes components and freight. Cost of net revenues for post contract support and other services includes primarily the cost of personnel and personnel-related expenses to conduct implementations and ongoing client support.

 

Advertising

 

Advertising costs are charged to selling, general and administrative expenses as incurred. Advertising and marketing costs for the three months ended September 30, 2024 and 2023 were $41,107 and $2,587, respectively. Advertising and marketing costs for the nine months ended September 30, 2024 and 2023 were $130,428 and $55,916, respectively.

 

 
12

Table of Contents

 

Shipping and Handling of Products

 

Amounts billed to customers for shipping and handling of products are included in net revenues. Costs incurred related to shipping and handling of products are included in cost of revenues.

 

Fair Value Measurements

 

Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy, which requires classification based on observable and unobservable inputs when measuring fair value. The fair value hierarchy distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs). The hierarchy consists of three levels:

 

Level 1 — Quoted prices in active markets for identical assets and liabilities;

 

Level 2 — Inputs other than level one inputs that are either directly or indirectly observable; and

 

Level 3 — Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

The recorded value of other financial assets and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other current assets, accounts payable and accrued expenses approximate the fair value of the respective assets and liabilities as of September 30, 2024 and December 31, 2023 are based upon the short-term nature of the assets and liabilities. The Company recorded its Senior Secured Convertible Promissory Note, earnout liability (unvested earnout shares), and the warrants that were issued with the Convertible Promissory Note at fair value, remeasured on a recurring basis and considered them as Level 3 instruments. The public and private warrants were considered Level 1 and 2 instruments, respectively. The fair value of the vested earnout shares was considered a Level 1 instrument. The method of determining the fair value of the Senior Secured Convertible Promissory Note and attached warrants is described below.

 

The Company classifies as liabilities any contracts that (i) require net-cash settlement (including a requirement to net- cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).

 

Accounting for Senior Secured Convertible Promissory Notes at Fair Value

 

The Company has elected the fair value option to account for the senior secured convertible note that was issued on June 22, 2023 and the convertible notes that were issued in October and November 2023 with changes in fair value recorded in the Consolidated Statements of Operations and Comprehensive Loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes are recognized in earnings as incurred and not deferred. Values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the liability. Considerable judgment is necessary to interpret market data and determine an estimated fair value. The use of different market assumptions or valuation methods may have a material effect on the estimated fair values. As of September 30, 2024, the Company has used a Monte Carlo simulation pricing model that factors in potential outcomes being consummated, such as the convertible notes being repaid in cash and the convertible notes being converted to common stock. All of these scenarios take into consideration the terms and conditions of the underlying convertible notes plus potential changes in the underlying value of the common stock. For the nine months ended September 30, 2024 and 2023, the Company recognized an unrealized loss of $141,636 and $400,921 for the change in fair value of the notes and is included in the Consolidated Statements of Operations and Comprehensive Loss. The Company believes accounting for the convertible notes at fair value better aligns the measurement methodologies of assets and liabilities, which may mitigate certain earnings volatility.

 

 
13

Table of Contents

 

Derivative Liabilities and Earnout Liabilities

 

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants and  earnout shares to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company classifies as liabilities any contracts that (i) require net-cash settlement (including a requirement to net- cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).

 

At the merger closing, the Company assumed 515,000 private placement warrants and 16,184,612 public warrants. On June 3, 2024, the Company permanently reduced the exercise price of such warrants from $11.50 per share to an exercise price of $7.80 per share. The purpose of this reduced exercise price was to potentially raise proceeds received from the exercise of such warrants, if any, for working capital and general corporate purposes. As of September 30, 2024, there were 515,000 private placement warrants and 16,159,012 public warrants outstanding. See Note 12– Private Placement and Public Warrants for more information.

 

Upon consummation of the merger, the Company evaluated the warrants and concluded that they did not meet the criteria to be classified within the stockholders’ deficit. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The initial estimated fair value of the warrants was measured using a Monte Carlo simulation. The subsequent estimated fair value of the public warrants is based on the listed price in an active market for such warrants while the fair value of the private placement warrants continues to be measured using a Monte Carlo simulation with the key inputs being directly or indirectly observable public warrants listed price. Since the public and private warrants meet the definition of a derivative, the Company recorded the public and private warrants as liabilities on the consolidated balance sheet at fair value upon the merger closing, with subsequent changes in the fair value recognized in the consolidated statements of operations at each reporting date.

 

At the closing of the merger, the Airship AI securityholders that hold shares of common stock of Airship AI, Airship AI options, Airship AI earnout warrants or Airship AI SARs have the contingent right to receive up to 5.0 million additional shares of common stock, subject to certain contingencies.  These earnout shares have been categorized into two components: (i) the vested shares that are associated with stockholders with vested equity at the closing of the merger that will be earned upon achievement of the earnout milestones and (ii) the unvested shares associated with stockholders with unvested equity at the closing of the merger that will be earned over the remaining service period with the Company on their unvested equity shares and upon achievement of the earnout milestones.

 

The earnout shares associated with vested shares are recognized as derivative liabilities in accordance with ASC 815-40, as the events that determine the number of earnout shares required to be released or issued, as the case may be, include events that were not solely indexed to the fair value of common stock of the Company. The earnout shares were measured at the merger closing and subsequently measured at each reporting date until settled or when they met the criteria for equity classification. Accordingly, the Company recognizes the earnout shares as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The earnout shares were valued using a Monte Carlo analysis.

 

At the closing of the merger, the unvested earnout shares were considered to be equity instruments and valued at approximately $2,675,000. This amount will be recognized as stock-based compensation going forward over the five-year vesting period.

 

Derivative warrant and earnout shares liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of significant current assets or require the creation of current liabilities.

 

 
14

Table of Contents

 

Stock-Based Compensation

 

The Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted stock, stock appreciation rights, incentive stock options, nonqualified stock options, unvested earnout shares and warrants to purchase shares of common stock at the fair market value at the time of grant. Stock-based compensation cost is measured by the Company at the grant date and the fair value of the award is recognized as an expense, over the requisite service period which is generally the vesting period. The Company adjusts stock-based compensation for changes to the estimate of expected equity award forfeitures based on actual forfeiture experience. The effect of adjusting the forfeiture rate is recognized in the period the forfeiture estimate is changed.

 

Income Taxes

 

Income taxes are accounted for using the liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The Company’s ability to realize deferred tax assets depends upon future taxable income, as well as the limitations discussed below. For financial reporting purposes, a deferred tax asset must be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized prior to expiration. The Company considers historical and future taxable income, future reversals of existing taxable temporary differences, taxable income in prior carryback years, and ongoing tax planning strategies in assessing the need for valuation.

 

Comprehensive Gain

 

Comprehensive gain is defined as the change in equity of a business during a period from non-owner sources. There was other comprehensive gain of $354 and loss of $2,410 related foreign exchange translation for the three months ended September 30, 2024 and 2023, respectively. There was other comprehensive gain of $9,338 and gain of $40,141 related foreign exchange translation for the nine months ended September 30, 2024 and 2023, respectively.

 

Going Concern Assessment

 

The Company applies Accounting Standards Codification 205-40 (“ASC 205-40”), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which the Financial Accounting Standards Board (“FASB”) issued to provide guidance on determining when and how reporting companies must disclose going concern uncertainties in their consolidated financial statements. ASC 205-40 requires management to perform assessments of an entity’s ability to continue as a going concern within one year of the date of issuance of the entity’s consolidated financial statements (or within one year after the date on which the consolidated financial statements are available to be issued, when applicable). Further, a company must provide certain disclosures if there is “substantial doubt about the entity’s ability to continue as a going concern” and management plans to alleviate the going concern. In November 2024, the Company analyzed its cash requirements and operations at least through November 2025 and has determined that, based upon the Company’s current available cash and operations, the Company has no substantial doubt about its ability to continue as a going concern.

 

Use of Estimates

 

In preparing these consolidated financial statements in conformity with GAAP, management is required to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates and assumptions included in the Company’s consolidated financial statements relate to the calculation of revenue recognition, stock-based compensation, valuation of common stock, valuation of senior secured convertible notes, warrant liability, earnout share liabilities, accruals for potential liabilities including income taxes, valuation of deferred tax assets and valuation assumptions related to share-based compensation.

 

 
15

Table of Contents

 

Income (Loss) Per Share

 

Basic income (loss) per share is based upon the net income (loss) for the three and nine months ended September 30, 2024 and 2023 divided by the weighted average shares of common stock outstanding. Diluted net income per share is determined using the weighted average number of common shares and potential common shares (representing the dilutive effect of stock options, warrants, convertible notes payable and stock appreciation rights) outstanding during the period using the treasury stock method for the three months ended September 30, 2024. Common stock equivalents for the three months ended September 30, 2023 and the nine months ended September 30, 2024 and 2023 are not included in the calculation of diluted earnings (loss) per share given the Company incurred a loss and they are anti-dilutive. See Note 15—Earnings per share.

 

Reportable Segments

 

The Financial Accounting Standards Board, or FASB, Accounting Standard Codification, or ASC, Topic 280, Segment Reporting, requires that an enterprise report selected information about reportable segments in its financial reports issued to its stockholders. Management monitors the revenue and expense components of the various products and services the Company offers, but operations are managed and financial performance is evaluated on a corporation-wide basis in comparison to a business plan which is developed each year. Accordingly, all operations are considered by management to be one operating segment and one reportable segment as contained in the Consolidated Statements of Operations and Comprehensive Loss to the consolidated financial statements.

 

Recent Accounting Pronouncements

 

All recent accounting pronouncements issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

 

3. Advances due to and from Founders

 

Advances due to Founders

 

Prior to 2023, the founders had advanced the Company a net $600,000. In the year ended December 31, 2023, Mr. Huang and Mr. Xu advanced Airship AI a total of $1,350,000 and were repaid a total of $200,000, with $1,750,000 recorded as advances from founders as of December 31, 2023. During 2024, Mr. Huang and Mr. Xu advanced Airship AI $2,100,000 and were repaid $2,100,000, with $1,750,000 recorded as advances from founders as of September 30, 2024. The outstanding advances as of September 30, 2024 are non-interest bearing and the Company expects to pay the balance off within a one year period.

 

Master Loan Agreement

 

On September 27, 2024, the Company entered into a Master Loan Agreement with Mr. Huang, whereby he may provide additional funding of up to $1,500,000 under certain terms and conditions. The Agreement provides for interest of 6%. The Company agreed to pay interest for the 2024 advances (described under Advances to Founders above) of $11,913 and issued warrants to purchase up to 220,000 shares of common stock. The warrants have an exercise price of $2.36 per share, are exercisable immediately upon issuance and will expire in five years following the date of issuance. The $284,478 fair value of the warrant is recorded in permanent equity in the consolidated balance sheets and was fully expensed on the date of grant. There are no outstanding advances under this Master Loan Agreement as of September 30, 2024.

 

4. Revenues

 

Disaggregation of Revenue

 

The Company’s net revenues for the nine months ended September 30, 2024 and 2023 consisted of approximately $16.5 million and $4.4 million, respectively, of hardware and software bundled systems for which revenue is transferred at a point in time The Company’s remaining net revenue for the nine months ended September 30, 2024 and 2023 of approximately $3.3 million and $3.7 million, respectively, related to PCS revenue and other services which are transferred over time. Within each product category, contract terms, conditions and economic factors affecting the nature, amount, timing, and uncertainty around revenue recognition and cash flow are substantially similar.

 

 
16

Table of Contents

 

Contract Balances

 

A receivable is recognized in the period the Company delivers goods or provides services or when the Company’s right to consideration is unconditional. The Company usually does not record contract assets because the Company has an unconditional right to payment upon satisfaction of the performance obligation, and therefore, a receivable is more commonly recorded than a contract asset. Receivables are generally paid within thirty days and there is no financing element to the customer contracts. As of September 30, 2024 and December 31, 2023, there were no unbilled receivable balances.

 

The Company’s short-term and long-term deferred revenue balances totaled $3,326,543 and $3,585,344 as of September 30, 2024. The Company’s short-term and long-term deferred revenue balances totaled $4,008,654 and $4,962,126 as of December 31, 2023. Of the deferred revenue balance of $8,970,780 as of January 1, 2024, the Company recognized approximately $933,675 and $3,061,613 during the three and nine months ended September 30, 2024, respectively.

 

Remaining Performance Obligations

 

As of September 30, 2024, the Company had approximately $6.9 million of remaining performance obligations, which were comprised of deferred service contracts not yet delivered. The Company expects to recognize approximately 15% of its remaining performance obligations as revenue in fiscal 2024 and the remaining 85% in fiscal 2025 and years thereafter.

 

Costs to Obtain or Fulfill a Contract

 

The Company does not pay any material variable compensation to obtain a customer contract. Additionally, the majority of the Company’s cost of fulfillment as a seller of products is classified as inventory and then cost of revenue when the product is sold. Other costs of contract fulfillment such as software maintenance are expensed in the period incurred and align with when the revenue is amortized.

 

5. Notes Payable and Convertible Notes Payable

 

On June 22, 2023, the Company issued a $2,000,000 senior secured convertible promissory note to Platinum Capital Partners, Inc.

 

On February 2, 2024, the Company issued an amended and restated senior secured convertible promissory note to Platinum in the principal amount of $2,000,000. Interest accrued on the Platinum convertible note at the rate of 6% per annum calculated on the basis of 360 days. At the option of Platinum, the $2,000,000 principal amount of the note plus any accrued but unpaid interest is convertible into shares of the Company’s common stock at a conversion price per share equal to the lower of (i) $3.69717, subject to appropriate adjustment as provided in the note, and (ii) 65% of the VWAP of the common stock for the five trading days immediately prior to any conversion, but in no event below $2.27518, subject to appropriate adjustment as provided in the note. The note contains “weighted average” anti-dilution protection for issuances of shares of common stock or common stock equivalents at a price less than the conversion price then in effect.

 

In connection with the issuance of the Platinum convertible note, the Company issued to Platinum an amended and restated common stock purchase warrant dated February 2, 2024, to purchase 189,334 shares of the Company’s common stock at an exercise price per share of $3.69717. On March 18, 2024, Platinum exercised the Platinum warrant and received 137,367 shares of common stock. Platinum forfeited 51,967 shares.

 

 
17

Table of Contents

 

On June 22, 2024, the Company entered into an extension agreement related to the Platinum convertible note. The extension agreement extended the due date of the note to June 22, 2025. In consideration for entering into the extension agreement, the Company issued to Platinum 232,360 shares of the Company’s restricted common stock in payment of all interest and extension fees through June 22, 2025 with a value of $1,008,400. Approximately $487,000 of the total payment related to the future interest periods and were recorded in prepaid expenses and others on the consolidated balance sheet. Subject to the terms and conditions of such extension agreement, for a period commencing on December 22, 2024 and ending at the close of business on December 22, 2025, Platinum has a one-time put right to have the Company purchase all or a portion of Platinum’s 232,360 restricted shares at $2.27518 per share. The Company granted piggyback registration rights to Platinum.

 

The obligations under the Platinum convertible note are secured by a blanket lien on all assets of the Company pursuant to an Amended and Restated Security Agreement dated February 2, 2024 and are guaranteed pursuant to an Amended and Restated Guaranty dated February 2, 2024. The Company also concurrently entered into an Amended and Restated Subordination Agreement.

 

During the nine months ended September 30, 2024, the Company issued 219,763 shares of common stock related to the conversion of $500,000 of the Platinum convertible note and recorded a loss on note conversion of $200,338.

 

On October 3, 2023, the Company issued senior secured convertible promissory notes for $600,000 to two private investors. At the option of the holders, the notes were convertible into cash, common stock or a combination of cash and stock. On March 5, 2024, the two private investors converted the notes with a face value of $600,000 and interest into 169,204 shares of the Company’s common stock valued at $835,610. On September 13, 2024, the Company issued an additional 86,198 shares of common stock related to the conversion of notes at $2.65 per share. The Company recognized a loss on debt conversion of $234,459 and $393,253, respectively during the three and nine months ended September 30, 2024.

 

The Company accounts for the notes under the fair value method of accounting and as of September 30, 2024 and December 31, 2023, the notes were recorded at $1,793,360 and $2,825,366, respectively.

 

During the nine months ended September 30, 2024 and 2023, the Company recorded an increase in the fair value of the convertible notes payable totaling $141,636 and $400,921, respectively, which were recorded as loss from change in fair value of convertible debt on the statement of operations and comprehensive loss. See Note 14 – Fair Value Measurements for more information.

 

Details on notes payable and convertible notes payable were disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and filed with the SEC on April 1, 2024.

 

6. Stockholders’ Deficit

 

Authorized and Outstanding Stock 

 

The Company is a Delaware company and its affairs are governed by its certificate of incorporation, its bylaws and the Delaware General Corporation Law and the common law of the State of Delaware. The Company’s charter authorizes the issuance of 205,000,000 shares, consisting of 200,000,000 shares of common stock and 5,000,000 shares of preferred stock, par value $0.0001 per share.

 

Details on the common stock, preferred stock and equity incentive plans were disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and filed with the SEC on April 1, 2024.

 

Common Stock 

 

As of September 30, 2024, there were 26,954,871 shares of common stock outstanding.

 

 
18

Table of Contents

 

Nine Months Ended September 30, 2024

 

During the nine months ended September 30, 2024, the Company had the following sales of unregistered equity securities:

 

On March 5, 2024, a private investor converted a senior secured convertible promissory note for $250,000 and interest into 70,502 shares of the Company’s common stock.

 

On March 5, 2024, a private investor converted a senior secured convertible promissory note for $350,000 and interest into 98,702 shares of the Company’s common stock.

 

On March 21, 2024, the Company issued 15,000 shares of common stock for services performed as of December 31, 2023 to MZHCI, LLC related to an investor relations consulting agreement.

 

On May 16, 2024, the Company issued 50,000 shares of common stock to Pamria LLC for consulting and investor relations services.

 

On June 22, 2024, the Company entered into an extension agreement with Platinum Capital Partners Inc. to extend the maturity date of the Platinum convertible note to June 22, 2025. In consideration for entering into the extension agreement, the Company issued to Platinum 232,360 shares of common stock in payment of all interest and extension fees through June 22, 2025.

 

On September 3, 2024, the Company issued 2,882,883 shares of common stock at a combined price of $2.775 related to the closing of a public offering. See Note 1.

 

On September 13, 2024, the Company issued an additional 86,198 shares of common stock related to the conversion of notes at $2.65 per share.

 

During the nine months ended September 30, 2024, the Company issued 219,763 shares of common stock related to the conversion of $500,000 of the Platinum convertible note.

 

During the nine months ended September 30, 2024, the Company issued an aggregate of 324,448 shares of common stock upon the exercise of stock options at $0.60 weighted average price.

 

During the nine months ended September 30, 2024, the Company issued an aggregate of 162,967 shares of common stock upon the exercise of warrants at $4.92 weighted average price.

 

2023 Equity Incentive Plan 

 

The Company has adopted the 2023 Equity Incentive Plan, which plan was approved by stockholders at the extraordinary general meeting held in December 2023. Details on the equity incentive plan were disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and filed with the SEC on April 1, 2024.

 

The aggregate number of shares of common stock initially reserved and available for grant and issuance under the equity incentive plan is 4,456,241 as of September 30, 2024. Such aggregate number of shares of stock will automatically increase on January 1 of each year for a period of ten years commencing on January 1, 2024 and ending on January 1, 2033, in an amount equal to 2.0% of the total number of shares of common stock outstanding on December 31 of the preceding year.

 

The Company had the following stock option activity during the nine months ended September 30, 2024:

 

During the nine months ended September 30, 2024, the Company granted stock options to seven employees to purchase an aggregate of 1,050,000 shares of common stock with an exercise price of $3.74 and which vest primarily quarterly over four years and expire March to August 2034.

 

During the nine months ended September 30, 2024, five employees voluntarily cancelled stock options to purchase an aggregate of 300,000 shares of common stock with an exercise price of $6.85.

 

During the nine months ended September 30, 2024, the Company issued an aggregate of 324,448 shares of common stock and received $196,173 upon the exercise of stock options at exercise prices ranging from $0.60 per share.

 

 
19

Table of Contents

 

Stock option activity for the nine months ended September 30, 2024 was as follows: 

 

 

 

Options

 

 

Weighted Average

 

 

 

Shares

 

 

Exercise Price

 

Outstanding as of December 31, 2023

 

 

4,664,589

 

 

$0.55

 

Granted

 

 

1,050,000

 

 

 

3.74

 

Exercised

 

 

(324,448)

 

 

(0.60)

Forfeited

 

 

(300,000)

 

 

(6.85)

Outstanding as of September 30. 2024

 

 

5,090,141

 

 

$0.83

 

  

The following table summarizes information about stock options outstanding and exercisable as of September 30, 2024:  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

Average

 

 

Weighted

 

 

 

 

 

Average

 

 

Remaining Life

 

Range of

 

 

Number

 

 

Remaining Life

 

 

Average

 

 

Number

 

 

Exercise Price

 

 

In Years - Vested

 

Exercise Prices

 

 

Outstanding

 

 

In Years

 

 

Exercise Price

 

 

Exercisable

 

 

Exercisable

 

 

and Exercisable

 

$

0.12

 

 

 

2,495,803

 

 

 

3.59

 

 

$0.12

 

 

 

2,495,803

 

 

$0.12

 

 

 

3.59

 

 

0.57

 

 

 

922,963

 

 

 

3.77

 

 

 

0.57

 

 

 

922,963

 

 

 

0.57

 

 

 

3.77

 

1.49-1.65

 

 

 

1,096,562

 

 

 

7.67

 

 

 

1.64

 

 

 

505,178

 

 

 

1.64

 

 

 

7.67

 

 

1.90

 

 

 

49,813

 

 

 

3.23

 

 

 

1.90

 

 

 

33,148

 

 

 

1.90

 

 

 

3.23

 

 

2.86

 

 

 

525,000

 

 

 

9.88

 

 

 

2.86

 

 

 

32,813

 

 

 

2.86

 

 

 

9.88

 

 

 

 

 

 

5,090,141

 

 

 

5.14

 

 

$0.83

 

 

 

3,989,905

 

 

$0.45

 

 

 

5.14

 

 

There were 5,090,141 options to purchase common stock at an average exercise price of $0.83 per share outstanding as of September 30, 2024 under the 2023 Equity Incentive Plan. The Company recorded $139,409 and $206,495 of compensation expense, net of related tax effects, relative to stock options for the three months ended September 30, 2024 and 2023, respectively.  The Company recorded $420,824 and $479,913 of compensation expense, net of related tax effects, relative to stock options for the nine months ended September 30, 2024 and 2023, respectively, in accordance with ASC 718. As of September 30, 2024, there was $1,962,124 of total unrecognized costs related to employee granted stock options that were not vested. These costs are expected to be recognized over a period of approximately 3.5 years.

 

In August 2024, the Company cancelled out-of-the money options to exercise 300,000 shares held by current employees and replaced them with 525,000 options at lower exercise prices. The new options were subject to the same service-based vesting schedule as the original options. The Company accounted for the replacement options as a modification of the terms of the cancelled option awards and in accordance with ASC 718-20-35-2A, the Company will recognize additional $205,879 stock compensation expense over the remaining vesting period as the incremental cost measured as the excess of the fair value of the replaced options on the grant date using the Black-Scholes-Merton option pricing model over the fair value of the cancelled option award at the cancellation date.

 

The significant weighted-average assumptions relating to the valuation of the Company’s stock option grants were as follows for the nine months ended:

 

Assumptions

 

9/30/2024

 

 

6/30/2024

 

 

3/31/2024

 

Estimated stock price

 

$2.86

 

 

$7.61

 

 

$1.49-$6.59

 

Exercise price

 

$2.86

 

 

$7.61

 

 

$1.49-$6.59

 

Dividend yield

 

 

0%

 

 

0%

 

 

0%

Expected life

 

4 years

 

 

4 years

 

 

5-10 years

 

Expected volatility

 

 

69%

 

 

69%

 

 

69%

Risk free interest rate

 

 

3.77%

 

 

4.68%

 

 

4.23%

  

 
20

Table of Contents

 

There were stock incentive plan awards outstanding at September 30, 2024 totaling 5,090,141 shares with an aggregate intrinsic value of $7,781,223.

 

As of September 30, 2024 and December 31, 2023 there were 1,758,000 SARs outstanding. There were no SAR grants in the nine months ended September 30, 2024 or the year ended December 31, 2023.

 

Warrants to Purchase Common Stock

 

See Note 12 for public and private placement warrants assumed after the merger.

 

The Company had the following warrant activity during the nine months ended September 30, 2024:

 

In connection with the issuance of the Platinum convertible note, the Company issued to Platinum an amended and restated common stock purchase warrant dated February 2, 2024 to purchase 189,334 shares of common stock at an exercise price per share of $3.69717. On March 18, 2024, Platinum exercised the Platinum warrant and received 137,367 shares of common stock. Platinum forfeited 51,967 shares.

 

On September 3, 2024 the Company issued warrants to purchase up to 2,882,883 shares of its common stock. The warrants have an exercise price of $2.65 per share, are exercisable immediately upon issuance and will expire five years following the date of issuance.

 

On September 3, 2024 the Company issued warrants to purchase up to 216,216 shares of its common stock. The warrants have an exercise price of $3.47 per share, are exercisable immediately upon issuance and will expire five years following the date of issuance.

 

On September 27, 2024, the Company issued warrants to purchase up to 220,000 shares of common stock. The warrants have an exercise price of $2.36 per share, are exercisable immediately upon issuance and will expire in five years following the date of issuance.

 

During the nine months ended September 30, 2024, investors exercised warrants for 25,600 shares of the Company’s common stock at $11.49 per share, and the Company received proceeds of $294,030.

 

Warrant activity for the nine months ended September 30, 2024 was as follows:

 

 

 

September 30, 2024

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Exercise

 

 

 

Shares

 

 

Price

 

Outstanding January 1, 2024

 

 

19,443,314

 

 

$10.16

 

Issued

 

 

3,454,033

 

 

 

2.72

 

Exercised

 

 

(162,967)

 

 

(4.92)

Forfeited

 

 

(51,967)

 

 

(3.70)

Expired

 

 

-

 

 

 

-

 

Outstanding at September 30, 2024

 

 

22,682,413

 

 

$6.34

 

  

 
21

Table of Contents

 

A summary of the warrants outstanding as of September 30, 2024 were as follows:

 

 

 

 

September 30, 2024

 

 

 

 

Weighted

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

Average

 

 

 

 

 

Average

 

Number of

 

 

Remaining

 

 

Exercise

 

 

Shares

 

 

Exercise

 

Warrants

 

 

Life ( In Years)

 

 

Price

 

 

Exercisable

 

 

Price

 

 

2,689,902

 

 

 

3.47

 

 

$1.77

 

 

 

2,689,902

 

 

$1.77

 

 

220,000

 

 

 

5.00

 

 

 

2.36

 

 

 

220,000

 

 

 

2.36

 

 

2,882,283

 

 

 

4.92

 

 

 

2.65

 

 

 

2,882,283

 

 

 

2.65

 

 

216,216

 

 

 

4.92

 

 

 

3.47

 

 

 

216,216

 

 

 

3.47

 

 

16,674,012

 

 

 

4.04

 

 

 

7.80

 

 

 

16,674,012

 

 

 

7.80

 

 

22,682,413

 

 

 

4.08

 

 

$6.34

 

 

 

22,682,413

 

 

$6.34

 

  

The significant weighted average assumptions relating to the valuation of the Company’s warrants issued for the nine months ended September 30, 2024 were as follows:

 

Assumptions

 

 

 

Dividend yield

 

 

0%

Stock price

 

$2.72

 

Exercise price

 

$2.72

 

Expected life

 

4 years

 

Expected volatility

 

 

69%

Risk free interest rate

 

 

3.77%

  

Earnout Liability

 

See Note 13 for common stock shares related to earnout liability.

 

7. Employee 401(k) Plan

 

The Company has a 401(k) plan for its employees. The plan provides for a 3.5% match on up to 6% of deferred salary. The Company expensed $52,456 and $44,973 of contributions during the three months ended September 30, 2024 and 2023, respectively. The Company expensed $153,254 and $138,532 of contributions during the nine months ended September 30, 2024 and 2023, respectively.

 

8. Related Party Transactions

 

Advances due to Founders

 

Prior to 2023, the founders had advanced the Company a net $600,000. In the year ended December 31, 2023, Mr. Huang and Mr. Xu advanced Airship AI a total of $1,350,000 and were repaid a total of $200,000, with $1,750,000 recorded as advances from founders as of December 31, 2023. During 2024, Mr. Huang and Mr. Xu advanced Airship AI $2,100,000 and was repaid $2,100,000, with $1,750,000 recorded as advances from founders as of September 30, 2024. The outstanding advances as of September 30, 2024 are non-interest bearing and the Company expects to pay the balance off within a one year period.

 

Master Loan Agreement

 

On September 27, 2024, the Company entered into a Master Loan Agreement with Mr. Huang, whereby he may provide additional funding of up to $1,500,000 under certain terms and conditions. The agreement provides for interest of 6%. The Company agreed to pay interest for the 2024 advances (described under Advances to Founders above) of $11,913 and the Company issued warrants to purchase up to 220,000 shares of the Company’s common stock. The warrants have an exercise price of $2.36 per share, are exercisable immediately upon issuance and will expire in five years following the date of issuance. The $284,478 fair value of the warrant is recorded in permanent equity in the consolidated balance sheets and was fully expensed on the date of grant. There are no outstanding advances under this Master Loan Agreement as of September 30, 2024.

 

 
22

Table of Contents

 

Warrants to Purchase Common Stock

 

On May 8, 2023, Airship AI issued warrants to purchase 1,344,951 shares of common stock to each of Victor Huang and Derek Xu. The warrants were valued at $2,136,115 based on the exercise price of $1.77, the fair market stock price of $1.89, a five year term, a volatility of 39.4% and interest of 3.41%. The warrants were recorded as stock-based compensation expense and as additional paid in capital. All warrants are fully vested as they were issued for services performed.

 

9. Commitments, Contingencies and Legal Proceedings

 

Legal Proceedings

 

The Company may from time to time become a party to various legal proceedings arising in the ordinary course of its business. The Company is currently not a party to any pending legal proceeding that is not ordinary routine litigation incidental to its business.

 

Properties and Operating Leases-Right of Use Asset and Lease Liability

 

Lease agreements are evaluated to determine whether an arrangement is or contains a lease in accordance with ASC 842, Leases. Right of use lease assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. The incremental borrowing taking into consideration the Company’s credit quality and borrowing rate for similar assets is used in determining the present value of future payments. Lease expense is recorded as general and administrative expenses on the Company’s consolidated statements of operations.

 

On July 13, 2023, the Company entered into a lease in Redmond, WA for 15,567 square feet of office and warehouse space which started October 1, 2023. The monthly payment is $25,000 per month. The lease expires October 31, 2027 and the monthly payment increases 3% on July 31, 2024 and each year thereafter. There is a one three year option to extend the lease based on the fair market rate on October 31, 2027, which the Company expects to exercise.

 

On February 29, 2024, the Company extended an office lease in Moorestown, North Carolina. The Company leases 3,621 square feet and the net monthly payment is $6,488. On August 27, 2024, the Company extended the lease to February 28, 2025.

 

The Company has entered into operating leases for office and development facilities for four years and include options to renew. The Company determines whether an arrangement is or contains a lease based upon the unique facts and circumstances at the inception of the lease. Operating lease liabilities and their corresponding right-of-use assets are recorded based upon the present value of the lease payments over the expected lease term. As of September 30, 2024 and December 31, 2023, total operating lease liabilities was $986,053 and $1,118,578, respectively. Right of use assets was $929,890 and $1,104,804 at September 30, 2024 and December 31, 2023, respectively. Current lease liabilities were $267,660 and $174,876 at September 30, 2024 and December 31, 2023, respectively. In the three months ended September 30, 2024 and 2023, the Company recognized $88,428 and $162,414 in total lease costs for the leases, respectively. In the nine months ended September 30, 2024 and 2023, the Company recognized $265,283 and $487,242 in total lease costs for the leases, respectively. Because the rate implicit in each lease is not readily determinable, the Company uses its estimated incremental borrowing rate to determine the present value of the lease payments.

 

The weighted average remaining lease term for the operating leases was thirty seven  months at September 30, 2024 and the weighted average discount rate was 7%. 

 

 
23

Table of Contents

 

The minimum future lease payments as of September 30, 2024 are as follows:

 

Years Ended September 30,

 

2025

 

$327,308

 

2026

 

 

367,606

 

2027

 

 

378,646

 

2028

 

 

32,333

 

Total remaining payments

 

 

1,105,893

 

Less Imputed Interest

 

 

(119,840)

Total lease liability

 

$986,053

 

 

Employment Agreement

 

On March 1, 2024, the Company entered into an employment agreement with Mark E. Scott, the Company’s Chief Financial Officer, which provides for a base salary of $250,000 annually. Mr. Scott is also eligible to participate in annual performance-based bonus programs established by the board or compensation committee, subject to the achievement of applicable performance criteria established by the board or compensation committee, which shall be determined in good faith by the board or compensation committee. Mr. Scott was also granted options to purchase up to twenty five thousand (25,000) shares of common stock with an exercise price equal to $1.49, which options vested in full on the date of issuance.

 

10. Income Taxes

 

The Company recorded a provision for income taxes of $0 for the nine months ended September 30, 2024 and 2023.

 

The Company’s effective tax rate was 0% for the nine months ended September 30, 2024 and 2023. The difference between the effective tax rate and the federal statutory tax rate for the nine months ended September 30, 2024 and 2023 primarily related to the valuation allowance on the Company’s deferred tax assets.

 

For interim periods, the Company estimates its annual effective income tax rate and applies the estimated rate to the year-to-date income or loss before income taxes. The Company also computes the tax provision or benefit related to items reported separately and recognizes the items net of their related tax effect in the interim periods in which they occur. The Company also recognizes the effect of changes in enacted tax laws or rates in the interim periods in which the changes occur.

 

As of September 30, 2024 and December 31, 2023, the Company retains a full valuation allowance on its deferred tax assets. The realization of the Company’s deferred tax assets depends primarily on its ability to generate taxable income in future periods. The amount of deferred tax assets considered realizable in future periods may change as management continues to reassess the underlying factors it uses in estimating future taxable income.

 

11. Reverse Recapitalization

 

On December 21, 2023, the Company completed the merger and received net proceeds of $2.8 million, net of transaction costs of $6.6 million.

 

The merger was accounted for as a reverse recapitalization in accordance with GAAP. Under this method of accounting, BYTS, who was the legal acquirer, was treated as the “acquired” company for accounting purposes and Airship AI was treated as the accounting acquirer. Accordingly, the merger was treated as the equivalent of Airship AI issuing shares at the closing of the merger for the net assets of BYTS as of the closing date, accompanied by a recapitalization. The net assets of BYTS was stated at historical cost, with no goodwill or other intangible assets recorded. Airship AI was determined to be the accounting acquirer based on evaluation of the following facts and circumstances:

 

 

Airship AI’s stockholders have the majority voting interest in the combined company;

 

 

 

 

The board of the post-merger company is composed of one (1) director designated by BYTS and four (4) directors designated by Airship AI;

 

 

 

 

Airship AI’s senior management is the senior management of the post-merger company;

 

 

 

 

The business of Airship AI comprises the ongoing operations of post-merger company; and

 

 

 

 

Airship AI is the larger entity, in terms of substantive assets.

 

 
24

Table of Contents

 

The table below summarizes the shares of common stock issued immediately after the closing of the merger as well as the impact on the consolidated statement of stockholders’ equity as of December 21, 2023:

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Accumulated

 

 

 

Shares

 

 

Par Amount

 

 

Common Stock

 

 

Paid in Capital

 

 

Deficit

 

SPAC Financing

 

 

8,891,718

 

 

$0.0001

 

 

$889

 

 

$8,315,186

 

 

$-

 

Transaction expenses (1)

 

 

532,986

 

 

 

0.0001

 

 

 

53

 

 

 

(6,651,674)

 

 

(894,662)
Earnout liability

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4,470,918)

 

 

(22,638,859)
Warrants liability

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,009,105)

 

 

-

 

Reverse capitalization on December 21, 2023 (1)

 

 

9,424,704

 

 

 

 

 

 

$942

 

 

$(4,816,511)

 

$(23,533,521)

  

 

(1)

Adjusted for correction of transaction expense discussed below.

 

Immaterial Revision of Prior Period Financial Information

 

In connection with the preparation of its consolidated financial statements, the Company identified an immaterial error related to the classification of prepaid expenses and transaction expenses (classified in accumulated deficit as reverse recapitalization). In accordance with SAB No. 99, “Materiality,” and SAB No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in the Current Year Financial Statements,” the Company evaluated the error and determined that the impact was not material to its financial statements for the prior annual and current interim period, accordingly the Company revised the prior period financial information for comparative purposes. The revision does not impact the consolidated statements of operations and comprehensive loss. A summary of the revision to the Company’s previously reported consolidated balance sheets is included below for comparative purposes:

 

 

 

As of December 31, 2023

 

 

 

As Reported

 

 

Adjustment

 

 

As Revised

 

Prepaid expenses and other

 

$

913,030

 

 

$

(894,662

)

 

$

18,368

 

Total current assets

 

 

5,693,577

 

 

 

(894,662

)

 

 

4,798,915

 

Total assets

 

 

6,982,575

 

 

 

(894,662

)

 

 

6,087,913

 

Accumulated deficit

 

 

(16,582,038

)

 

 

(894,662

)

 

 

(17,476,700

)

Total stockholders' deficit

 

 

(16,592,565

)

 

 

(894,662

)

 

 

(17,487,227

)

 

The revision had no impact to cash provided by operating activities in such period.

 

12. Private Placement and Public Warrants

 

At the merger closing, the Company assumed 515,000 private placement warrants and 16,184,612 public warrants. On June 3, 2024, the Company permanently reduced the exercise price of such warrants from $11.50 per share to an exercise price of $7.80 per share. The purpose of this reduced exercise price was to potentially raise proceeds received from the exercise of such warrants, if any, for working capital and general corporate purposes. As of September 30, 2024, there were 515,000 private placement warrants and 16,159,012 public warrants outstanding.

 

Details on the warrants were disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and filed with the SEC on April 1, 2024. The public warrants will expire on December 21, 2028.

 

 
25

Table of Contents

 

The following table is a summary of the number of shares of the Company’s common stock issuable upon exercise of the public and private warrants outstanding as of September 30, 2024:

 

 

 

Number of Shares

 

 

Exercise Price

 

 

Expiration Date

 

Fair Value

 

Public Warrants

 

 

16,159,012

 

 

$7.80

 

 

December 21, 2028

 

$3,393,393

 

Private Warrants

 

 

515,000

 

 

$7.80

 

 

December 21, 2028

 

$108,150

 

  

13. Earnout Liability

 

At the closing of the merger, the Airship AI securityholders that hold shares of common stock of Airship AI, Airship AI options, Airship AI earnout warrants or Airship AI SARs have the contingent right to receive up to 5,000,000 earnout shares of the Company’s common stock if the following earnout milestones are met.

 

 

(A)

25% of the earnout shares if, for the period starting on the closing date and ending on the last day of the full calendar quarter immediately following the first anniversary of the closing date, (1) company revenue (as defined in the merger agreement) is at least $39 million, or (2) the aggregate value of new contract awards with federal law enforcement agencies has grown by at least 100% as compared to the year-over-year amount for the twelve-month period ending on the date of the merger agreement (the “First Operating Performance Milestone”);

 

 

(B)

75% of the earnout shares if, for the period starting on the closing date and ending on the last day of the full calendar quarter immediately following the third anniversary of the closing date, company revenue is at least $100 million;

 

 

 

 

(C)

50% of the earnout shares if, at any time during the period starting on the closing date and ending on the fifth anniversary of the closing date, over any twenty (20) trading days within any thirty (30) trading day period the volume weighted average price (“VWAP”) of the common stock is greater than or equal to $12.50 per share; and

 

 

 

 

(D)

50% of the earnout shares if, at any time during the period starting on the closing date and ending on the fifth anniversary of the closing date, over any twenty (20) trading days within any thirty (30) trading day period the VWAP of the common stock is greater than or equal to $15.00 per share.

 

Any earnout shares issuable under the merger agreement to a Airship AI securityholder in respect of each Airship AI option or Airship AI SAR held by such holder as of immediately prior to the effective time of the merger shall be earned by such holder on the later of (i) the occurrence of the applicable earnout milestone, and (ii) the date on which the option in respect of such Airship AI option or SAR in respect of such Airship AI SAR, as applicable, becomes vested pursuant to its applicable vesting schedule, but only if such holder continues to provide services (whether as an employee, director or individual independent contractor) to the Company or one of its subsidiaries through such date. Notwithstanding the foregoing, any earnout shares that are not earned by Airship AI securityholder in respect of its options or SARs on or before the fifth anniversary of the closing date of the merger shall be forfeited without any consideration. Any earnout shares that are forfeited pursuant to the merger agreement shall be reallocated to the other Airship AI securityholders who remain entitled to receive earnout shares in accordance with their respective earnout pro rata shares.

 

These earnout shares have been categorized into two components: (i) the “Vested Shares” - those associated with earnout holders with vested equity at the closing of the merger that will be earned upon achievement of the earnout milestones and (ii) the “Unvested Shares” - those associated with earnout holders with unvested equity at the closing of the merger that will be earned over the remaining service period with the Company on their unvested equity shares and upon achievement of the earnout milestones. The Vested Shares, which represent 95% of the total earnout shares are classified as liabilities in the consolidated balance sheet at fair value with changes in fair value recognized in the consolidated statements of operations due to the variability in the number of earnout shares at settlement which could change upon a change of control event. The earnout arrangement contains a settlement provision that violates the indexation guidance under ASC 815-40. The Unvested Shares are equity-classified share-based compensation to be recognized over time under ASC 718 due to the service component.

 

 
26

Table of Contents

 

At the closing of the merger on December 21, 2023, the earnout liability had an initial fair value of $27,109,777, which was recorded as a long-term liability and a reduction to additional paid in capital in the consolidated balance sheet. As of December 31, 2023, the earnout liability had decreased to $5,133,428 as a result of the decline in the Company’s share price since the closing of the merger. As of September 30, 2024, the estimated fair value of the earnout liability increased to $6,229,390 primarily due to the increase in the Company’s share price, which resulted in a gain (loss) due to the change in fair value of the earnout liability during the three and nine months ended September 30, 2024 of $5,511,961 and $(1,095,962), respectively, and is recorded on the consolidated statements of operations and comprehensive loss. See Note 14– Fair Value Measurements for more information.

 

In addition, a portion of the earnout shares may be issued to individuals with unvested equity awards. While the payout of these shares requires the achievement of the earnout milestones, the individuals must complete the remaining service period associated with these unvested equity awards to be eligible to receive the earnout shares. As a result, these unvested earn-out shares are equity-classified awards and have an aggregated grant date fair value of $2,675,223 (or $5.96 per share). During the three and nine months ended September 30, 2024, the Company stock-based compensation expense for the vesting of earnout shares was $133,761 and $401,283, respectively. As of September 30, 2024, unrecognized compensation cost related to unvested earnout shares totaled $2,273,941. The weighted average period over which this remaining compensation cost is expected to be recognized is 4.25 years.

 

As of September 30, 2024, the Company determined the First Operating Performance Milestone (A,2) is achieved and 1,250,000 shares are to be issued to applicable personnel in early January 2025. The fair value of the 1,250,000 vested shares as of September 30, 2024 of $2,875,000 was determined using the Company’s closing trading price on September 30, 2024 and is included in the earnout liability on the consolidated balance sheet. The vested earnout shares are considered a level 1 fair value instrument. See Note 14.

 

14. Fair Value Measurements

 

The following table sets forth by level within the ASC 820, Fair Value Measurement, fair value hierarchy of the Company’s liabilities that are measured at fair value on a recurring basis as of September 30, 2024:

 

 

 

 

 

September 30, 2024

 

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Liabilities-

 

 

 

 

 

 

 

 

 

 

 

 

Earnout liability

 

$2,875,000

 

 

$-

 

 

$3,354,390

 

 

$6,229,390

 

Senior Secured Convertible Promissory Notes

 

 

-

 

 

 

-

 

 

 

1,793,360

 

 

 

1,793,360

 

Warrant liability (Public Warrants)

 

 

3,393,393

 

 

 

-

 

 

 

-

 

 

 

3,393,393

 

Warrant liability (Private Warrants)

 

 

-

 

 

 

108,150

 

 

 

-

 

 

 

108,150

 

Total liabilities measured at fair value

 

$6,268,393

 

 

$108,150

 

 

$5,147,750

 

 

$11,524,293

 

  

The following table sets forth by level within the ASC 820, Fair Value Measurement, fair value hierarchy of the Company’s liabilities that are measured at fair value on a recurring basis as of December 31, 2023:

 

 

 

December 31, 2023

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Earnout liability

 

$

-

 

 

$

-

 

 

$

5,133,428

 

 

$

5,133,428

 

Senior Secured Convertible Promissory Notes

 

 

-

 

 

 

-

 

 

 

2,825,366

 

 

 

2,825,366

 

Warrant liability (Public Warrants)

 

 

646,428

 

 

 

-

 

 

 

-

 

 

 

646,428

 

Warrant liability (Private Warrants)

 

 

-

 

 

 

21,557

 

 

 

-

 

 

 

21,557

 

Total liabilities measured at fair value

 

$

646,428

 

 

$

21,557

 

 

$

7,958,794

 

 

$

8,626,779

 

 

 
27

Table of Contents

 

The estimated fair value of the earnout liability was determined using a Monte Carlo Model. The assumptions utilized in the calculation are based on the achievement of certain stock price milestones including projected stock price, volatility, probability of meeting the federal law enforcement agency growth and risk-free rate. The following assumptions were used in the simulation at each valuation date:

 

 

 

September 30,

2024

 

 

December 31,

2023

 

Stock price

 

$2.30

 

 

$1.70

 

Risk-free interest rate

 

 

3.58%

 

 

3.84%
Expected term (in years)

 

 

4.3

 

 

 

5

 

Expected volatility

 

 

60.4%

 

 

75.9%
Dividend yield

 

 

0%

 

 

0%

  

The assumptions also included the probability of meeting the federal law enforcement agency growth milestone at 100%. The fair value of the 1,250,000 vested shares as of September 30, 2024 of $2,875,000 was determined using the Company’s closing trading price on September 30, 2024.

 

The initial estimated fair value of the private warrants was measured using a Monte Carlo simulation. The estimated fair value of the public warrants is based on the listed price in an active market for such warrants and the fair value of the private placement warrants continues to be measured based on the public warrants listed price.

 

The estimated fair value of the senior secured convertible promissory notes was measured using a Monte Carlo simulation pricing model that factors in potential outcomes being consummated, such as the convertible notes being repaid in cash and the convertible notes being converted to common stock. All of these scenarios take into consideration the terms and conditions of the underlying convertible notes plus potential changes in the underlying value of the common stock. The following assumptions were used in the simulation:

 

 

 

September 30,

2024

 

 

December 31,

2023

 

Stock price

 

$2.30

 

 

 

1.70

 

Effective discount rate

 

 

12.28%

 

 

12.95%

Expected term (in years)

 

 

0.73

 

 

0.48 to 0.75

 

Expected volatility

 

 

55.0%

 

 

62.5%

Dividend yield

 

 

0%

 

 

0%

  

On September 13, 2024, the vested earnout shares were transferred from Level 3 to Level 1 upon the Board approval of the achievement of the First Operating Performance Milestone (A,2). The fair value on the day of transfer was $3,400,000. There were no transfers of financial instruments between valuation levels during the year ended December 31, 2023. The changes in Level 3 liabilities measured at fair value for the nine months ended September 30, 2024 were as follows:

 

 

 

Level 3

 

 

 

Beginning Balance

 

 

Unrealized and

 

 

Conversions /

 

 

Transfers out

 

 

Ending Balance as of

 

 

 

January 1, 2024

 

 

Realized Loss

 

 

Settlements (a)

 

 

of Level 3

 

 

September 30, 2024

 

Liabilities-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnout liability

 

$5,133,428

 

 

$1,620,962

 

 

$-

 

 

$(3,400,000)

 

$3,354,390

 

Senior Secured Convertible Promissory Notes

 

 

2,825,366

 

 

 

735,227

 

 

 

(1,767,233)

 

 

-

 

 

 

1,793,360

 

 

 

$7,958,794

 

 

$2,356,189

 

 

$(1,767,233)

 

$(3,400,000)

 

$5,147,750

 

  

(a) The conversions and settlements represent the fair value of the Senior Secured Convertible Promissory Notes at the dates of conversion.  

 

 
28

Table of Contents

 

15. Earnings per Share

 

The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders:

 

 

 

September 30, 2024,

 

 

September 30, 2023,

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Three Months Ended

 

 

Nine Months Ended

 

Net Income (loss)

 

$6,213,956

 

 

$(7,288,520)

 

$(1,666,607)

 

$(6,482,062)

Less: interest expense and gain on remeasurement of

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

convertible debt

 

 

(236,724)

 

 

-

 

 

 

-

 

 

 

-

 

Net income (loss) - Diluted

 

$5,977,232

 

 

$(7,288,520)

 

$(1,666,607)

 

$(6,482,062)

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

24,696,425

 

 

 

23,609,189

 

 

 

22,812,048

 

 

 

22,812,048

 

Add: dilutive effect of convertible debt, stock options, SARs, vested earnout shares and warrants

 

 

10,749,269

 

 

 

-

 

 

 

-

 

 

 

-

 

Diluted

 

 

35,445,694

 

 

 

23,609,189

 

 

 

22,812,048

 

 

 

22,812,048

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$0.25

 

 

$(0.31)

 

$(0.07)

 

$(0.28)

Diluted

 

$0.17

 

 

$(0.31)

 

$(0.07)

 

$(0.28)

  

The following potentially dilutive shares were not included in the calculation of diluted shares outstanding for the periods presented as the effect would have been anti-dilutive:

 

 

 

September 30,

2024

 

 

September 30,

2023

 

Public Warrants

 

 

16,159,012

 

 

 

-

 

Private Warrants

 

 

515,000

 

 

 

-

 

Convertible debt

 

 

-

 

 

 

367,000

 

Warrants

 

 

216,216

 

 

 

-

 

Outstanding stock options

 

 

525,000

 

 

 

-

 

 

 

 

17,415,228

 

 

 

367,000

 

  

The 3,750,000 remaining unvested earnout shares as of September 30, 2024 are excluded from basic and diluted net loss per share as such shares are contingently issuable until the Company exceeds certain milestone thresholds that have not been achieved. The 1,250,000 vested earnout shares are included in the diluted earnings per share calculation for the three-month period ended September 30, 2024 and will be issued to applicable personnel in early January 2025.

 

As a result of the merger, the weighted-average number of shares of common stock used in the calculation of net income (loss) per share have been retroactively converted by applying the conversion ratio.

 

16. Subsequent Events

 

The Company evaluated subsequent events, for the purpose of adjustment or disclosure, up through the date the financial statements were issued. Subsequent to September 30, 2024, there were the following material transaction that occurred that would require recognition or disclosure in the financial statements:

 

On November 11, 2024, the Company issued 109,881 shares of common stock related to the conversion of the Platinum convertible note. This issuance was made pursuant to the exemption from registration under the Securities Act in reliance on Section 4(a)(2).

 

On November 13, 2024, the Company issued 219,763 shares of common stock related to the conversion of the Platinum convertible note. This issuance was made pursuant to the exemption from registration under the Securities Act in reliance on Section 4(a)(2).

 

 

 
29

Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

The following discussion and analysis summarizes the significant factors affecting our operating results, financial condition, liquidity and cash flows as of and for the periods presented below. The following discussion and analysis should be read in conjunction with our financial statements and the related notes thereto included elsewhere in this report. The discussion contains forward-looking statements that are based on the beliefs of management, as well as assumptions made by, and information currently available to, management. Actual results could differ materially from those discussed in or implied by forward-looking statements as a result of various factors, including those discussed below and elsewhere in this report, particularly in the sections titled “Risk Factors” and “Special Note Regarding Forward-Looking Statements.”

 

Overview

 

We are a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources.

 

We solve these challenges by structuring “dark” or unstructured data at the edge, the location at which the data is generated and collected, and leveraging purpose-built AI models. Unstructured, or “dark” data, which is typically categorized as qualitative data, cannot be processed and analyzed via conventional data tools and methods. Conversely, structured data, typically categorized as quantitative data, is highly organized and easily decipherable by machine learning algorithms.

 

Structuring and then analyzing data using AI models at the edge, versus transmitting the data from the edge back to a central processing location for structuring and analysis, enables real-time decision making and data-driven operational efficiency.

 

We specialize in ingesting all available metadata from edge-based sensors used by government and law enforcement agencies around the world, including surveillance cameras (video), audio, telemetry, acoustic, seismic, and autonomous devices, along with large commercial corporations with fundamentally similar capabilities and requirements.

 

Data generated by these edge-based sensors, including video, can then be run through our trained AI models to detect objects present within the video frame. Once an object is detected, for example an automobile, additional identifying characteristics of the object can be extracted from the image including the license plate characters and the make, model, and color of the automobile. This process of analyzing, logging and categorizing ingested data is referred to as “structuring” the data.

 

Airship AI’s software allows customers to view structured data both in real-time as well as to conduct searches on the structured data at a later point in time. Real-time structured data use includes, for example, alarms on a specific license plate or a specific make, model or color of automobile. Non-real-time structured data use includes, for example, searching a database of video data that has been previously ingested and stored to find instances of a particular license plate being visible, along with other logged vehicle characteristics such as make, model and color of an automobile.

 

Additional edge deployed AI models enable similar object detection and recognition of common and custom trained objects, such as an aircraft, boat, person, animal, bag, or weapon. Airship AI’s models provide similar data points for these object types allowing analysts the ability to be notified in real-time of the detection of a specified object and similarly search for historically detected objects. Examples include detecting aircrafts and boats along with their respective tail numbers and hull registration numbers.

 

Our AI modelling process starts with pre-trained AI models from our technology ecosystem partners which we then customize using proprietary datasets tailored towards our customers unique workflow requirements. Where customers have pre-existing AI models or engines, we integrate those models or engines into our edge platform allowing customers to leverage proprietary models within the Airship AI software ecosystem.

 

Our primary offerings include Outpost AI, Acropolis, and Airship Command. Our offerings allow customers to manage their data across the full data lifecycle, when and where they need it, using a highly secure permissioned based architecture.

 

Recent Developments

 

On June 3, 2024, we permanently reduced the exercise price of our outstanding 16,184,612 public warrants and 515,000 private warrants, previously exercisable at $11.50 per share, to an exercise price of $7.80 per share. The purpose of this reduced exercise price was to potentially raise proceeds received from the exercise of such warrants, if any, for working capital and general corporate purposes.

 

 
30

Table of Contents

 

On June 22, 2024, we entered into an extension agreement with Platinum Capital Partner, Inc. to extend the maturity date of a $2,000,000 senior secured convertible promissory note to June 22, 2025. In consideration for entering into the extension agreement, we issued to Platinum 232,360 shares of common stock in payment of all interest and extension fees through June 22, 2025. During the three months ended September 30, 2024, the Company issued 219,763 shares of common stock related to the conversion of $500,000 of the senior secured convertible note.

 

On September 3, 2024, we closed an offering of $8 million of shares of common stock and common stock purchase warrants and received net proceeds of approximately $7.3 million, after deducting the estimated offering expenses payable by us, including the placement agent fees. We intend to use the net proceeds from the offering for working capital and general corporate purposes, including cost of goods sold purchases, personnel and product development.

 

On September 27, 2024, the Company entered into a Master Loan Agreement with Mr. Huang, whereby he may provide additional funding of up to $1,500,000 under certain terms and conditions. The agreement provides for interest of 6%. The Company agreed to pay interest for the 2024 advances of $11,913 and issued warrants to purchase up to 220,000 shares of common stock. The warrants have an exercise price of $2.36 per share, are exercisable immediately upon issuance and will expire in five years following the date of issuance. There are no outstanding advances under this Master Loan Agreement as of September 30, 2024.

 

Fair Value Transactions

 

As a result of the merger, we entered into the following transactions that were measured at fair value and vary quarterly with the share price and other items. Any change is non-cash and is recorded as a gain or loss in other income (expense). See Note 14– Fair Value Measurements for more information.

 

 

 

Liability as of

 

 

Liability as of

 

 

 

September 30, 2024

 

 

December 31, 2023

 

 

 

 

 

 

 

 

Earnout liability

 

$6,229,390

 

 

$5,133,428

 

Senior Secured Convertible Promissory Notes

 

 

1,793,360

 

 

 

2,825,366

 

Warrant liability (Public Warrants)

 

 

3,393,393

 

 

 

646,428

 

Warrant liability (Private Warrants)

 

 

108,150

 

 

 

21,557

 

Total liabilities measured at fair value

 

$11,524,293

 

 

$8,626,779

 

 

 

 

 

 

 

 

 

 

Other loss related to instruments recorded at fair value during the nine months ended September 30, 2024 and 2023

 

$(4,071,156)

 

$(400,921)

  

Private Placement and Public Warrants

 

At the merger closing, we assumed 515,000 private placement warrants and 16,184,612 public warrants. On June 3, 2024, we permanently reduced the exercise price of such warrants from $11.50 per share to an exercise price of $7.80 per share. The purpose of this reduced exercise price was to potentially raise proceeds received from the exercise of such warrants, if any, for working capital and general corporate purposes. As of September 30, 2024, there were 515,000 private placement warrants and 16,159,012 public warrants outstanding.

 

Key Performance Indicators

 

Historically, a majority of our product revenue has consisted primarily of a bundled hardware and software product and to date we have sold or licensed a minimal amount of standalone software. In the future, we expect to see more delivery of our products using a cloud based software solution which will allow us to create additional subscription revenue.

 

 
31

Table of Contents

 

We have historically evaluated our business solely based on revenue generated from customers and we have not tracked any other customer-related metrics. As we grow and increase our product offerings and customer base, we intend to modify and develop more advanced performance indicators. We believe the following key performance indicators apply to us in the future:

 

 

Growth within existing government customers. While we currently have a strong footprint across multiple large U.S. government agencies, growing our business within these agencies outside of the investigation focused departments is a fundamental area of our projected growth. Our ability to expand our footprint by implementing AI based solutions that leverage our core existing competencies within the agencies will be a critical indicator of the success of this strategy. We will measure progress against this objective through the disclosure of awards for new business within these agencies during the affected timeframe, providing tangible evidence of the success of our strategy to both management and investors alike.

 

 

 

 

Greater penetration into the commercial marketplace. While we have several existing customers in the commercial marketplace, our ability to build on the solutions we provide those customers and expand that base will be critical to our projected growth objectives. We will measure progress against this objective through the disclosure of the number of new commercial customers added during the affected timeframe, providing tangible evidence of the success of our strategy to both management and investors alike.

 

 

 

 

Expansion of our edge AI based solutions. We began to sell AI based solutions in late 2022. Our current strategy is highly focused on the transition of data management and analysis workloads to the edge, driving efficiency and cost savings for our customers. This strategy also includes new models being trained to extract data at the edge which enables real-time intelligent decision making for our customers. We will measure progress against this objective through the disclosure of the numbers of edge AI hardware devices we are selling as well as the growth of our edge AI analytic capabilities, providing tangible evidence of the success of our strategy to both management and investors alike.

 

Principal Factors Affecting Our Financial Performance

 

We believe the following factors and trends may cause previously reported financial information not to be necessarily indicative of future operating results or future financial conditions:

 

 

Increase in the sales of lower margin solutions as we expand our operational footprint. While our current focus remains on expanding our AI driven software application portfolio, opportunities will continue to present themselves to provide those software-based solutions as part of a larger hardware-based turn-key solutions where Airship AI can provide a unique value-add to the customer. While these solutions will positively affect revenue we anticipate our operating profits in future periods may be adversely affected as compared to previous years due to the lower operating margin for hardware versus software applications.

 

 

 

 

Challenges due to geo-political driven supply-chain constraints. While many of the COVID-19 driven supply chain issues have been resolved, challenges to the timely production and delivery of Taiwan based products we utilize for our edge AI platform due to geo-political factors is a concern looking forward. In the event that our suppliers are unable to provide timely delivery of those supplies it will significantly impact our ability to meet delivery schedules for existing and anticipated edge AI hardware-based solutions.

 

 

 

 

Near-term impacts due to merger and acquisition activity. If Airship AI merges with or acquires another company, it is reasonably expected that there will be increased operating expenses and costs associated with the merger that could negatively impact operating profits in the future periods immediately following the M&A event. The extent and longevity of those impacts is not possible to quantify.

 

Segment Reporting

 

The Financial Accounting Standards Board, or FASB, Accounting Standard Codification, or ASC, Topic 280, Segment Reporting, requires that an enterprise report selected information about reportable segments in its financial reports issued to its stockholders. Management monitors the revenue and expense components of the various products and services the Company offers, but operations are managed and financial performance is evaluated on a corporation-wide basis in comparison to a business plan which is developed each year. Accordingly, all operations are considered by management to be one operating segment and one reportable segment as contained in the Consolidated Statements of Operations and Comprehensive Loss to the consolidated financial statements.

 

 
32

Table of Contents

 

Results of Operations

 

The following table sets forth key components of our results of operations during the three months ended September 30, 2024 and 2023.

 

(dollars in thousands)

 

 

 

Three Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

$ Variance

 

 

% Variance

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$2,868

 

 

$2,384

 

 

$484

 

 

 

20.3%

Cost of net revenues

 

 

714

 

 

 

782

 

 

 

68

 

 

 

8.7%

Gross profit

 

 

2,154

 

 

 

1,602

 

 

 

552

 

 

 

34.5%

Research and development expenses

 

 

1,074

 

 

 

689

 

 

 

(385)

 

 

-55.9%

Selling, general and administrative expenses

 

 

2,667

 

 

 

2,142

 

 

 

(525)

 

 

-24.5%

Total operating expenses

 

 

3,741

 

 

 

2,831

 

 

 

(910)

 

 

-32.1%

Operating loss

 

 

(1,587)

 

 

(1,229)

 

 

(358)

 

 

-29.1%

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain from change in fair value of earnout liability

 

 

5,512

 

 

 

-

 

 

 

5,512

 

 

 

100.0%

Gain from change in fair value of warrant liability

 

 

2,471

 

 

 

-

 

 

 

2,471

 

 

 

100.0%

Gain (loss) from change in fair value of convertible debt

 

 

371

 

 

 

(401)

 

 

772

 

 

 

-192.5%

Loss on note conversion

 

 

(435)

 

 

-

 

 

 

(435)

 

 

-100.0%

Interest expense, net

 

 

(134)

 

 

(39)

 

 

(95)

 

 

-243.6%

Other income (expense)

 

 

16

 

 

 

2

 

 

 

14

 

 

 

-700.0%

Total other income (expense), net

 

 

7,801

 

 

 

(438)

 

 

8,239

 

 

 

1881.1%

Income (loss) before income taxes

 

 

6,214

 

 

 

(1,667)

 

 

7,881

 

 

 

472.8%

Provision for income taxes

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net income (loss)

 

$6,214

 

 

$(1,667)

 

$7,881

 

 

 

472.8%

  

Net Revenues — Net revenues for the three months ended September 30, 2024 increased $484,000 to $2,868,000 as compared to $2,384,000 for the three months ended September 30, 2023, as a result of increased product sales. We received purchase orders from various federal government agency customers totaling over $16 million from which we partially shipped in the three months ended September 30, 2024.

 

Cost of Net Revenues — Cost of net revenues primarily consists of product costs and post customer support. For the three months ended September 30, 2024, cost of sales decreased $68,000 to $714,000 as compared to $782,000 for the three months ended September 30, 2023. The decrease was due to reduced equipment purchases and increased Outpost AI sales during the three months ended September 30, 2024. 

 

Research and Development Expenses — Research and development expenses for the three months ended September 30, 2024 increased $385,000 to $1,074,000 as compared to $689,000 for the three months ended September 30, 2023. The increase was due to increased expenses for product development.

 

Selling, General and Administrative Expenses — Selling, general and administrative expenses for the three months ended September 30, 2024 increased $525,000 to $2,667,000 as compared to $2,142,000 for the three months ended September 30, 2023. The increase was due to (i) increased insurance costs of $142,000; (ii) increased professional fees of $333,000, primarily related to the merger and the Nasdaq listing; and (iii) increased other operating expenses of $50,000.

 

 
33

Table of Contents

 

Other Income Expense — Other income for the three months ended September 30, 2024 was $7,801,000 as compared to other expense of $438,000 for the three months ended September 30, 2023. Other expense for the three months ended September 30, 2024 consisted of (i) gain from change in fair value of earnout liability of $5,512,000; (ii) gain from change in fair value of warrant liability of $2,471,000; (iii) gain from change in fair value of convertible debt of $371,000; (iv) other income of $16,000; offset by (v) loss on note conversion of $435,000; and (vi) interest expense of $134,000. The gain from change in fair value of various financial instruments was primarily the result of a lower stock price.

 

The other expense for the three months ended September 30, 2023 related to (i) the loss in change of the fair value of the convertible note of $401,000; (ii) interest expense of $39,000; and offset by (iii) other income of $2,000.

 

Net Income/Loss — Net income for the three months ended September 30, 2024 was $6,214,000 as compared to net loss of $1,667,000 for the three months ended September 30, 2023. The net income is reduced by noncash items of $7,338,000, primarily the gain from the change in fair value of various financial instruments. Noncash items included (i) stock based compensation of $557,000; (ii) net amortization of operating lease right of use asset of $24,000; (iii) loss on note conversions of $434,000; offset by (iv) gain from change in fair value of warrant liability of $2,471,000; (v) gain from change in fair value of earnout liability of $5,571,000; and (vi) gain from change in fair value of convertible note of $370,000.

 

The net loss for the three months ended September 30, 2023 included noncash expenses of $687,000.

 

The following table sets forth key components of our results of operations during the nine months ended September 30, 2024 and 2023.

 

(dollars in thousands)

 

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

$ Variance

 

 

% Variance

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$19,844

 

 

$8,093

 

 

$11,751

 

 

 

145.2%

Cost of net revenues

 

 

10,556

 

 

 

4,013

 

 

 

(6,543)

 

 

-163.0%

Gross profit

 

 

9,288

 

 

 

4,080

 

 

 

5,208

 

 

 

127.6%

Research and development expenses

 

 

2,472

 

 

 

2,028

 

 

 

(444)

 

 

-21.9%

Selling, general and administrative expenses

 

 

8,830

 

 

 

8,068

 

 

 

(762)

 

 

-9.4%

Total operating expenses

 

 

11,302

 

 

 

10,096

 

 

 

(1,206)

 

 

-11.9%

Operating loss

 

 

(2,014)

 

 

(6,016)

 

 

4,002

 

 

 

66.5%

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from change in fair value of earnout liability

 

 

(1,096)

 

 

-

 

 

 

(1,096)

 

 

-100.0%

Loss from change in fair value of warrant liability

 

 

(2,834)

 

 

-

 

 

 

(2,834)

 

 

-100.0%

Loss from change in fair value of convertible debt

 

 

(142)

 

 

(401)

 

 

259

 

 

 

-64.6%

Loss on note conversion

 

 

(593)

 

 

-

 

 

 

(593)

 

 

-100.0%

Interest expense, net

 

 

(587)

 

 

(58)

 

 

(529)

 

 

-912.1%

Other (expense)

 

 

(23)

 

 

(7)

 

 

(16)

 

 

-228.6%

Total other income (expense), net

 

 

(5,275)

 

 

(466)

 

 

(4,809)

 

 

-1032.0%

Loss before income taxes

 

 

(7,289)

 

 

(6,482)

 

 

(807)

 

 

-12.4%

Provision for income taxes

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net (loss)

 

$(7,289)

 

$(6,482)

 

$(807)

 

 

-12.4%

  

Net Revenues — Net revenues for the nine months ended September 30, 2024 increased $11,751,000 to $19,844,000 as compared to $8,093,000 for the nine months ended September 30, 2023, as a result of increased product sales. We received purchase orders from various federal government agency customers totaling over $16 million from which we shipped in the nine months ended September 30, 2024.

 

 
34

Table of Contents

 

Cost of Net Revenues — Cost of net revenues primarily consists of product costs and post customer support. For the nine months ended September 30, 2024, cost of sales increased $6,543,000 to $10,556,000 as compared to $4,013,000 for the nine months ended September 30, 2023. The increase was due to higher product sales and product mix with increased equipment purchases during the nine months ended September 30, 2024.

 

Research and Development Expenses — Research and development expenses for the nine months ended September 30, 2024 increased $444,000 to $2,472,000 as compared to $2,028,000 for the nine months ended September 30, 2023. The increase was due to increased expenses for product development.

 

Selling, General and Administrative Expenses — Selling, general and administrative expenses for the nine months ended September 30, 2024 increased $762,000 to $8,830,000 as compared to $8,068,000 for the nine months ended September 30, 2023. The increase was due to (i) increased insurance costs of $574,000; (ii) increased professional fees of $1,712,000, primarily related to the merger and the Nasdaq listing; (iii) increased other operating expenses of $4,000; and offset by (iv) decreased stock based compensation of $1,527,000. The stock based compensation during the nine months ended September 30, 2023 included warrants to purchase common stock issued on May 8, 2023 for 765,000 shares to each of the two founders valued at $2,136,000.

 

Other Expense — Other expense for the nine months ended September 30, 2024 was $5,275,000 as compared to other expense of $466,000 for the nine months ended September 30, 2023. Other expense for the nine months ended September 30, 2024 consisted of (i) loss from change in fair value of earnout liability of $1,096,000; (ii) loss from change in fair value of warrant liability of $2,834,000; (iii) loss from change in fair value of convertible debt of $142,000; (iv) loss on note conversion of $593,000; (v) interest expense of $587,000: and (vi) other expense of $23,000. The loss from change in fair value of various financial instruments was primarily the result of an increase in the stock price.

 

The other expense for the nine months ended September 30, 2023 related to (i) the loss in change of the fair value of the convertible note of $401,000; (ii) interest expense of $58,000; and (iii) other expense of $7,000.

 

Net Loss — Net loss for the nine months ended September 30, 2024 was $7,289,000 as compared to a net loss of $6,482,000 for the nine months ended September 30, 2023. The net loss primarily related to noncash items of   $6,649,000. Noncash items included (i) depreciation of $2,000; (ii) stock based compensation of $1,088,000; (iii) net amortization of operating lease right of use asset of $175,000; (iv) issuance of common stock for services of $198,000; (v) noncash interest expense of $521,000; (vi) loss from change in fair value of warrant liability of $2,834,000; (vii) loss from change in fair value of earnout liability of $1,096,000; (viii) loss from change in fair value of convertible note of $142,000; and (ix) loss on note conversions of $593,000.

 

The net loss for the nine months ended September 30, 2023 included noncash expenses of $3,462,000 of which stock-based compensation was $2,616,000.

 

Liquidity and Capital Resources as of September 30, 2024 and December 31, 2023

 

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable and accounts payable and capital expenditures. We have incurred losses from operations in the past few years and had an accumulated deficit of $24.8 million as of September 30, 2024. As disclosed in Note 1, we closed an $8 million public offering with approximately $7.3 million in net proceeds. In November 2024, we analyzed our cash requirements and operations at least through November 2025 and determined that, based upon our current available cash and operations, we have no substantial doubt about our ability to continue as a going concern. Our assessment of the period of time through which its financial resources will be adequate to support our operations is a forward-looking statement and involves risks and uncertainties. Our actual results could vary as a result of its near and long-term future capital requirements that will depend on many factors. 

 

Operating Activities

 

Net cash used in operating activities for the nine months ended September 30, 2024 was $4,398,000. This amount was primarily related to (i) net loss of $7,289,000; and (ii) net working capital reductions of $3,758,000 (including a $2,059,000 reduction in deferred revenues); offset by (iii) noncash items of $6,649,000. Noncash items included (iv) depreciation of $2,000; (v) stock based compensation of $1,088,000; (vi) net amortization of operating lease right of use asset of $175,000; (vii) issuance of common stock for services of $198,000; (viii) noncash interest expense of $521,000; (ix) loss from change in warrant liability of $2,834,000; (x) loss from change in earnout liability of $1,096,000; (xi) loss from change in fair value of convertible note of $142,000; and (xii) loss on note conversions of $593,000.

 

 
35

Table of Contents

 

Net cash used in operating activities for the nine months ended September 30, 2023 was $2,524,000. This amount was primarily related to (i) a net loss of $6,482,000; offset by (ii) depreciation of $11,000; (iii) stock based compensation of $2,616,000; (iv) net amortization of operating lease right of use asset of $513,000; (v) accelerated amortization of ROU asset of $265,000; (vi) gain from lease termination of $344,000; (vii) unrealized loss for increase in fair value of convertible promissory note of $401,000; and (viii) working capital changes of $496,000.

 

Financing Activities

 

Net cash provided by financing activities for the nine months ended September 30, 2024 was $7,780,000 and consisted of (i) proceeds from offering of $7,290,000; (ii) proceeds from exercise of warrants of $294,000; and (iii) proceeds from stock option exercises of $196,000.

 

Net cash provided by financing activities for the nine months ended September 30, 2023 was $2,710,000 and consisted of (i) issuance of a senior secured convertible promissory note of $1,985,000; (ii) net advances provided by the founders of $1,150,000; and offset by (iii) the payoff of small business loan and line of credit of $425,000.

 

Debt Financing Arrangements

 

On June 22, 2023, we entered into a senior secured convertible promissory note with Platinum Capital Partners Inc. and received $2,000,000.

 

On February 2, 2024, we issued an amended and restated senior secured convertible promissory note to Platinum in the principal amount of $2,000,000. Interest accrued on the Platinum convertible note at the rate of 6% per annum calculated on the basis of 360 days. At the option of Platinum, the $2,000,000 principal amount of the note plus any accrued but unpaid interest is convertible into shares of common stock at a conversion price per share equal to the lower of (i) $3.69717, subject to appropriate adjustment as provided in the note, and (ii) 65% of the VWAP of the common stock for the five trading days immediately prior to any conversion, but in no event below $2.27518, subject to appropriate adjustment as provided in the note. The note contains “weighted average” anti-dilution protection for issuances of shares of common stock or common stock equivalents at a price less than the conversion price then in effect.

 

In connection with the issuance of the Platinum convertible note, we issued to Platinum an amended and restated common stock purchase warrant dated February 2, 2024, to purchase 189,334 shares of the Company’s common stock at an exercise price per share of $3.69717. On March 18, 2024, Platinum exercised the Platinum warrant and received 137,367 shares of common stock. Platinum forfeited 51,967 shares.

 

On June 22, 2024, we entered into an extension agreement related to the Platinum convertible note. The extension agreement extended the due date of the note to June 22, 2025. In consideration for entering into the extension agreement, we issued to Platinum 232,360 shares of restricted common stock in payment of all interest and extension fees through June 22, 2025. Subject to the terms and conditions of such extension agreement, for a period commencing on December 22, 2024 and ending at the close of business on December 22, 2025, Platinum has a one-time put right to have us purchase all or a portion of Platinum’s 232,360 restricted shares at $2.27518 per share. We granted piggyback registration rights to Platinum.

 

The obligations under the Platinum convertible note are secured by a blanket lien on all our assets pursuant to an Amended and Restated Security Agreement dated February 2, 2024 and are guaranteed pursuant to an Amended and Restated Guaranty dated February 2, 2024. We also concurrently entered into an Amended and Restated Subordination Agreement.

 

 
36

Table of Contents

 

Contractual Obligations and Commitments

 

 

 

 

 

 

Less Than

 

 

 

 

 

 

 

Contractual Cash Obligations

 

Total

 

 

1 Year

 

 

1-3 Years

 

 

4-5 Years

 

Operating lease cash payments

 

$1,138,331

 

 

$359,746

 

 

$746,252

 

 

$32,333

 

 

On July 13, 2023, we entered into a lease in Redmond, WA for 15,567 square feet of office and warehouse space which started October 1, 2023. The monthly payment is $25,000 per month. The lease expires October 31, 2027 and the monthly payment increases 3% on July 31, 2024 and each year thereafter. There is a one three year option to extend the lease based on the fair market rate on October 31, 2027, which we expect to exercise.

 

On February 29, 2024, we extended an office lease in Moorestown, North Carolina. We lease 3,621 square feet and the net monthly payment is $6,488. On August 27, 2024, we extended the lease to February 28, 2025.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements (as that term is defined in Item 303 of Regulation S-K) that are reasonably likely to have a current or future material effect on our financial condition, revenue or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

Critical Accounting Policies and Estimates

 

Our consolidated financial statements have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Actual results could differ materially from those estimates due to risks and uncertainties, including uncertainty in the current economic environment. To the extent that there are material differences between these estimates and our actual results, our future consolidated financial statements will be affected.

 

We believe that the significant accounting policies described in “Note 2, Summary of Significant Accounting Policies” to our audited consolidated financial statements are accurate and complete. The critical accounting estimates and policies during the nine months ended September 30, 2024 have not materially changed to those discussed in our Annual Report on Form 10-K for the year ended December 31, 2023.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

Not applicable to smaller reporting companies.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

a) Evaluation of Disclosure Controls and Procedures

 

We conducted an evaluation, under the supervision and with the participation of our management, of the effectiveness of the design and operation of our disclosure controls and procedures. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended (“Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms. Disclosure controls and procedures also include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2024, our disclosure controls and procedures are effective at the reasonable assurance level.

 

b) Inherent Limitations on Internal controls  

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. A control system, no matter how well designed and operated can provide only reasonable, but not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their cost.

 

c) Changes in Internal Control over Financial Reporting

 

During the nine months ended September 30, 2024, there were no other changes in our internal controls over financial reporting, which were identified in connection with our management’s evaluation required by paragraph (d) of rules 13a-15 and 15d-15 under the Exchange Act, that materially affected, or is reasonably likely to have a material effect on our internal control over financial reporting.

 

 
37

Table of Contents

 

PART II

 

ITEM 1. LEGAL PROCEEDINGS.

 

From time to time, we may become involved in actions, claims, litigation, and other legal proceedings occurring in the ordinary course of its business from time to time, including assertions by third parties relating to intellectual property infringement, contract or warranty breaches, or employment-related matters. We are not currently a party to any actions, claims, suits, or other legal procedures whose conclusion, if not determined in our favor, would have a major adverse effect on our business, financial condition, or results of operations, either individually or in the aggregate.

 

ITEM 1A. RISK FACTORS.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item. Our market risks are similar to those disclosed under the caption “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023, and our other filings with the SEC.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

During the three months ended September 30, 2024, we had the following sales of unregistered equity securities:

 

We issued an aggregate of 49,197 shares of common stock upon the exercise of stock options at an exercise price of $1.64 per share. This issuance was made pursuant to the exemption from registration under the Securities Act in reliance on Section 4(a)(2).

 

During the three months ended September 30, 2024, we issued 219,763 shares of common stock  related to the conversion of the Platinum convertible note. This issuance was made pursuant to the exemption from registration under the Securities Act in reliance on Section 4(a)(2).

 

On September 13, 2024, we issued an additional 86,198 shares of common stock related to the conversion of notes at $2.65 per share.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 5. OTHER INFORMATION.

 

None. 

 

 
38

Table of Contents

 

ITEM 6. EXHIBITS.

 

Exhibit No.

 

Description

4.1

 

Warrant Agency Agreement, dated September 3, 2024, between the Company and Equiniti Trust Company, LLC, as warrant agent (incorporated by reference to Exhibit 4.1 of the Company’s Current Report on Form 8-K filed with the SEC on September 4, 2024).

4.2

 

Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.2 of the Company’s Current Report on Form 8-K filed with the SEC on September 4, 2024).

4.3

 

Placement Agent Warrant, dated September 3, 2024 (incorporated by reference to Exhibit 4.3 of the Company’s Current Report on Form 8-K filed with the SEC on September 4, 2024).

10.1

 

Placement Agency Agreement dated August 29, 2024, between the Company and Roth Capital Partners, LLC and The Benchmark Company, LLC (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on September 4, 2024).

10.2

 

Securities Purchase Agreement, dated August 29, 2024, between the Company and the purchaser party thereto (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on September 4, 2024).

10.3

 

Form of Lock-up Agreement (incorporated by reference to Exhibit 10.16 of the Company’s Amendment No. 1 to Registration Statement on Form S-1 (File No. 333-281333), filed with the SEC on August 22, 2024).

10.4

 

Master Loan Agreement dated September 27, 2024 by and between Airship AI Holdings, Inc. and Victor Huang (attached herewith)

31.1

 

Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

 

Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

 

Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

 

Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

 

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because iXBRL tags are embedded within the Inline XBRL document).

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document. 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document. 

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document. 

101.LAB

 

Inline XBRL Taxonomy Extension Labels Linkbase Document. 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document. 

104

 

The Cover Page Interactive Data File, formatted in Inline XBRL (included within the Exhibit 101 attachments).

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

nullnullnullnullnullv3.24.3
Cover - shares
9 Months Ended
Sep. 30, 2024
Nov. 14, 2024
Document Information Line Items    
Entity Registrant Name Airship AI Holdings, Inc.  
Entity Central Index Key 0001842566  
Document Type 10-Q  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company true  
Entity Current Reporting Status Yes  
Document Period End Date Sep. 30, 2024  
Entity Filer Category Non-accelerated Filer  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2024  
Entity Ex Transition Period false  
Entity Common Stock Shares Outstanding   27,284,515
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-40222  
Entity Incorporation State Country Code DE  
Entity Tax Identification Number 93-4974766  
Entity Address Address Line 1 8210 154th Ave NE  
Entity Address City Or Town Redmond  
Entity Address Postal Zip Code 98052  
City Area Code 877  
Local Phone Number 462-4250  
Entity Interactive Data Current Yes  
Entity Address State Or Province WA  
Common Stocks [Member]    
Document Information Line Items    
Security 12b Title Common Stock  
Trading Symbol AISP  
Security Exchange Name NASDAQ  
Warrants [Member]    
Document Information Line Items    
Security 12b Title Warrant  
Trading Symbol AISPW  
Security Exchange Name NASDAQ  
v3.24.3
CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2024
Dec. 31, 2023
CURRENT ASSETS:    
Cash and cash equivalents $ 6,515,688 $ 3,124,413
Accounts receivable, net of allowance for credit losses of $0 1,121,862 1,648,904
Prepaid expenses and other 373,498 18,368
Income tax receivable 0 7,230
Total current assets 8,011,048 4,798,915
PROPERTY AND EQUIPMENT, NET 0 1,861
OTHER ASSETS    
Other assets 155,432 182,333
Operating lease right of use asset 929,890 1,104,804
TOTAL ASSETS 9,096,370 6,087,913
CURRENT LIABILITIES:    
Accounts payable - trade 722,742 2,908,472
Advances from founders 1,750,000 1,750,000
Accrued expenses 121,978 200,531
Senior Secured Convertible Promissory Notes 1,793,360 2,825,366
Current portion of operating lease liability 267,660 174,876
Deferred revenue- current portion 3,326,543 4,008,654
Total current liabilities 7,982,283 11,867,899
NON-CURRENT LIABILITIES:    
Operating lease liability, net of current portion 718,393 943,702
Warrant liability 3,501,543 667,985
Earnout liability 6,229,390 5,133,428
Deferred revenue- non-current 3,585,344 4,962,126
Total liabilities 22,016,953 23,575,140
STOCKHOLDERS' DEFICIT:    
Preferred stock - no par value, 5,000,000 shares authorized, 0 shares issued and outstanding as of September 30, 2024 and December 31, 2023 0 0
Common stock - $0.0001 par value, 200,000,000 shares authorized, 26,954,871 and 22,812,048 shares issued and outstanding as of September 30, 2024 and December 31, 2023 2,692 2,281
Additional paid in capital 11,845,413 0
Accumulated deficit (24,765,218) (17,476,700)
Accumulated other comprehensive loss (3,470) (12,808)
Total stockholders' deficit (12,920,583) (17,487,227)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 9,096,370 $ 6,087,913
v3.24.3
CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
CONSOLIDATED BALANCE SHEETS    
Accounts receivable, net of provision $ 0 $ 0
Preferred stock, par value $ 0 $ 0
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.0001 $ 0.0001
Common stock, authorized 200,000,000 200,000,000
Common stock, issued 26,954,871 22,812,048
Common stock, outstanding 26,954,871 22,812,048
v3.24.3
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) (Unaudited)        
Product $ 1,730,521 $ 910,441 $ 16,525,515 $ 4,415,386
Post contract support 1,137,128 1,473,915 3,318,180 3,677,585
Revenues 2,867,649 2,384,356 19,843,695 8,092,971
COST OF NET REVENUES:        
Cost of Sales 285,448 439,565 9,381,244 2,575,523
Post contract support 428,820 342,869 1,174,737 1,437,910
Cost of Revenue 714,268 782,434 10,555,981 4,013,433
GROSS PROFIT 2,153,381 1,601,922 9,287,714 4,079,538
RESEARCH AND DEVELOPMENT EXPENSES 1,073,735 688,798 2,471,872 2,028,081
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES 2,667,130 2,142,327 8,829,544 8,067,343
TOTAL OPERATING EXPENSES 3,740,865 2,831,125 11,301,416 10,095,424
OPERATING INCOME (LOSS) (1,587,484) (1,229,203) (2,013,702) (6,015,886)
OTHER INCOME (EXPENSE):        
Gain (loss) from change in fair value of earnout liability 5,511,961 0 (1,095,962) 0
Gain (loss) from change in fair value of warrant liability 2,471,186 0 (2,833,558) 0
Gain (loss) from change in fair value of convertible debt 370,548 (400,921) (141,636) (400,921)
Loss on note conversion (434,797) 0 (593,591) 0
Interest expense, net (133,824) (33,761) (587,149) (57,830)
Other (expense) income (16,366) (2,722) (22,922) (7,425)
Total other income (expense), net 7,801,440 (437,404) (5,274,818) (466,176)
INCOME (LOSS) BEFORE PROVISON FOR INCOME TAXES 6,213,956 (1,666,607) (7,288,520) (6,482,062)
Provision for income taxes 0 0 0 0
NET INCOME (LOSS) 6,213,956 (1,666,607) (7,288,520) (6,482,062)
OTHER COMPREHENSIVE INCOME        
Foreign currency translation income, net 354 (2,410) 9,338 40,141
TOTAL COMPREHENSIVE INCOME (LOSS) $ 6,214,310 $ (1,669,017) $ (7,279,182) $ (6,441,921)
NET INCOME (LOSS) PER SHARE:        
Basic $ 0.25 $ (0.07) $ (0.31) $ (0.28)
Diluted $ 0.17 $ (0.07) $ (0.31) $ (0.28)
Weighted average shares of common stock outstanding        
Basic 24,696,425 22,812,048 23,609,189 22,812,048
Diluted 35,445,694 22,812,048 23,609,189 22,812,048
v3.24.3
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Other Comprehensive Income (Loss)
Balance, shares at Dec. 31, 2022   22,812,048      
Balance, amount at Dec. 31, 2022 $ (8,358,411) $ 2,281 $ 1,963,727 $ (10,314,313) $ (10,106)
Stock-based compensation 136,709 0 136,709 0 0
Net loss (1,712,176) $ 0 0 (1,712,176) 0
Balance, shares at Mar. 31, 2023   22,812,048      
Balance, amount at Mar. 31, 2023 (9,933,878) $ 2,281 2,100,436 (12,026,489) (10,106)
Balance, shares at Dec. 31, 2022   22,812,048      
Balance, amount at Dec. 31, 2022 (8,358,411) $ 2,281 1,963,727 (10,314,313) (10,106)
Net loss (6,482,062)        
Balance, shares at Sep. 30, 2023   22,812,048      
Balance, amount at Sep. 30, 2023 (12,226,689) $ 2,281 4,537,370 (16,796,375) 30,035
Balance, shares at Mar. 31, 2023   22,812,048      
Balance, amount at Mar. 31, 2023 (9,933,878) $ 2,281 2,100,436 (12,026,489) (10,106)
Stock-based compensation 136,709 0 136,709 0 0
Net loss 3,103,279 0 0 (3,103,279) 0
Stock based compensation- warrants 2,136,115 0 2,136,115 0 0
Foreign currency translation gain 42,551 $ 0 0 0 42,551
Balance, shares at Jun. 30, 2023   22,812,048      
Balance, amount at Jun. 30, 2023 (10,721,782) $ 2,281 4,373,260 (15,129,768) 32,445
Net loss (1,666,607) 0 0 (1,666,607) 0
Foreign currency translation gain (2,410) 0 0 0 (2,410)
Stock-based compensation- stock option grants 164,110 $ 0 164,110 0 0
Balance, shares at Sep. 30, 2023   22,812,048      
Balance, amount at Sep. 30, 2023 (12,226,689) $ 2,281 4,537,370 (16,796,375) 30,035
Balance, shares at Dec. 31, 2023   22,812,048      
Balance, amount at Dec. 31, 2023 (17,487,227) $ 2,281 0 (17,476,700) (12,808)
Stock-based compensation 268,989 0 268,989 0 0
Net loss (31,964,469) 0 0 (31,964,469) 0
Foreign currency translation gain 3,239 $ 0 0 0 3,239
Issuance of common stock for prior period services, shares   15,000      
Issuance of common stock for prior period services, amount 0 $ 0 0 0 0
Issuance of common stock for conversion of debt, shares   169,204      
Issuance of common stock for conversion of debt, amount 835,610 $ 17 835,593 0 0
Issuance of common stock for exercise of warrants, shares   162,867      
Issuance of common stock for exercise of warrants, amount 293,249 $ 16 293,233 0 0
Balance, shares at Mar. 31, 2024   23,159,119      
Balance, amount at Mar. 31, 2024 (48,050,609) $ 2,314 1,397,815 (49,441,169) (9,569)
Balance, shares at Dec. 31, 2023   22,812,048      
Balance, amount at Dec. 31, 2023 (17,487,227) $ 2,281 0 (17,476,700) (12,808)
Net loss (7,288,520)        
Balance, shares at Sep. 30, 2024   26,954,871      
Balance, amount at Sep. 30, 2024 (12,920,583) $ 2,692 11,845,413 (24,765,218) (3,470)
Balance, shares at Mar. 31, 2024   23,159,119      
Balance, amount at Mar. 31, 2024 (48,050,609) $ 2,314 1,397,815 (49,441,169) (9,569)
Stock-based compensation 261,636 0 261,636 0 0
Net loss 18,461,995 0 0 18,461,995 0
Foreign currency translation gain 5,745 $ 0 0 0 5,745
Issuance of common stock for exercise of warrants, shares   100      
Issuance of common stock for exercise of warrants, amount 800 $ 0 800 0 0
Issuance of common stock for services, shares   50,000      
Issuance of common stock for services, amount 198,500 $ 5 198,495 0 0
Issuance of common stock for stock options exercise, shares   294,448      
Issuance of common stock for stock options exercise, amount 146,973 $ 29 146,944 0 0
Issuance of common stock for debt interest payment, shares   232,360      
Issuance of common stock for debt interest payment, amount 1,008,423 $ 23 1,008,400 0 0
Balance, shares at Jun. 30, 2024   23,736,027      
Balance, amount at Jun. 30, 2024 (27,966,537) $ 2,371 3,014,090 (30,979,174) (3,824)
Stock-based compensation 273,170 0 273,170 0 0
Net loss 6,213,956 0 0 (6,213,956) 0
Stock based compensation- warrants 284,478 0 284,478 0 0
Foreign currency translation gain 354 $ 0 0 0 354
Issuance of common stock for conversion of debt, shares   305,961      
Issuance of common stock for conversion of debt, amount 934,796 $ 30 934,766 0 0
Issuance of common stock for stock options exercise, shares   30,000      
Issuance of common stock for stock options exercise, amount 49,200 $ 3 49,197 0 0
Issuance of common stock and warrants for offering, net, shares   2,882,883      
Issuance of common stock and warrants for offering, net, amount 7,290,000 $ 288 7,289,712 0 0
Balance, shares at Sep. 30, 2024   26,954,871      
Balance, amount at Sep. 30, 2024 $ (12,920,583) $ 2,692 $ 11,845,413 $ (24,765,218) $ (3,470)
v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (7,288,520) $ (6,482,062)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 1,861 11,160
Stock-based compensation- stock option grants 803,797 479,913
Stock-based compensation- warrants 284,478 2,136,115
Amortization of operating lease right of use asset 174,914 513,234
Accelerated amortization of ROU asset - lease termination 0 265,130
Gain from lease termination 0 (344,093)
Issuance of common stock for services 198,500 0
Noncash interest expense 520,758 0
Loss from change in fair value of warrant liability 2,833,558 0
Loss from change in fair value of earnout liability 1,095,962 0
Loss from change in fair value of convertible note 141,636 400,921
Loss on note conversions 593,591 0
Changes in operating assets and liabilities:    
Accounts receivable 527,042 104,814
Prepaid expenses and other 132,512 (295)
Other assets 26,901 (255,431)
Operating lease liability (132,525) (461,203)
Payroll and income tax receivable 7,230 960,383
Accounts payable - trade and accrued expenses (2,261,087) 377,519
Accrued income tax expense 0 (10,000)
Deferred revenue (2,058,893) (220,144)
NET CASH USED IN OPERATING ACTIVITIES (4,398,285) (2,524,039)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Issuance of common stock and warrants for offering, net 7,290,000 0
Proceeds from convertible promissory note 0 1,984,582
Proceeds from warrant exercise 294,049 0
Advances from founders, net 0 1,150,000
Proceeds from stock option exercises 196,173 0
Repayment of small business loan and line of credit 0 (424,540)
NET CASH PROVIDED BY FINANCING ACTIVITIES 7,780,222 2,710,042
Effect from exchange rate on cash 9,338 (2,244)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS 3,381,937 186,003
CASH AND CASH EQUIVALENTS, beginning of period 3,124,413 298,614
CASH AND CASH EQUIVALENTS, end of period 6,515,688 482,373
Supplemental disclosures of cash flow information:    
Interest paid 0 21,438
Taxes paid 2,410 17,247
Noncash investing and financing    
Elimination of advances to founders in connection with contribution of Zeppelin by shareholders 0 1,100,000
Elimination of payables to founders in connection with contribution of Zeppelin by shareholders 0 1,100,000
Issuance of common stock for debt interest payment 487,642  
Issuance of common stock for debt conversion 1,770,340 0
Recognition of warrant liability $ 0 $ 15,418
v3.24.3
Organization
9 Months Ended
Sep. 30, 2024
Organization  
Organization

1. Organization

 

Airship AI Holdings, Inc. (the “Company” or “Airship”) is a holding company incorporated in Delaware that executes business through its wholly owned subsidiary, Airship AI, Inc. (“Airship AI”). Prior to the formation of Super Simple AI, Inc. in 2022, the Company operated as Airship AI, Inc. (formerly known as JDL Digital Systems, Inc.). On March 7, 2023, Super Simple AI, Inc. changed its name to Airship AI Holdings, Inc. Super Simple AI, Inc. was formed in January 2022 through a share exchange with JDL Digital Systems, Inc. JDL Digital Systems, Inc. was incorporated under the laws of the State of Washington on June 30, 2003.

 

On December 21, 2023, the Company completed the merger contemplated by the Merger Agreement, dated as of June 27, 2023 and amended on September 22, 2023, by and among BYTE Acquisition Corp. (“BYTS”), BYTE Merger Sub, Inc., a Washington corporation and a direct, wholly-owned subsidiary of BYTS (“Merger Sub”), and Airship AI.

 

Effective December 21, 2023, Merger Sub merged with and into Airship AI with Airship AI as the surviving corporation. Thus, Airship AI became a wholly-owned subsidiary of the Company. In connection with the merger, Airship AI changed its name from “Airship AI Holdings, Inc.” to “Airship AI, Inc.” See Note 11 —Reverse Recapitalization for additional information.

 

Fair Value Transactions

 

As a result of the merger, the Company entered into the following transactions that were measured at fair value and vary quarterly with the share price and other items. Any change is non-cash and is recorded as a gain or loss in other income (expense). See Note 14– Fair Value Measurements for more information.

 

 

 

Liability as of

 

 

Liability as of

 

 

 

September 30, 2024

 

 

December 31, 2023

 

 

 

 

 

 

 

 

Earnout liability

 

$6,229,390

 

 

$5,133,428

 

Senior Secured Convertible Promissory Notes

 

 

1,793,360

 

 

 

2,825,366

 

Warrant liability (Public Warrants)

 

 

3,393,393

 

 

 

646,428

 

Warrant liability (Private Warrants)

 

 

108,150

 

 

 

21,557

 

Total liabilities measured at fair value

 

$11,524,293

 

 

$8,626,779

 

 

 

 

 

 

 

 

 

 

Other loss related to instruments recorded at fair value during the nine months ended September 30, 2024 and 2023

 

$(4,071,156)

 

$(400,921)

  

Common Stock and Warrant Offering

 

On September 3, 2024, the Company closed an $8 million public offering with net proceeds of approximately $7.3 million, after deducting the estimated offering expenses payable by the Company, including the placement agent fees. The offering consisted of 2,882,883 shares of its common stock and warrants to purchase up to an aggregate of 2,882,883 shares of its common stock at a combined public offering price of $2.775 per share and associated common stock warrant. The warrants have an exercise price of $2.65 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance. The warrants are classified as a component of permanent equity because they are freestanding financial instruments that are legally detachable and separately exercisable from the shares of common stock with which they were issued, do not embody an obligation for the Company to repurchase its shares, and permit the holders to receive a fixed numbers of shares of common stock upon exercise.

 

The Company intends to use the net proceeds from the offering for working capital and general corporate purposes, including cost of goods sold purchases, personnel and product development.

Private Placement and Public Warrants

 

At the merger closing, the Company assumed 515,000 private placement warrants and 16,184,612 public warrants. On June 3, 2024, the Company permanently reduced the exercise price of such warrants from $11.50 per share to an exercise price of $7.80 per share. The purpose of this reduced exercise price was to potentially raise proceeds received from the exercise of such warrants, if any, for working capital and general corporate purposes. As of September 30, 2024, there were 515,000 private placement warrants and 16,159,012 public warrants outstanding. See Note 12– Private Placement and Public Warrants for more information.

 

Business

 

The Company is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources.

 

The Company solves these challenges by structuring “dark” or unstructured data at the edge, the location at which the data is generated and collected, and leveraging purpose-built AI models. Unstructured, or “dark” data, which is typically categorized as qualitative data, cannot be processed and analyzed via conventional data tools and methods. Conversely, structured data, typically categorized as quantitative data, is highly organized and easily decipherable by machine learning algorithms.

 

Structuring and then analyzing data using AI models at the edge, versus transmitting the data from the edge back to a central processing location for structuring and analysis, enables real-time decision making and data-driven operational efficiency.

 

The Company specializes in ingesting all available metadata from edge-based sensors used by government and law enforcement agencies around the world, including surveillance cameras (video), audio, telemetry, acoustic, seismic, and autonomous devices, along with large commercial corporations with fundamentally similar capabilities and requirements.

 

Data generated by these edge-based sensors, including video, can then be run through the Company’s trained AI models to detect objects present within the video frame. Once an object is detected, for example an automobile, additional identifying characteristics of the object can be extracted from the image including the license plate characters and the make, model, and color of the automobile. This process of analyzing, logging and categorizing ingested data is referred to as “structuring” the data.

 

Airship AI’s software allows customers to view structured data both in real-time as well as to conduct searches on the structured data at a later point in time. Real-time structured data use includes, for example, alarms on a specific license plate or a specific make, model or color of automobile. Non-real-time structured data use includes, for example, searching a database of video data that has been previously ingested and stored to find instances of a particular license plate being visible, along with other logged vehicle characteristics such as make, model and color of an automobile.

 

Additional edge deployed AI models enable similar object detection and recognition of common and custom trained objects, such as an aircraft, boat, person, animal, bag, or weapon. Airship AI’s models provide similar data points for these object types allowing analysts the ability to be notified in real-time of the detection of a specified object and similarly search for historically detected objects. Examples include detecting aircrafts and boats along with their respective tail numbers and hull registration numbers.

 

The Company’s AI modelling process starts with pre-trained AI models from its technology ecosystem partners which the Company then customizes using proprietary datasets tailored towards its customers’ unique workflow requirements. Where customers have pre-existing AI models or engines, the Company integrates those models or engines into its edge platform allowing customers to leverage proprietary models within the Airship AI software ecosystem.

The Company’s primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where they need it, using a highly secure permissioned based architecture.

 

The Company employed fifty one employees as of September 30, 2024. The employees are headquartered in Redmond, WA and are supported by a growing team at its Customer Center of Excellence located in Charlotte, NC. The Company employed eight research and development personnel in Taiwan as of September 30, 2024.

v3.24.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2024
Summary of Significant Accounting Policies  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

 

Basis of Presentation and Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany accounts and transactions have been eliminated. The preparation of these consolidated financial statements were prepared in conformity with U.S. generally accepted accounting principles (“GAAP”).

 

For periods prior to the merger, the reported share and per share amounts have been retroactively converted by the applicable exchange ratio with the exception of the authorized shares and shares reserved for issuance. See Note 11—Reverse Recapitalization for additional information.

 

Functional Currency

 

The Company’s  reporting  currency  is the U.S.  Dollar. The Company’s  functional currency for U.S. operations is  the U.S. Dollar. The operations of Zeppelin Worldwide, Inc. and its subsidiary, Zeppelin Taiwan, Ltd. (together “Zeppelin”) use the Taiwan Dollar as its functional currency. At each period end, Zeppelin’s balance sheet is translated into U.S. Dollars based upon the period end exchange rate, while their statements of operations and comprehensive loss and statements of cash flows are translated into U.S. Dollars based upon an average exchange rate during the period.

 

Cash and Cash Equivalents

 

The Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash equivalents. The Company maintains cash balances at various financial institutions. Balances at US banks are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk for cash on deposit.

 

Revenue Recognition and Deferred Revenue

 

The Company primarily generates revenue from sales of systems and products and the related post contract support to customers. The Company’s primary systems and products include Outpost AI, Acropolis and Airship Command. To date, the majority of the Company’s product revenue that has been recognized consists primarily of a bundled offering of hardware and software which delivers on premise solutions to its customers. Separate limited software subscription services have been delivered to customers including those customers that are able to operate in a cloud based environment. The transaction price recognized as revenue represents the amount the Company expects to be entitled to and is primarily comprised of product revenue, net of returns and variable consideration, including sales incentives provided to customers. Payment is typically due within 30 to 90 calendar days of the invoice date.

 

The Company recognizes revenue when promised goods or services are transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services by following a five-step process: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price, and (5) recognize revenue when or as the Company satisfies a performance obligation, as further described below.

Product Revenue

 

Product revenue is derived primarily from sales of the Company’s system offerings, Outpost AI, Acropolis and Airship Command. The Company recognizes product revenue at a point in time when title transfers, when the products are shipped, or when control of the system is transferred to the customer, which usually is upon delivery of the system and when contractual performance obligations have been satisfied.

 

Post Contract Support Revenue

 

Post Contract Support (“PCS”) revenue is derived primarily from the Company’s support and software maintenance agreements (“SMA”). The Company’s PCS includes the right to receive, on a when and if available basis, future unspecified firmware upgrades and features as well as bug fixes, and email and telephone support. The Company allocates a portion of the transaction price to the PCS performance obligation based on a cost-plus methodology and recognizes the associated revenue on a straight-line basis over the estimated term of the support period. The Company’s support contracts are typically one to five years with an average of four years, payment is due within 30 to 90 calendars days of the invoice date and may include options to renew. For the three months ended September 30, 2024 and 2023, the Company recognized revenue of $95,120 and $60,367, respectively, related to one-year support contracts. For the three months ended September 30, 2024 and 2023, the Company recognized revenue of $1,042,008 and $1,413,548, respectively, related to multi-year support contracts. For the nine months ended September 30, 2024 and 2023, the Company recognized revenue of $234,717 and $141,582, respectively, related to one-year support contracts. For the nine months ended September 30, 2024 and 2023, the Company recognized revenue of $3,083,464 and $3,536,003 respectively, related to multi-year support contracts.

 

Other Services

 

The Company earns other service revenues from installation services, training and licensing which are short-term in nature and revenue for these services are recognized at the time of performance when the service is provided.

 

Contracts with Multiple Performance Obligations

 

The Company’s contracts with customers often contain multiple performance obligations that can include three separate obligations: (i) a hardware component (which may be bundled with hardware accessories) and the embedded firmware essential to the functionality of the hardware component delivered at the time of sale; (ii) the right to the Company’s downloadable free application and software solutions, and (iii) the right for the customer to receive post contract support (“PCS”) after the initial sale. The Company’s products and PCS offerings have significant standalone functionalities and capabilities. Accordingly, the products are distinct from the Company’s PCS services as customers can benefit from the products without the PCS services and such PCS services are separately identifiable within the contracts. The Company accounts for multiple agreements with a single customer as a single contract if the contractual terms and/or substance of those agreements indicate that they may be so closely related that they are, in effect, parts of a single contract. The amount of consideration the Company expects to receive in exchange for delivering on the contract is allocated to each performance obligation based on its relative standalone selling price.

 

The Company establishes the standalone selling price using the prices charged for a deliverable when sold separately. If the standalone selling price is not observable through past transactions, the Company estimates the standalone selling price based on its pricing model and offering type (products or PCS services).

 

The Company has elected the practical expedient to not assess whether a contract has a significant financing component as the Company’s standard payment terms are less than one year.

 

The Company sells its products primarily through a direct sales force. The Company considers revenue to be earned when all of the following criteria are met:

 

 

The Company has a contract with a customer that creates enforceable rights and obligations,

 

 

 

 

Promised performance obligations are identified,

 

 

 

 

The transaction price, or the amount the Company expects to receive, is determinable and

 

 

 

 

The Company has satisfied the performance obligations to the customer.

Transfer of control is evidenced upon passage of title and risk of loss to the customer unless the Company is required to provide additional services.

 

The Company’s short-term and long-term deferred revenue balances totaled $3,326,543 and 3,585,344 as of September 30, 2024. The Company’s short-term and long-term deferred revenue balances totaled $4,008,654 and $4,962,126 as of December 31, 2023. Of the deferred revenue balance of $8,970,780 as of January 1, 2024, the Company recognized approximately $933,675 and $3,061,613 during the three and nine months ended September 30, 2024, respectively.

 

Accounts Receivable and Provision for Credit Losses

 

The Company generally sells its products to large governmental entities and large corporations in the United States. Accounts receivable are recorded at invoiced amounts and are non-interest bearing.

 

The Company adopted Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments — Credit Losses (codified as Accounting Standards Codification (“ASC”) 326) on January 1, 2023. ASC 326 adds to U.S. GAAP the current expected credit loss (“CECL”) model, a measurement model based on expected losses rather than incurred losses. Prior to the adoption of ASC 326, the Company evaluated receivables regularly and adjusted the allowance for doubtful accounts accordingly. The Company determined estimates of uncollectible accounts receivable based primarily on actual historical bad debt and sales return trends, customers financial condition and general economic conditions. Under the application of ASC 326, the Company’s historical credit loss experience provides the basis for the estimation of expected credit losses, as well as current economic and business conditions, and anticipated future economic events that may impact collectability. In developing its expected credit loss estimate, the Company evaluated the appropriate grouping of financial assets based upon its evaluation of risk characteristics, including consideration of the types of products and services sold. Account balances are written off against the allowance for expected credit losses after all means of collection have been exhausted and the potential for recovery is considered remote.

 

Occasionally certain long-standing customers, who routinely place large orders, will have unusually large receivables balances relative to the total gross receivables. Management monitors the payments for these large balances closely and very often requires payment of existing invoices before shipping new sales orders. As of September 30, 2024 and December 31, 2023, the Company did not have a reserve for credit losses as all accounts receivable are considered collectible. Accounts receivable balances as of September 30, 2024 and December 31, 2023 were $1,121,862 and $1,648,904, respectively.

 

Concentration of Credit and Sales Risk

 

The Company sells its product to commercial and government customers under agreements that are normally paid within 30 days of contract completion.    

 

For the nine months ended September 30, 2024, the Company had revenue from sixty eight customers and one customer represented 63% of total revenue, although such a high level of customer concentration is not typical. The primary reason for the high level of customer concentration for the nine months ended September 30, 2024 was due to one large order received in late 2023 which was fulfilled in the nine months ended September 30, 2024. As of September 30, 2024, five customers represent approximately 21%, 20%, 16%, 12% and 11% of outstanding account receivables. Due to the nature of the customers and timely payment history, customer concentration and credit risk in account receivables is estimated to be minimal.

 

For the nine months ended September 30, 2023, two customers represent approximately 49% and 16% of total revenue. As of December 31, 2023, three customers represent approximately 51%, 26% and 17% of outstanding account receivables. Due to the nature of the customers and timely payment history, customer concentration and credit risk in account receivables is estimated to be minimal.

Inventory

 

The Company’s purchase of inventory, primarily computer servers, is undertaken to match purchase orders received from customers. Upon receipt of inventory, the Company generally configures the servers and loads proprietary software onto the servers before shipping out. The Company holds inventory for a short period of time and as of September 30, 2024 and December 31, 2023, it had no inventory in stock. Inventory value is primarily material costs and is valued at the lower of cost (first in, first out method) or net realizable value.

 

Long-Lived Assets

 

The Company reviews its long-lived assets for impairment annually or when changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets under certain circumstances are reported at the lower of carrying amount or fair value. Assets to be disposed of and assets not expected to provide any future service potential to the Company are recorded at the lower of carrying amount or fair value (less the projected cost associated with selling the asset). To the extent carrying values exceed fair values, an impairment loss is recognized in operating results. The Company recorded impairment losses of $0 for the nine months ended September 30, 2024 and 2023.

 

Research and Development Expenses

 

Research and development expenses consist of the cost of employees, consultants and contractors who design, engineer and develop new products and processes as well as materials, supplies and facilities used in producing prototypes.

 

The Company’s current research and development efforts are primarily focused on improving the Company’s products. The Company is also actively involved in identifying new applications. The Company’s current internal team along with outside consultants has considerable experience working with the application of the Company’s technologies and their applications. The Company engages third party experts as required to supplement the Company’s internal team. The Company believes that continued development of new and enhanced technologies is essential to the Company’s future success. The Company incurred research and development expenses of $1,073,735 and $688,798 for the three months ended September 30, 2024 and 2023, respectively, on development activities. The Company incurred research and development expenses of $2,471,872 and $2,028,081 for the nine months ended September 30, 2024 and 2023, respectively, on development activities.

 

Software Development Costs

 

Costs incurred in the development of software programs for the Company’s products are charged to operations as incurred until technological feasibility of the software has been established. Generally, technological feasibility is established when the software module performs its primary functions described in its original specifications, contains features required for it to be usable in a production environment, is completely documented and the related hardware portion of the product is complete. After technological feasibility is established, any additional costs are capitalized. Capitalization of software costs ceases when the software is substantially complete and is ready for its intended use. No software development costs have been capitalized as of September 30, 2024 and December 31, 2023.

 

Cost of Net Revenues

 

Cost of net revenues for products includes components and freight. Cost of net revenues for post contract support and other services includes primarily the cost of personnel and personnel-related expenses to conduct implementations and ongoing client support.

 

Advertising

 

Advertising costs are charged to selling, general and administrative expenses as incurred. Advertising and marketing costs for the three months ended September 30, 2024 and 2023 were $41,107 and $2,587, respectively. Advertising and marketing costs for the nine months ended September 30, 2024 and 2023 were $130,428 and $55,916, respectively.

Shipping and Handling of Products

 

Amounts billed to customers for shipping and handling of products are included in net revenues. Costs incurred related to shipping and handling of products are included in cost of revenues.

 

Fair Value Measurements

 

Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy, which requires classification based on observable and unobservable inputs when measuring fair value. The fair value hierarchy distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs). The hierarchy consists of three levels:

 

Level 1 — Quoted prices in active markets for identical assets and liabilities;

 

Level 2 — Inputs other than level one inputs that are either directly or indirectly observable; and

 

Level 3 — Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

The recorded value of other financial assets and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other current assets, accounts payable and accrued expenses approximate the fair value of the respective assets and liabilities as of September 30, 2024 and December 31, 2023 are based upon the short-term nature of the assets and liabilities. The Company recorded its Senior Secured Convertible Promissory Note, earnout liability (unvested earnout shares), and the warrants that were issued with the Convertible Promissory Note at fair value, remeasured on a recurring basis and considered them as Level 3 instruments. The public and private warrants were considered Level 1 and 2 instruments, respectively. The fair value of the vested earnout shares was considered a Level 1 instrument. The method of determining the fair value of the Senior Secured Convertible Promissory Note and attached warrants is described below.

 

The Company classifies as liabilities any contracts that (i) require net-cash settlement (including a requirement to net- cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).

 

Accounting for Senior Secured Convertible Promissory Notes at Fair Value

 

The Company has elected the fair value option to account for the senior secured convertible note that was issued on June 22, 2023 and the convertible notes that were issued in October and November 2023 with changes in fair value recorded in the Consolidated Statements of Operations and Comprehensive Loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes are recognized in earnings as incurred and not deferred. Values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the liability. Considerable judgment is necessary to interpret market data and determine an estimated fair value. The use of different market assumptions or valuation methods may have a material effect on the estimated fair values. As of September 30, 2024, the Company has used a Monte Carlo simulation pricing model that factors in potential outcomes being consummated, such as the convertible notes being repaid in cash and the convertible notes being converted to common stock. All of these scenarios take into consideration the terms and conditions of the underlying convertible notes plus potential changes in the underlying value of the common stock. For the nine months ended September 30, 2024 and 2023, the Company recognized an unrealized loss of $141,636 and $400,921 for the change in fair value of the notes and is included in the Consolidated Statements of Operations and Comprehensive Loss. The Company believes accounting for the convertible notes at fair value better aligns the measurement methodologies of assets and liabilities, which may mitigate certain earnings volatility.

Derivative Liabilities and Earnout Liabilities

 

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants and  earnout shares to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company classifies as liabilities any contracts that (i) require net-cash settlement (including a requirement to net- cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).

 

At the merger closing, the Company assumed 515,000 private placement warrants and 16,184,612 public warrants. On June 3, 2024, the Company permanently reduced the exercise price of such warrants from $11.50 per share to an exercise price of $7.80 per share. The purpose of this reduced exercise price was to potentially raise proceeds received from the exercise of such warrants, if any, for working capital and general corporate purposes. As of September 30, 2024, there were 515,000 private placement warrants and 16,159,012 public warrants outstanding. See Note 12– Private Placement and Public Warrants for more information.

 

Upon consummation of the merger, the Company evaluated the warrants and concluded that they did not meet the criteria to be classified within the stockholders’ deficit. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The initial estimated fair value of the warrants was measured using a Monte Carlo simulation. The subsequent estimated fair value of the public warrants is based on the listed price in an active market for such warrants while the fair value of the private placement warrants continues to be measured using a Monte Carlo simulation with the key inputs being directly or indirectly observable public warrants listed price. Since the public and private warrants meet the definition of a derivative, the Company recorded the public and private warrants as liabilities on the consolidated balance sheet at fair value upon the merger closing, with subsequent changes in the fair value recognized in the consolidated statements of operations at each reporting date.

 

At the closing of the merger, the Airship AI securityholders that hold shares of common stock of Airship AI, Airship AI options, Airship AI earnout warrants or Airship AI SARs have the contingent right to receive up to 5.0 million additional shares of common stock, subject to certain contingencies.  These earnout shares have been categorized into two components: (i) the vested shares that are associated with stockholders with vested equity at the closing of the merger that will be earned upon achievement of the earnout milestones and (ii) the unvested shares associated with stockholders with unvested equity at the closing of the merger that will be earned over the remaining service period with the Company on their unvested equity shares and upon achievement of the earnout milestones.

 

The earnout shares associated with vested shares are recognized as derivative liabilities in accordance with ASC 815-40, as the events that determine the number of earnout shares required to be released or issued, as the case may be, include events that were not solely indexed to the fair value of common stock of the Company. The earnout shares were measured at the merger closing and subsequently measured at each reporting date until settled or when they met the criteria for equity classification. Accordingly, the Company recognizes the earnout shares as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The earnout shares were valued using a Monte Carlo analysis.

 

At the closing of the merger, the unvested earnout shares were considered to be equity instruments and valued at approximately $2,675,000. This amount will be recognized as stock-based compensation going forward over the five-year vesting period.

 

Derivative warrant and earnout shares liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of significant current assets or require the creation of current liabilities.

Stock-Based Compensation

 

The Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted stock, stock appreciation rights, incentive stock options, nonqualified stock options, unvested earnout shares and warrants to purchase shares of common stock at the fair market value at the time of grant. Stock-based compensation cost is measured by the Company at the grant date and the fair value of the award is recognized as an expense, over the requisite service period which is generally the vesting period. The Company adjusts stock-based compensation for changes to the estimate of expected equity award forfeitures based on actual forfeiture experience. The effect of adjusting the forfeiture rate is recognized in the period the forfeiture estimate is changed.

 

Income Taxes

 

Income taxes are accounted for using the liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The Company’s ability to realize deferred tax assets depends upon future taxable income, as well as the limitations discussed below. For financial reporting purposes, a deferred tax asset must be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized prior to expiration. The Company considers historical and future taxable income, future reversals of existing taxable temporary differences, taxable income in prior carryback years, and ongoing tax planning strategies in assessing the need for valuation.

 

Comprehensive Gain

 

Comprehensive gain is defined as the change in equity of a business during a period from non-owner sources. There was other comprehensive gain of $354 and loss of $2,410 related foreign exchange translation for the three months ended September 30, 2024 and 2023, respectively. There was other comprehensive gain of $9,338 and gain of $40,141 related foreign exchange translation for the nine months ended September 30, 2024 and 2023, respectively.

 

Going Concern Assessment

 

The Company applies Accounting Standards Codification 205-40 (“ASC 205-40”), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which the Financial Accounting Standards Board (“FASB”) issued to provide guidance on determining when and how reporting companies must disclose going concern uncertainties in their consolidated financial statements. ASC 205-40 requires management to perform assessments of an entity’s ability to continue as a going concern within one year of the date of issuance of the entity’s consolidated financial statements (or within one year after the date on which the consolidated financial statements are available to be issued, when applicable). Further, a company must provide certain disclosures if there is “substantial doubt about the entity’s ability to continue as a going concern” and management plans to alleviate the going concern. In November 2024, the Company analyzed its cash requirements and operations at least through November 2025 and has determined that, based upon the Company’s current available cash and operations, the Company has no substantial doubt about its ability to continue as a going concern.

 

Use of Estimates

 

In preparing these consolidated financial statements in conformity with GAAP, management is required to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates and assumptions included in the Company’s consolidated financial statements relate to the calculation of revenue recognition, stock-based compensation, valuation of common stock, valuation of senior secured convertible notes, warrant liability, earnout share liabilities, accruals for potential liabilities including income taxes, valuation of deferred tax assets and valuation assumptions related to share-based compensation.

Income (Loss) Per Share

 

Basic income (loss) per share is based upon the net income (loss) for the three and nine months ended September 30, 2024 and 2023 divided by the weighted average shares of common stock outstanding. Diluted net income per share is determined using the weighted average number of common shares and potential common shares (representing the dilutive effect of stock options, warrants, convertible notes payable and stock appreciation rights) outstanding during the period using the treasury stock method for the three months ended September 30, 2024. Common stock equivalents for the three months ended September 30, 2023 and the nine months ended September 30, 2024 and 2023 are not included in the calculation of diluted earnings (loss) per share given the Company incurred a loss and they are anti-dilutive. See Note 15—Earnings per share.

 

Reportable Segments

 

The Financial Accounting Standards Board, or FASB, Accounting Standard Codification, or ASC, Topic 280, Segment Reporting, requires that an enterprise report selected information about reportable segments in its financial reports issued to its stockholders. Management monitors the revenue and expense components of the various products and services the Company offers, but operations are managed and financial performance is evaluated on a corporation-wide basis in comparison to a business plan which is developed each year. Accordingly, all operations are considered by management to be one operating segment and one reportable segment as contained in the Consolidated Statements of Operations and Comprehensive Loss to the consolidated financial statements.

 

Recent Accounting Pronouncements

 

All recent accounting pronouncements issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

v3.24.3
Advances due to and from Founders
9 Months Ended
Sep. 30, 2024
Advances due to and from Founders  
Advances due to and from Founders

3. Advances due to and from Founders

 

Advances due to Founders

 

Prior to 2023, the founders had advanced the Company a net $600,000. In the year ended December 31, 2023, Mr. Huang and Mr. Xu advanced Airship AI a total of $1,350,000 and were repaid a total of $200,000, with $1,750,000 recorded as advances from founders as of December 31, 2023. During 2024, Mr. Huang and Mr. Xu advanced Airship AI $2,100,000 and were repaid $2,100,000, with $1,750,000 recorded as advances from founders as of September 30, 2024. The outstanding advances as of September 30, 2024 are non-interest bearing and the Company expects to pay the balance off within a one year period.

 

Master Loan Agreement

 

On September 27, 2024, the Company entered into a Master Loan Agreement with Mr. Huang, whereby he may provide additional funding of up to $1,500,000 under certain terms and conditions. The Agreement provides for interest of 6%. The Company agreed to pay interest for the 2024 advances (described under Advances to Founders above) of $11,913 and issued warrants to purchase up to 220,000 shares of common stock. The warrants have an exercise price of $2.36 per share, are exercisable immediately upon issuance and will expire in five years following the date of issuance. The $284,478 fair value of the warrant is recorded in permanent equity in the consolidated balance sheets and was fully expensed on the date of grant. There are no outstanding advances under this Master Loan Agreement as of September 30, 2024.

v3.24.3
Revenues
9 Months Ended
Sep. 30, 2024
Revenues  
Revenues

4. Revenues

 

Disaggregation of Revenue

 

The Company’s net revenues for the nine months ended September 30, 2024 and 2023 consisted of approximately $16.5 million and $4.4 million, respectively, of hardware and software bundled systems for which revenue is transferred at a point in time The Company’s remaining net revenue for the nine months ended September 30, 2024 and 2023 of approximately $3.3 million and $3.7 million, respectively, related to PCS revenue and other services which are transferred over time. Within each product category, contract terms, conditions and economic factors affecting the nature, amount, timing, and uncertainty around revenue recognition and cash flow are substantially similar.

Contract Balances

 

A receivable is recognized in the period the Company delivers goods or provides services or when the Company’s right to consideration is unconditional. The Company usually does not record contract assets because the Company has an unconditional right to payment upon satisfaction of the performance obligation, and therefore, a receivable is more commonly recorded than a contract asset. Receivables are generally paid within thirty days and there is no financing element to the customer contracts. As of September 30, 2024 and December 31, 2023, there were no unbilled receivable balances.

 

The Company’s short-term and long-term deferred revenue balances totaled $3,326,543 and $3,585,344 as of September 30, 2024. The Company’s short-term and long-term deferred revenue balances totaled $4,008,654 and $4,962,126 as of December 31, 2023. Of the deferred revenue balance of $8,970,780 as of January 1, 2024, the Company recognized approximately $933,675 and $3,061,613 during the three and nine months ended September 30, 2024, respectively.

 

Remaining Performance Obligations

 

As of September 30, 2024, the Company had approximately $6.9 million of remaining performance obligations, which were comprised of deferred service contracts not yet delivered. The Company expects to recognize approximately 15% of its remaining performance obligations as revenue in fiscal 2024 and the remaining 85% in fiscal 2025 and years thereafter.

 

Costs to Obtain or Fulfill a Contract

 

The Company does not pay any material variable compensation to obtain a customer contract. Additionally, the majority of the Company’s cost of fulfillment as a seller of products is classified as inventory and then cost of revenue when the product is sold. Other costs of contract fulfillment such as software maintenance are expensed in the period incurred and align with when the revenue is amortized.

v3.24.3
Notes Payable, Line of Credit and Convertible Notes Payable
9 Months Ended
Sep. 30, 2024
Notes Payable, Line of Credit and Convertible Notes Payable  
Notes Payable, Line of Credit and Convertible Notes Payable

5. Notes Payable and Convertible Notes Payable

 

On June 22, 2023, the Company issued a $2,000,000 senior secured convertible promissory note to Platinum Capital Partners, Inc.

 

On February 2, 2024, the Company issued an amended and restated senior secured convertible promissory note to Platinum in the principal amount of $2,000,000. Interest accrued on the Platinum convertible note at the rate of 6% per annum calculated on the basis of 360 days. At the option of Platinum, the $2,000,000 principal amount of the note plus any accrued but unpaid interest is convertible into shares of the Company’s common stock at a conversion price per share equal to the lower of (i) $3.69717, subject to appropriate adjustment as provided in the note, and (ii) 65% of the VWAP of the common stock for the five trading days immediately prior to any conversion, but in no event below $2.27518, subject to appropriate adjustment as provided in the note. The note contains “weighted average” anti-dilution protection for issuances of shares of common stock or common stock equivalents at a price less than the conversion price then in effect.

 

In connection with the issuance of the Platinum convertible note, the Company issued to Platinum an amended and restated common stock purchase warrant dated February 2, 2024, to purchase 189,334 shares of the Company’s common stock at an exercise price per share of $3.69717. On March 18, 2024, Platinum exercised the Platinum warrant and received 137,367 shares of common stock. Platinum forfeited 51,967 shares.

On June 22, 2024, the Company entered into an extension agreement related to the Platinum convertible note. The extension agreement extended the due date of the note to June 22, 2025. In consideration for entering into the extension agreement, the Company issued to Platinum 232,360 shares of the Company’s restricted common stock in payment of all interest and extension fees through June 22, 2025 with a value of $1,008,400. Approximately $487,000 of the total payment related to the future interest periods and were recorded in prepaid expenses and others on the consolidated balance sheet. Subject to the terms and conditions of such extension agreement, for a period commencing on December 22, 2024 and ending at the close of business on December 22, 2025, Platinum has a one-time put right to have the Company purchase all or a portion of Platinum’s 232,360 restricted shares at $2.27518 per share. The Company granted piggyback registration rights to Platinum.

 

The obligations under the Platinum convertible note are secured by a blanket lien on all assets of the Company pursuant to an Amended and Restated Security Agreement dated February 2, 2024 and are guaranteed pursuant to an Amended and Restated Guaranty dated February 2, 2024. The Company also concurrently entered into an Amended and Restated Subordination Agreement.

 

During the nine months ended September 30, 2024, the Company issued 219,763 shares of common stock related to the conversion of $500,000 of the Platinum convertible note and recorded a loss on note conversion of $200,338.

 

On October 3, 2023, the Company issued senior secured convertible promissory notes for $600,000 to two private investors. At the option of the holders, the notes were convertible into cash, common stock or a combination of cash and stock. On March 5, 2024, the two private investors converted the notes with a face value of $600,000 and interest into 169,204 shares of the Company’s common stock valued at $835,610. On September 13, 2024, the Company issued an additional 86,198 shares of common stock related to the conversion of notes at $2.65 per share. The Company recognized a loss on debt conversion of $234,459 and $393,253, respectively during the three and nine months ended September 30, 2024.

 

The Company accounts for the notes under the fair value method of accounting and as of September 30, 2024 and December 31, 2023, the notes were recorded at $1,793,360 and $2,825,366, respectively.

 

During the nine months ended September 30, 2024 and 2023, the Company recorded an increase in the fair value of the convertible notes payable totaling $141,636 and $400,921, respectively, which were recorded as loss from change in fair value of convertible debt on the statement of operations and comprehensive loss. See Note 14 – Fair Value Measurements for more information.

 

Details on notes payable and convertible notes payable were disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and filed with the SEC on April 1, 2024.

v3.24.3
Stockholders Deficit
9 Months Ended
Sep. 30, 2024
STOCKHOLDERS' DEFICIT:  
Stockholders' Deficit

6. Stockholders’ Deficit

 

Authorized and Outstanding Stock 

 

The Company is a Delaware company and its affairs are governed by its certificate of incorporation, its bylaws and the Delaware General Corporation Law and the common law of the State of Delaware. The Company’s charter authorizes the issuance of 205,000,000 shares, consisting of 200,000,000 shares of common stock and 5,000,000 shares of preferred stock, par value $0.0001 per share.

 

Details on the common stock, preferred stock and equity incentive plans were disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and filed with the SEC on April 1, 2024.

 

Common Stock 

 

As of September 30, 2024, there were 26,954,871 shares of common stock outstanding.

Nine Months Ended September 30, 2024

 

During the nine months ended September 30, 2024, the Company had the following sales of unregistered equity securities:

 

On March 5, 2024, a private investor converted a senior secured convertible promissory note for $250,000 and interest into 70,502 shares of the Company’s common stock.

 

On March 5, 2024, a private investor converted a senior secured convertible promissory note for $350,000 and interest into 98,702 shares of the Company’s common stock.

 

On March 21, 2024, the Company issued 15,000 shares of common stock for services performed as of December 31, 2023 to MZHCI, LLC related to an investor relations consulting agreement.

 

On May 16, 2024, the Company issued 50,000 shares of common stock to Pamria LLC for consulting and investor relations services.

 

On June 22, 2024, the Company entered into an extension agreement with Platinum Capital Partners Inc. to extend the maturity date of the Platinum convertible note to June 22, 2025. In consideration for entering into the extension agreement, the Company issued to Platinum 232,360 shares of common stock in payment of all interest and extension fees through June 22, 2025.

 

On September 3, 2024, the Company issued 2,882,883 shares of common stock at a combined price of $2.775 related to the closing of a public offering. See Note 1.

 

On September 13, 2024, the Company issued an additional 86,198 shares of common stock related to the conversion of notes at $2.65 per share.

 

During the nine months ended September 30, 2024, the Company issued 219,763 shares of common stock related to the conversion of $500,000 of the Platinum convertible note.

 

During the nine months ended September 30, 2024, the Company issued an aggregate of 324,448 shares of common stock upon the exercise of stock options at $0.60 weighted average price.

 

During the nine months ended September 30, 2024, the Company issued an aggregate of 162,967 shares of common stock upon the exercise of warrants at $4.92 weighted average price.

 

2023 Equity Incentive Plan 

 

The Company has adopted the 2023 Equity Incentive Plan, which plan was approved by stockholders at the extraordinary general meeting held in December 2023. Details on the equity incentive plan were disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and filed with the SEC on April 1, 2024.

 

The aggregate number of shares of common stock initially reserved and available for grant and issuance under the equity incentive plan is 4,456,241 as of September 30, 2024. Such aggregate number of shares of stock will automatically increase on January 1 of each year for a period of ten years commencing on January 1, 2024 and ending on January 1, 2033, in an amount equal to 2.0% of the total number of shares of common stock outstanding on December 31 of the preceding year.

 

The Company had the following stock option activity during the nine months ended September 30, 2024:

 

During the nine months ended September 30, 2024, the Company granted stock options to seven employees to purchase an aggregate of 1,050,000 shares of common stock with an exercise price of $3.74 and which vest primarily quarterly over four years and expire March to August 2034.

 

During the nine months ended September 30, 2024, five employees voluntarily cancelled stock options to purchase an aggregate of 300,000 shares of common stock with an exercise price of $6.85.

 

During the nine months ended September 30, 2024, the Company issued an aggregate of 324,448 shares of common stock and received $196,173 upon the exercise of stock options at exercise prices ranging from $0.60 per share.

Stock option activity for the nine months ended September 30, 2024 was as follows: 

 

 

 

Options

 

 

Weighted Average

 

 

 

Shares

 

 

Exercise Price

 

Outstanding as of December 31, 2023

 

 

4,664,589

 

 

$0.55

 

Granted

 

 

1,050,000

 

 

 

3.74

 

Exercised

 

 

(324,448)

 

 

(0.60)

Forfeited

 

 

(300,000)

 

 

(6.85)

Outstanding as of September 30. 2024

 

 

5,090,141

 

 

$0.83

 

  

The following table summarizes information about stock options outstanding and exercisable as of September 30, 2024:  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

Average

 

 

Weighted

 

 

 

 

 

Average

 

 

Remaining Life

 

Range of

 

 

Number

 

 

Remaining Life

 

 

Average

 

 

Number

 

 

Exercise Price

 

 

In Years - Vested

 

Exercise Prices

 

 

Outstanding

 

 

In Years

 

 

Exercise Price

 

 

Exercisable

 

 

Exercisable

 

 

and Exercisable

 

$

0.12

 

 

 

2,495,803

 

 

 

3.59

 

 

$0.12

 

 

 

2,495,803

 

 

$0.12

 

 

 

3.59

 

 

0.57

 

 

 

922,963

 

 

 

3.77

 

 

 

0.57

 

 

 

922,963

 

 

 

0.57

 

 

 

3.77

 

1.49-1.65

 

 

 

1,096,562

 

 

 

7.67

 

 

 

1.64

 

 

 

505,178

 

 

 

1.64

 

 

 

7.67

 

 

1.90

 

 

 

49,813

 

 

 

3.23

 

 

 

1.90

 

 

 

33,148

 

 

 

1.90

 

 

 

3.23

 

 

2.86

 

 

 

525,000

 

 

 

9.88

 

 

 

2.86

 

 

 

32,813

 

 

 

2.86

 

 

 

9.88

 

 

 

 

 

 

5,090,141

 

 

 

5.14

 

 

$0.83

 

 

 

3,989,905

 

 

$0.45

 

 

 

5.14

 

 

There were 5,090,141 options to purchase common stock at an average exercise price of $0.83 per share outstanding as of September 30, 2024 under the 2023 Equity Incentive Plan. The Company recorded $139,409 and $206,495 of compensation expense, net of related tax effects, relative to stock options for the three months ended September 30, 2024 and 2023, respectively.  The Company recorded $420,824 and $479,913 of compensation expense, net of related tax effects, relative to stock options for the nine months ended September 30, 2024 and 2023, respectively, in accordance with ASC 718. As of September 30, 2024, there was $1,962,124 of total unrecognized costs related to employee granted stock options that were not vested. These costs are expected to be recognized over a period of approximately 3.5 years.

 

In August 2024, the Company cancelled out-of-the money options to exercise 300,000 shares held by current employees and replaced them with 525,000 options at lower exercise prices. The new options were subject to the same service-based vesting schedule as the original options. The Company accounted for the replacement options as a modification of the terms of the cancelled option awards and in accordance with ASC 718-20-35-2A, the Company will recognize additional $205,879 stock compensation expense over the remaining vesting period as the incremental cost measured as the excess of the fair value of the replaced options on the grant date using the Black-Scholes-Merton option pricing model over the fair value of the cancelled option award at the cancellation date.

 

The significant weighted-average assumptions relating to the valuation of the Company’s stock option grants were as follows for the nine months ended:

 

Assumptions

 

9/30/2024

 

 

6/30/2024

 

 

3/31/2024

 

Estimated stock price

 

$2.86

 

 

$7.61

 

 

$1.49-$6.59

 

Exercise price

 

$2.86

 

 

$7.61

 

 

$1.49-$6.59

 

Dividend yield

 

 

0%

 

 

0%

 

 

0%

Expected life

 

4 years

 

 

4 years

 

 

5-10 years

 

Expected volatility

 

 

69%

 

 

69%

 

 

69%

Risk free interest rate

 

 

3.77%

 

 

4.68%

 

 

4.23%

There were stock incentive plan awards outstanding at September 30, 2024 totaling 5,090,141 shares with an aggregate intrinsic value of $7,781,223.

 

As of September 30, 2024 and December 31, 2023 there were 1,758,000 SARs outstanding. There were no SAR grants in the nine months ended September 30, 2024 or the year ended December 31, 2023.

 

Warrants to Purchase Common Stock

 

See Note 12 for public and private placement warrants assumed after the merger.

 

The Company had the following warrant activity during the nine months ended September 30, 2024:

 

In connection with the issuance of the Platinum convertible note, the Company issued to Platinum an amended and restated common stock purchase warrant dated February 2, 2024 to purchase 189,334 shares of common stock at an exercise price per share of $3.69717. On March 18, 2024, Platinum exercised the Platinum warrant and received 137,367 shares of common stock. Platinum forfeited 51,967 shares.

 

On September 3, 2024 the Company issued warrants to purchase up to 2,882,883 shares of its common stock. The warrants have an exercise price of $2.65 per share, are exercisable immediately upon issuance and will expire five years following the date of issuance.

 

On September 3, 2024 the Company issued warrants to purchase up to 216,216 shares of its common stock. The warrants have an exercise price of $3.47 per share, are exercisable immediately upon issuance and will expire five years following the date of issuance.

 

On September 27, 2024, the Company issued warrants to purchase up to 220,000 shares of common stock. The warrants have an exercise price of $2.36 per share, are exercisable immediately upon issuance and will expire in five years following the date of issuance.

 

During the nine months ended September 30, 2024, investors exercised warrants for 25,600 shares of the Company’s common stock at $11.49 per share, and the Company received proceeds of $294,030.

 

Warrant activity for the nine months ended September 30, 2024 was as follows:

 

 

 

September 30, 2024

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Exercise

 

 

 

Shares

 

 

Price

 

Outstanding January 1, 2024

 

 

19,443,314

 

 

$10.16

 

Issued

 

 

3,454,033

 

 

 

2.72

 

Exercised

 

 

(162,967)

 

 

(4.92)

Forfeited

 

 

(51,967)

 

 

(3.70)

Expired

 

 

-

 

 

 

-

 

Outstanding at September 30, 2024

 

 

22,682,413

 

 

$6.34

 

A summary of the warrants outstanding as of September 30, 2024 were as follows:

 

 

 

 

September 30, 2024

 

 

 

 

Weighted

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

Average

 

 

 

 

 

Average

 

Number of

 

 

Remaining

 

 

Exercise

 

 

Shares

 

 

Exercise

 

Warrants

 

 

Life ( In Years)

 

 

Price

 

 

Exercisable

 

 

Price

 

 

2,689,902

 

 

 

3.47

 

 

$1.77

 

 

 

2,689,902

 

 

$1.77

 

 

220,000

 

 

 

5.00

 

 

 

2.36

 

 

 

220,000

 

 

 

2.36

 

 

2,882,283

 

 

 

4.92

 

 

 

2.65

 

 

 

2,882,283

 

 

 

2.65

 

 

216,216

 

 

 

4.92

 

 

 

3.47

 

 

 

216,216

 

 

 

3.47

 

 

16,674,012

 

 

 

4.04

 

 

 

7.80

 

 

 

16,674,012

 

 

 

7.80

 

 

22,682,413

 

 

 

4.08

 

 

$6.34

 

 

 

22,682,413

 

 

$6.34

 

  

The significant weighted average assumptions relating to the valuation of the Company’s warrants issued for the nine months ended September 30, 2024 were as follows:

 

Assumptions

 

 

 

Dividend yield

 

 

0%

Stock price

 

$2.72

 

Exercise price

 

$2.72

 

Expected life

 

4 years

 

Expected volatility

 

 

69%

Risk free interest rate

 

 

3.77%

  

Earnout Liability

 

See Note 13 for common stock shares related to earnout liability.

v3.24.3
Employee 401(k) Plan
9 Months Ended
Sep. 30, 2024
Employee 401(k) Plan  
Employee 401(k) Plan

7. Employee 401(k) Plan

 

The Company has a 401(k) plan for its employees. The plan provides for a 3.5% match on up to 6% of deferred salary. The Company expensed $52,456 and $44,973 of contributions during the three months ended September 30, 2024 and 2023, respectively. The Company expensed $153,254 and $138,532 of contributions during the nine months ended September 30, 2024 and 2023, respectively.

v3.24.3
Related Party Transactions
9 Months Ended
Sep. 30, 2024
Related Party Transactions  
Related Party Transactions

8. Related Party Transactions

 

Advances due to Founders

 

Prior to 2023, the founders had advanced the Company a net $600,000. In the year ended December 31, 2023, Mr. Huang and Mr. Xu advanced Airship AI a total of $1,350,000 and were repaid a total of $200,000, with $1,750,000 recorded as advances from founders as of December 31, 2023. During 2024, Mr. Huang and Mr. Xu advanced Airship AI $2,100,000 and was repaid $2,100,000, with $1,750,000 recorded as advances from founders as of September 30, 2024. The outstanding advances as of September 30, 2024 are non-interest bearing and the Company expects to pay the balance off within a one year period.

 

Master Loan Agreement

 

On September 27, 2024, the Company entered into a Master Loan Agreement with Mr. Huang, whereby he may provide additional funding of up to $1,500,000 under certain terms and conditions. The agreement provides for interest of 6%. The Company agreed to pay interest for the 2024 advances (described under Advances to Founders above) of $11,913 and the Company issued warrants to purchase up to 220,000 shares of the Company’s common stock. The warrants have an exercise price of $2.36 per share, are exercisable immediately upon issuance and will expire in five years following the date of issuance. The $284,478 fair value of the warrant is recorded in permanent equity in the consolidated balance sheets and was fully expensed on the date of grant. There are no outstanding advances under this Master Loan Agreement as of September 30, 2024.

Warrants to Purchase Common Stock

 

On May 8, 2023, Airship AI issued warrants to purchase 1,344,951 shares of common stock to each of Victor Huang and Derek Xu. The warrants were valued at $2,136,115 based on the exercise price of $1.77, the fair market stock price of $1.89, a five year term, a volatility of 39.4% and interest of 3.41%. The warrants were recorded as stock-based compensation expense and as additional paid in capital. All warrants are fully vested as they were issued for services performed.

v3.24.3
Commitments, Contingencies and Legal Proceedings
9 Months Ended
Sep. 30, 2024
COMMITMENTS AND CONTINGENCIES (Note 9)  
Commitments, Contingencies and Legal Proceedings

9. Commitments, Contingencies and Legal Proceedings

 

Legal Proceedings

 

The Company may from time to time become a party to various legal proceedings arising in the ordinary course of its business. The Company is currently not a party to any pending legal proceeding that is not ordinary routine litigation incidental to its business.

 

Properties and Operating Leases-Right of Use Asset and Lease Liability

 

Lease agreements are evaluated to determine whether an arrangement is or contains a lease in accordance with ASC 842, Leases. Right of use lease assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. The incremental borrowing taking into consideration the Company’s credit quality and borrowing rate for similar assets is used in determining the present value of future payments. Lease expense is recorded as general and administrative expenses on the Company’s consolidated statements of operations.

 

On July 13, 2023, the Company entered into a lease in Redmond, WA for 15,567 square feet of office and warehouse space which started October 1, 2023. The monthly payment is $25,000 per month. The lease expires October 31, 2027 and the monthly payment increases 3% on July 31, 2024 and each year thereafter. There is a one three year option to extend the lease based on the fair market rate on October 31, 2027, which the Company expects to exercise.

 

On February 29, 2024, the Company extended an office lease in Moorestown, North Carolina. The Company leases 3,621 square feet and the net monthly payment is $6,488. On August 27, 2024, the Company extended the lease to February 28, 2025.

 

The Company has entered into operating leases for office and development facilities for four years and include options to renew. The Company determines whether an arrangement is or contains a lease based upon the unique facts and circumstances at the inception of the lease. Operating lease liabilities and their corresponding right-of-use assets are recorded based upon the present value of the lease payments over the expected lease term. As of September 30, 2024 and December 31, 2023, total operating lease liabilities was $986,053 and $1,118,578, respectively. Right of use assets was $929,890 and $1,104,804 at September 30, 2024 and December 31, 2023, respectively. Current lease liabilities were $267,660 and $174,876 at September 30, 2024 and December 31, 2023, respectively. In the three months ended September 30, 2024 and 2023, the Company recognized $88,428 and $162,414 in total lease costs for the leases, respectively. In the nine months ended September 30, 2024 and 2023, the Company recognized $265,283 and $487,242 in total lease costs for the leases, respectively. Because the rate implicit in each lease is not readily determinable, the Company uses its estimated incremental borrowing rate to determine the present value of the lease payments.

 

The weighted average remaining lease term for the operating leases was thirty seven  months at September 30, 2024 and the weighted average discount rate was 7%. 

The minimum future lease payments as of September 30, 2024 are as follows:

 

Years Ended September 30,

 

2025

 

$327,308

 

2026

 

 

367,606

 

2027

 

 

378,646

 

2028

 

 

32,333

 

Total remaining payments

 

 

1,105,893

 

Less Imputed Interest

 

 

(119,840)

Total lease liability

 

$986,053

 

 

Employment Agreement

 

On March 1, 2024, the Company entered into an employment agreement with Mark E. Scott, the Company’s Chief Financial Officer, which provides for a base salary of $250,000 annually. Mr. Scott is also eligible to participate in annual performance-based bonus programs established by the board or compensation committee, subject to the achievement of applicable performance criteria established by the board or compensation committee, which shall be determined in good faith by the board or compensation committee. Mr. Scott was also granted options to purchase up to twenty five thousand (25,000) shares of common stock with an exercise price equal to $1.49, which options vested in full on the date of issuance.

v3.24.3
Income Taxes
9 Months Ended
Sep. 30, 2024
Income Taxes  
Income Taxes

10. Income Taxes

 

The Company recorded a provision for income taxes of $0 for the nine months ended September 30, 2024 and 2023.

 

The Company’s effective tax rate was 0% for the nine months ended September 30, 2024 and 2023. The difference between the effective tax rate and the federal statutory tax rate for the nine months ended September 30, 2024 and 2023 primarily related to the valuation allowance on the Company’s deferred tax assets.

 

For interim periods, the Company estimates its annual effective income tax rate and applies the estimated rate to the year-to-date income or loss before income taxes. The Company also computes the tax provision or benefit related to items reported separately and recognizes the items net of their related tax effect in the interim periods in which they occur. The Company also recognizes the effect of changes in enacted tax laws or rates in the interim periods in which the changes occur.

 

As of September 30, 2024 and December 31, 2023, the Company retains a full valuation allowance on its deferred tax assets. The realization of the Company’s deferred tax assets depends primarily on its ability to generate taxable income in future periods. The amount of deferred tax assets considered realizable in future periods may change as management continues to reassess the underlying factors it uses in estimating future taxable income.

v3.24.3
Reverse Recapitalization
9 Months Ended
Sep. 30, 2024
Reverse Recapitalization  
Reverse Recapitalization

11. Reverse Recapitalization

 

On December 21, 2023, the Company completed the merger and received net proceeds of $2.8 million, net of transaction costs of $6.6 million.

 

The merger was accounted for as a reverse recapitalization in accordance with GAAP. Under this method of accounting, BYTS, who was the legal acquirer, was treated as the “acquired” company for accounting purposes and Airship AI was treated as the accounting acquirer. Accordingly, the merger was treated as the equivalent of Airship AI issuing shares at the closing of the merger for the net assets of BYTS as of the closing date, accompanied by a recapitalization. The net assets of BYTS was stated at historical cost, with no goodwill or other intangible assets recorded. Airship AI was determined to be the accounting acquirer based on evaluation of the following facts and circumstances:

 

 

Airship AI’s stockholders have the majority voting interest in the combined company;

 

 

 

 

The board of the post-merger company is composed of one (1) director designated by BYTS and four (4) directors designated by Airship AI;

 

 

 

 

Airship AI’s senior management is the senior management of the post-merger company;

 

 

 

 

The business of Airship AI comprises the ongoing operations of post-merger company; and

 

 

 

 

Airship AI is the larger entity, in terms of substantive assets.

The table below summarizes the shares of common stock issued immediately after the closing of the merger as well as the impact on the consolidated statement of stockholders’ equity as of December 21, 2023:

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Accumulated

 

 

 

Shares

 

 

Par Amount

 

 

Common Stock

 

 

Paid in Capital

 

 

Deficit

 

SPAC Financing

 

 

8,891,718

 

 

$0.0001

 

 

$889

 

 

$8,315,186

 

 

$-

 

Transaction expenses (1)

 

 

532,986

 

 

 

0.0001

 

 

 

53

 

 

 

(6,651,674)

 

 

(894,662)
Earnout liability

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4,470,918)

 

 

(22,638,859)
Warrants liability

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,009,105)

 

 

-

 

Reverse capitalization on December 21, 2023 (1)

 

 

9,424,704

 

 

 

 

 

 

$942

 

 

$(4,816,511)

 

$(23,533,521)

  

 

(1)

Adjusted for correction of transaction expense discussed below.

 

Immaterial Revision of Prior Period Financial Information

 

In connection with the preparation of its consolidated financial statements, the Company identified an immaterial error related to the classification of prepaid expenses and transaction expenses (classified in accumulated deficit as reverse recapitalization). In accordance with SAB No. 99, “Materiality,” and SAB No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in the Current Year Financial Statements,” the Company evaluated the error and determined that the impact was not material to its financial statements for the prior annual and current interim period, accordingly the Company revised the prior period financial information for comparative purposes. The revision does not impact the consolidated statements of operations and comprehensive loss. A summary of the revision to the Company’s previously reported consolidated balance sheets is included below for comparative purposes:

 

 

 

As of December 31, 2023

 

 

 

As Reported

 

 

Adjustment

 

 

As Revised

 

Prepaid expenses and other

 

$

913,030

 

 

$

(894,662

)

 

$

18,368

 

Total current assets

 

 

5,693,577

 

 

 

(894,662

)

 

 

4,798,915

 

Total assets

 

 

6,982,575

 

 

 

(894,662

)

 

 

6,087,913

 

Accumulated deficit

 

 

(16,582,038

)

 

 

(894,662

)

 

 

(17,476,700

)

Total stockholders' deficit

 

 

(16,592,565

)

 

 

(894,662

)

 

 

(17,487,227

)

 

The revision had no impact to cash provided by operating activities in such period.

v3.24.3
Private Placement and Public Warrants
9 Months Ended
Sep. 30, 2024
Private Placement and Public Warrants  
Private Placement and Public Warrants

12. Private Placement and Public Warrants

 

At the merger closing, the Company assumed 515,000 private placement warrants and 16,184,612 public warrants. On June 3, 2024, the Company permanently reduced the exercise price of such warrants from $11.50 per share to an exercise price of $7.80 per share. The purpose of this reduced exercise price was to potentially raise proceeds received from the exercise of such warrants, if any, for working capital and general corporate purposes. As of September 30, 2024, there were 515,000 private placement warrants and 16,159,012 public warrants outstanding.

 

Details on the warrants were disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and filed with the SEC on April 1, 2024. The public warrants will expire on December 21, 2028.

The following table is a summary of the number of shares of the Company’s common stock issuable upon exercise of the public and private warrants outstanding as of September 30, 2024:

 

 

 

Number of Shares

 

 

Exercise Price

 

 

Expiration Date

 

Fair Value

 

Public Warrants

 

 

16,159,012

 

 

$7.80

 

 

December 21, 2028

 

$3,393,393

 

Private Warrants

 

 

515,000

 

 

$7.80

 

 

December 21, 2028

 

$108,150

 

v3.24.3
Earnout Liability
9 Months Ended
Sep. 30, 2024
Earnout Liability  
Earnout Liability

13. Earnout Liability

 

At the closing of the merger, the Airship AI securityholders that hold shares of common stock of Airship AI, Airship AI options, Airship AI earnout warrants or Airship AI SARs have the contingent right to receive up to 5,000,000 earnout shares of the Company’s common stock if the following earnout milestones are met.

 

 

(A)

25% of the earnout shares if, for the period starting on the closing date and ending on the last day of the full calendar quarter immediately following the first anniversary of the closing date, (1) company revenue (as defined in the merger agreement) is at least $39 million, or (2) the aggregate value of new contract awards with federal law enforcement agencies has grown by at least 100% as compared to the year-over-year amount for the twelve-month period ending on the date of the merger agreement (the “First Operating Performance Milestone”);

 

 

(B)

75% of the earnout shares if, for the period starting on the closing date and ending on the last day of the full calendar quarter immediately following the third anniversary of the closing date, company revenue is at least $100 million;

 

 

 

 

(C)

50% of the earnout shares if, at any time during the period starting on the closing date and ending on the fifth anniversary of the closing date, over any twenty (20) trading days within any thirty (30) trading day period the volume weighted average price (“VWAP”) of the common stock is greater than or equal to $12.50 per share; and

 

 

 

 

(D)

50% of the earnout shares if, at any time during the period starting on the closing date and ending on the fifth anniversary of the closing date, over any twenty (20) trading days within any thirty (30) trading day period the VWAP of the common stock is greater than or equal to $15.00 per share.

 

Any earnout shares issuable under the merger agreement to a Airship AI securityholder in respect of each Airship AI option or Airship AI SAR held by such holder as of immediately prior to the effective time of the merger shall be earned by such holder on the later of (i) the occurrence of the applicable earnout milestone, and (ii) the date on which the option in respect of such Airship AI option or SAR in respect of such Airship AI SAR, as applicable, becomes vested pursuant to its applicable vesting schedule, but only if such holder continues to provide services (whether as an employee, director or individual independent contractor) to the Company or one of its subsidiaries through such date. Notwithstanding the foregoing, any earnout shares that are not earned by Airship AI securityholder in respect of its options or SARs on or before the fifth anniversary of the closing date of the merger shall be forfeited without any consideration. Any earnout shares that are forfeited pursuant to the merger agreement shall be reallocated to the other Airship AI securityholders who remain entitled to receive earnout shares in accordance with their respective earnout pro rata shares.

 

These earnout shares have been categorized into two components: (i) the “Vested Shares” - those associated with earnout holders with vested equity at the closing of the merger that will be earned upon achievement of the earnout milestones and (ii) the “Unvested Shares” - those associated with earnout holders with unvested equity at the closing of the merger that will be earned over the remaining service period with the Company on their unvested equity shares and upon achievement of the earnout milestones. The Vested Shares, which represent 95% of the total earnout shares are classified as liabilities in the consolidated balance sheet at fair value with changes in fair value recognized in the consolidated statements of operations due to the variability in the number of earnout shares at settlement which could change upon a change of control event. The earnout arrangement contains a settlement provision that violates the indexation guidance under ASC 815-40. The Unvested Shares are equity-classified share-based compensation to be recognized over time under ASC 718 due to the service component.

At the closing of the merger on December 21, 2023, the earnout liability had an initial fair value of $27,109,777, which was recorded as a long-term liability and a reduction to additional paid in capital in the consolidated balance sheet. As of December 31, 2023, the earnout liability had decreased to $5,133,428 as a result of the decline in the Company’s share price since the closing of the merger. As of September 30, 2024, the estimated fair value of the earnout liability increased to $6,229,390 primarily due to the increase in the Company’s share price, which resulted in a gain (loss) due to the change in fair value of the earnout liability during the three and nine months ended September 30, 2024 of $5,511,961 and $(1,095,962), respectively, and is recorded on the consolidated statements of operations and comprehensive loss. See Note 14– Fair Value Measurements for more information.

 

In addition, a portion of the earnout shares may be issued to individuals with unvested equity awards. While the payout of these shares requires the achievement of the earnout milestones, the individuals must complete the remaining service period associated with these unvested equity awards to be eligible to receive the earnout shares. As a result, these unvested earn-out shares are equity-classified awards and have an aggregated grant date fair value of $2,675,223 (or $5.96 per share). During the three and nine months ended September 30, 2024, the Company stock-based compensation expense for the vesting of earnout shares was $133,761 and $401,283, respectively. As of September 30, 2024, unrecognized compensation cost related to unvested earnout shares totaled $2,273,941. The weighted average period over which this remaining compensation cost is expected to be recognized is 4.25 years.

 

As of September 30, 2024, the Company determined the First Operating Performance Milestone (A,2) is achieved and 1,250,000 shares are to be issued to applicable personnel in early January 2025. The fair value of the 1,250,000 vested shares as of September 30, 2024 of $2,875,000 was determined using the Company’s closing trading price on September 30, 2024 and is included in the earnout liability on the consolidated balance sheet. The vested earnout shares are considered a level 1 fair value instrument. See Note 14.

v3.24.3
Fair Value Measurements
9 Months Ended
Sep. 30, 2024
Fair Value Measurements  
Fair Value Measurements

14. Fair Value Measurements

 

The following table sets forth by level within the ASC 820, Fair Value Measurement, fair value hierarchy of the Company’s liabilities that are measured at fair value on a recurring basis as of September 30, 2024:

 

 

 

 

 

September 30, 2024

 

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Liabilities-

 

 

 

 

 

 

 

 

 

 

 

 

Earnout liability

 

$2,875,000

 

 

$-

 

 

$3,354,390

 

 

$6,229,390

 

Senior Secured Convertible Promissory Notes

 

 

-

 

 

 

-

 

 

 

1,793,360

 

 

 

1,793,360

 

Warrant liability (Public Warrants)

 

 

3,393,393

 

 

 

-

 

 

 

-

 

 

 

3,393,393

 

Warrant liability (Private Warrants)

 

 

-

 

 

 

108,150

 

 

 

-

 

 

 

108,150

 

Total liabilities measured at fair value

 

$6,268,393

 

 

$108,150

 

 

$5,147,750

 

 

$11,524,293

 

  

The following table sets forth by level within the ASC 820, Fair Value Measurement, fair value hierarchy of the Company’s liabilities that are measured at fair value on a recurring basis as of December 31, 2023:

 

 

 

December 31, 2023

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Earnout liability

 

$

-

 

 

$

-

 

 

$

5,133,428

 

 

$

5,133,428

 

Senior Secured Convertible Promissory Notes

 

 

-

 

 

 

-

 

 

 

2,825,366

 

 

 

2,825,366

 

Warrant liability (Public Warrants)

 

 

646,428

 

 

 

-

 

 

 

-

 

 

 

646,428

 

Warrant liability (Private Warrants)

 

 

-

 

 

 

21,557

 

 

 

-

 

 

 

21,557

 

Total liabilities measured at fair value

 

$

646,428

 

 

$

21,557

 

 

$

7,958,794

 

 

$

8,626,779

 

The estimated fair value of the earnout liability was determined using a Monte Carlo Model. The assumptions utilized in the calculation are based on the achievement of certain stock price milestones including projected stock price, volatility, probability of meeting the federal law enforcement agency growth and risk-free rate. The following assumptions were used in the simulation at each valuation date:

 

 

 

September 30,

2024

 

 

December 31,

2023

 

Stock price

 

$2.30

 

 

$1.70

 

Risk-free interest rate

 

 

3.58%

 

 

3.84%
Expected term (in years)

 

 

4.3

 

 

 

5

 

Expected volatility

 

 

60.4%

 

 

75.9%
Dividend yield

 

 

0%

 

 

0%

  

The assumptions also included the probability of meeting the federal law enforcement agency growth milestone at 100%. The fair value of the 1,250,000 vested shares as of September 30, 2024 of $2,875,000 was determined using the Company’s closing trading price on September 30, 2024.

 

The initial estimated fair value of the private warrants was measured using a Monte Carlo simulation. The estimated fair value of the public warrants is based on the listed price in an active market for such warrants and the fair value of the private placement warrants continues to be measured based on the public warrants listed price.

 

The estimated fair value of the senior secured convertible promissory notes was measured using a Monte Carlo simulation pricing model that factors in potential outcomes being consummated, such as the convertible notes being repaid in cash and the convertible notes being converted to common stock. All of these scenarios take into consideration the terms and conditions of the underlying convertible notes plus potential changes in the underlying value of the common stock. The following assumptions were used in the simulation:

 

 

 

September 30,

2024

 

 

December 31,

2023

 

Stock price

 

$2.30

 

 

 

1.70

 

Effective discount rate

 

 

12.28%

 

 

12.95%

Expected term (in years)

 

 

0.73

 

 

0.48 to 0.75

 

Expected volatility

 

 

55.0%

 

 

62.5%

Dividend yield

 

 

0%

 

 

0%

  

On September 13, 2024, the vested earnout shares were transferred from Level 3 to Level 1 upon the Board approval of the achievement of the First Operating Performance Milestone (A,2). The fair value on the day of transfer was $3,400,000. There were no transfers of financial instruments between valuation levels during the year ended December 31, 2023. The changes in Level 3 liabilities measured at fair value for the nine months ended September 30, 2024 were as follows:

 

 

 

Level 3

 

 

 

Beginning Balance

 

 

Unrealized and

 

 

Conversions /

 

 

Transfers out

 

 

Ending Balance as of

 

 

 

January 1, 2024

 

 

Realized Loss

 

 

Settlements (a)

 

 

of Level 3

 

 

September 30, 2024

 

Liabilities-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnout liability

 

$5,133,428

 

 

$1,620,962

 

 

$-

 

 

$(3,400,000)

 

$3,354,390

 

Senior Secured Convertible Promissory Notes

 

 

2,825,366

 

 

 

735,227

 

 

 

(1,767,233)

 

 

-

 

 

 

1,793,360

 

 

 

$7,958,794

 

 

$2,356,189

 

 

$(1,767,233)

 

$(3,400,000)

 

$5,147,750

 

  

(a) The conversions and settlements represent the fair value of the Senior Secured Convertible Promissory Notes at the dates of conversion.  

v3.24.3
Earnings per Share
9 Months Ended
Sep. 30, 2024
Earnings per Share  
Earnings per Share

15. Earnings per Share

 

The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders:

 

 

 

September 30, 2024,

 

 

September 30, 2023,

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Three Months Ended

 

 

Nine Months Ended

 

Net Income (loss)

 

$6,213,956

 

 

$(7,288,520)

 

$(1,666,607)

 

$(6,482,062)

Less: interest expense and gain on remeasurement of

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

convertible debt

 

 

(236,724)

 

 

-

 

 

 

-

 

 

 

-

 

Net income (loss) - Diluted

 

$5,977,232

 

 

$(7,288,520)

 

$(1,666,607)

 

$(6,482,062)

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

24,696,425

 

 

 

23,609,189

 

 

 

22,812,048

 

 

 

22,812,048

 

Add: dilutive effect of convertible debt, stock options, SARs, vested earnout shares and warrants

 

 

10,749,269

 

 

 

-

 

 

 

-

 

 

 

-

 

Diluted

 

 

35,445,694

 

 

 

23,609,189

 

 

 

22,812,048

 

 

 

22,812,048

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$0.25

 

 

$(0.31)

 

$(0.07)

 

$(0.28)

Diluted

 

$0.17

 

 

$(0.31)

 

$(0.07)

 

$(0.28)

  

The following potentially dilutive shares were not included in the calculation of diluted shares outstanding for the periods presented as the effect would have been anti-dilutive:

 

 

 

September 30,

2024

 

 

September 30,

2023

 

Public Warrants

 

 

16,159,012

 

 

 

-

 

Private Warrants

 

 

515,000

 

 

 

-

 

Convertible debt

 

 

-

 

 

 

367,000

 

Warrants

 

 

216,216

 

 

 

-

 

Outstanding stock options

 

 

525,000

 

 

 

-

 

 

 

 

17,415,228

 

 

 

367,000

 

  

The 3,750,000 remaining unvested earnout shares as of September 30, 2024 are excluded from basic and diluted net loss per share as such shares are contingently issuable until the Company exceeds certain milestone thresholds that have not been achieved. The 1,250,000 vested earnout shares are included in the diluted earnings per share calculation for the three-month period ended September 30, 2024 and will be issued to applicable personnel in early January 2025.

 

As a result of the merger, the weighted-average number of shares of common stock used in the calculation of net income (loss) per share have been retroactively converted by applying the conversion ratio.

v3.24.3
Subsequent Events
9 Months Ended
Sep. 30, 2024
Subsequent Events  
Subsequent Events

16. Subsequent Events

 

The Company evaluated subsequent events, for the purpose of adjustment or disclosure, up through the date the financial statements were issued. Subsequent to September 30, 2024, there were the following material transaction that occurred that would require recognition or disclosure in the financial statements:

 

On November 11, 2024, the Company issued 109,881 shares of common stock related to the conversion of the Platinum convertible note. This issuance was made pursuant to the exemption from registration under the Securities Act in reliance on Section 4(a)(2).

 

On November 13, 2024, the Company issued 219,763 shares of common stock related to the conversion of the Platinum convertible note. This issuance was made pursuant to the exemption from registration under the Securities Act in reliance on Section 4(a)(2).

 

v3.24.3
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2024
Summary of Significant Accounting Policies  
Basis of Presentation and Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany accounts and transactions have been eliminated. The preparation of these consolidated financial statements were prepared in conformity with U.S. generally accepted accounting principles (“GAAP”).

 

For periods prior to the merger, the reported share and per share amounts have been retroactively converted by the applicable exchange ratio with the exception of the authorized shares and shares reserved for issuance. See Note 11—Reverse Recapitalization for additional information.

Functional Currency

The Company’s  reporting  currency  is the U.S.  Dollar. The Company’s  functional currency for U.S. operations is  the U.S. Dollar. The operations of Zeppelin Worldwide, Inc. and its subsidiary, Zeppelin Taiwan, Ltd. (together “Zeppelin”) use the Taiwan Dollar as its functional currency. At each period end, Zeppelin’s balance sheet is translated into U.S. Dollars based upon the period end exchange rate, while their statements of operations and comprehensive loss and statements of cash flows are translated into U.S. Dollars based upon an average exchange rate during the period.

Cash and Cash Equivalents

The Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash equivalents. The Company maintains cash balances at various financial institutions. Balances at US banks are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk for cash on deposit.

Revenue Recognition and Deferred Revenue

The Company primarily generates revenue from sales of systems and products and the related post contract support to customers. The Company’s primary systems and products include Outpost AI, Acropolis and Airship Command. To date, the majority of the Company’s product revenue that has been recognized consists primarily of a bundled offering of hardware and software which delivers on premise solutions to its customers. Separate limited software subscription services have been delivered to customers including those customers that are able to operate in a cloud based environment. The transaction price recognized as revenue represents the amount the Company expects to be entitled to and is primarily comprised of product revenue, net of returns and variable consideration, including sales incentives provided to customers. Payment is typically due within 30 to 90 calendar days of the invoice date.

 

The Company recognizes revenue when promised goods or services are transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services by following a five-step process: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price, and (5) recognize revenue when or as the Company satisfies a performance obligation, as further described below.

Product Revenue

Product revenue is derived primarily from sales of the Company’s system offerings, Outpost AI, Acropolis and Airship Command. The Company recognizes product revenue at a point in time when title transfers, when the products are shipped, or when control of the system is transferred to the customer, which usually is upon delivery of the system and when contractual performance obligations have been satisfied.

Post Contract Support Revenue

Post Contract Support (“PCS”) revenue is derived primarily from the Company’s support and software maintenance agreements (“SMA”). The Company’s PCS includes the right to receive, on a when and if available basis, future unspecified firmware upgrades and features as well as bug fixes, and email and telephone support. The Company allocates a portion of the transaction price to the PCS performance obligation based on a cost-plus methodology and recognizes the associated revenue on a straight-line basis over the estimated term of the support period. The Company’s support contracts are typically one to five years with an average of four years, payment is due within 30 to 90 calendars days of the invoice date and may include options to renew. For the three months ended September 30, 2024 and 2023, the Company recognized revenue of $95,120 and $60,367, respectively, related to one-year support contracts. For the three months ended September 30, 2024 and 2023, the Company recognized revenue of $1,042,008 and $1,413,548, respectively, related to multi-year support contracts. For the nine months ended September 30, 2024 and 2023, the Company recognized revenue of $234,717 and $141,582, respectively, related to one-year support contracts. For the nine months ended September 30, 2024 and 2023, the Company recognized revenue of $3,083,464 and $3,536,003 respectively, related to multi-year support contracts.

Other Services

The Company earns other service revenues from installation services, training and licensing which are short-term in nature and revenue for these services are recognized at the time of performance when the service is provided.

Contracts with Multiple Performance Obligations

The Company’s contracts with customers often contain multiple performance obligations that can include three separate obligations: (i) a hardware component (which may be bundled with hardware accessories) and the embedded firmware essential to the functionality of the hardware component delivered at the time of sale; (ii) the right to the Company’s downloadable free application and software solutions, and (iii) the right for the customer to receive post contract support (“PCS”) after the initial sale. The Company’s products and PCS offerings have significant standalone functionalities and capabilities. Accordingly, the products are distinct from the Company’s PCS services as customers can benefit from the products without the PCS services and such PCS services are separately identifiable within the contracts. The Company accounts for multiple agreements with a single customer as a single contract if the contractual terms and/or substance of those agreements indicate that they may be so closely related that they are, in effect, parts of a single contract. The amount of consideration the Company expects to receive in exchange for delivering on the contract is allocated to each performance obligation based on its relative standalone selling price.

 

The Company establishes the standalone selling price using the prices charged for a deliverable when sold separately. If the standalone selling price is not observable through past transactions, the Company estimates the standalone selling price based on its pricing model and offering type (products or PCS services).

 

The Company has elected the practical expedient to not assess whether a contract has a significant financing component as the Company’s standard payment terms are less than one year.

 

The Company sells its products primarily through a direct sales force. The Company considers revenue to be earned when all of the following criteria are met:

 

 

The Company has a contract with a customer that creates enforceable rights and obligations,

 

 

 

 

Promised performance obligations are identified,

 

 

 

 

The transaction price, or the amount the Company expects to receive, is determinable and

 

 

 

 

The Company has satisfied the performance obligations to the customer.

Transfer of control is evidenced upon passage of title and risk of loss to the customer unless the Company is required to provide additional services.

 

The Company’s short-term and long-term deferred revenue balances totaled $3,326,543 and 3,585,344 as of September 30, 2024. The Company’s short-term and long-term deferred revenue balances totaled $4,008,654 and $4,962,126 as of December 31, 2023. Of the deferred revenue balance of $8,970,780 as of January 1, 2024, the Company recognized approximately $933,675 and $3,061,613 during the three and nine months ended September 30, 2024, respectively.

Accounts Receivable and Provision for Credit Losses

The Company generally sells its products to large governmental entities and large corporations in the United States. Accounts receivable are recorded at invoiced amounts and are non-interest bearing.

 

The Company adopted Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments — Credit Losses (codified as Accounting Standards Codification (“ASC”) 326) on January 1, 2023. ASC 326 adds to U.S. GAAP the current expected credit loss (“CECL”) model, a measurement model based on expected losses rather than incurred losses. Prior to the adoption of ASC 326, the Company evaluated receivables regularly and adjusted the allowance for doubtful accounts accordingly. The Company determined estimates of uncollectible accounts receivable based primarily on actual historical bad debt and sales return trends, customers financial condition and general economic conditions. Under the application of ASC 326, the Company’s historical credit loss experience provides the basis for the estimation of expected credit losses, as well as current economic and business conditions, and anticipated future economic events that may impact collectability. In developing its expected credit loss estimate, the Company evaluated the appropriate grouping of financial assets based upon its evaluation of risk characteristics, including consideration of the types of products and services sold. Account balances are written off against the allowance for expected credit losses after all means of collection have been exhausted and the potential for recovery is considered remote.

 

Occasionally certain long-standing customers, who routinely place large orders, will have unusually large receivables balances relative to the total gross receivables. Management monitors the payments for these large balances closely and very often requires payment of existing invoices before shipping new sales orders. As of September 30, 2024 and December 31, 2023, the Company did not have a reserve for credit losses as all accounts receivable are considered collectible. Accounts receivable balances as of September 30, 2024 and December 31, 2023 were $1,121,862 and $1,648,904, respectively.

Concentration of Credit and Sales Risk

The Company sells its product to commercial and government customers under agreements that are normally paid within 30 days of contract completion.    

 

For the nine months ended September 30, 2024, the Company had revenue from sixty eight customers and one customer represented 63% of total revenue, although such a high level of customer concentration is not typical. The primary reason for the high level of customer concentration for the nine months ended September 30, 2024 was due to one large order received in late 2023 which was fulfilled in the nine months ended September 30, 2024. As of September 30, 2024, five customers represent approximately 21%, 20%, 16%, 12% and 11% of outstanding account receivables. Due to the nature of the customers and timely payment history, customer concentration and credit risk in account receivables is estimated to be minimal.

 

For the nine months ended September 30, 2023, two customers represent approximately 49% and 16% of total revenue. As of December 31, 2023, three customers represent approximately 51%, 26% and 17% of outstanding account receivables. Due to the nature of the customers and timely payment history, customer concentration and credit risk in account receivables is estimated to be minimal.

Inventory

The Company’s purchase of inventory, primarily computer servers, is undertaken to match purchase orders received from customers. Upon receipt of inventory, the Company generally configures the servers and loads proprietary software onto the servers before shipping out. The Company holds inventory for a short period of time and as of September 30, 2024 and December 31, 2023, it had no inventory in stock. Inventory value is primarily material costs and is valued at the lower of cost (first in, first out method) or net realizable value.

Long-Lived Assets

The Company reviews its long-lived assets for impairment annually or when changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets under certain circumstances are reported at the lower of carrying amount or fair value. Assets to be disposed of and assets not expected to provide any future service potential to the Company are recorded at the lower of carrying amount or fair value (less the projected cost associated with selling the asset). To the extent carrying values exceed fair values, an impairment loss is recognized in operating results. The Company recorded impairment losses of $0 for the nine months ended September 30, 2024 and 2023.

Research and Development Expenses

Research and development expenses consist of the cost of employees, consultants and contractors who design, engineer and develop new products and processes as well as materials, supplies and facilities used in producing prototypes.

 

The Company’s current research and development efforts are primarily focused on improving the Company’s products. The Company is also actively involved in identifying new applications. The Company’s current internal team along with outside consultants has considerable experience working with the application of the Company’s technologies and their applications. The Company engages third party experts as required to supplement the Company’s internal team. The Company believes that continued development of new and enhanced technologies is essential to the Company’s future success. The Company incurred research and development expenses of $1,073,735 and $688,798 for the three months ended September 30, 2024 and 2023, respectively, on development activities. The Company incurred research and development expenses of $2,471,872 and $2,028,081 for the nine months ended September 30, 2024 and 2023, respectively, on development activities.

Software Development Costs

Costs incurred in the development of software programs for the Company’s products are charged to operations as incurred until technological feasibility of the software has been established. Generally, technological feasibility is established when the software module performs its primary functions described in its original specifications, contains features required for it to be usable in a production environment, is completely documented and the related hardware portion of the product is complete. After technological feasibility is established, any additional costs are capitalized. Capitalization of software costs ceases when the software is substantially complete and is ready for its intended use. No software development costs have been capitalized as of September 30, 2024 and December 31, 2023.

Cost of Net Revenues

Cost of net revenues for products includes components and freight. Cost of net revenues for post contract support and other services includes primarily the cost of personnel and personnel-related expenses to conduct implementations and ongoing client support.

Advertising

Advertising costs are charged to selling, general and administrative expenses as incurred. Advertising and marketing costs for the three months ended September 30, 2024 and 2023 were $41,107 and $2,587, respectively. Advertising and marketing costs for the nine months ended September 30, 2024 and 2023 were $130,428 and $55,916, respectively.

Shipping and Handling of Products

Amounts billed to customers for shipping and handling of products are included in net revenues. Costs incurred related to shipping and handling of products are included in cost of revenues.

Fair Value Measurements

Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy, which requires classification based on observable and unobservable inputs when measuring fair value. The fair value hierarchy distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs). The hierarchy consists of three levels:

 

Level 1 — Quoted prices in active markets for identical assets and liabilities;

 

Level 2 — Inputs other than level one inputs that are either directly or indirectly observable; and

 

Level 3 — Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

The recorded value of other financial assets and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other current assets, accounts payable and accrued expenses approximate the fair value of the respective assets and liabilities as of September 30, 2024 and December 31, 2023 are based upon the short-term nature of the assets and liabilities. The Company recorded its Senior Secured Convertible Promissory Note, earnout liability (unvested earnout shares), and the warrants that were issued with the Convertible Promissory Note at fair value, remeasured on a recurring basis and considered them as Level 3 instruments. The public and private warrants were considered Level 1 and 2 instruments, respectively. The fair value of the vested earnout shares was considered a Level 1 instrument. The method of determining the fair value of the Senior Secured Convertible Promissory Note and attached warrants is described below.

 

The Company classifies as liabilities any contracts that (i) require net-cash settlement (including a requirement to net- cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).

Accounting for Senior Secured Convertible Promissory Notes at Fair Value

The Company has elected the fair value option to account for the senior secured convertible note that was issued on June 22, 2023 and the convertible notes that were issued in October and November 2023 with changes in fair value recorded in the Consolidated Statements of Operations and Comprehensive Loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes are recognized in earnings as incurred and not deferred. Values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the liability. Considerable judgment is necessary to interpret market data and determine an estimated fair value. The use of different market assumptions or valuation methods may have a material effect on the estimated fair values. As of September 30, 2024, the Company has used a Monte Carlo simulation pricing model that factors in potential outcomes being consummated, such as the convertible notes being repaid in cash and the convertible notes being converted to common stock. All of these scenarios take into consideration the terms and conditions of the underlying convertible notes plus potential changes in the underlying value of the common stock. For the nine months ended September 30, 2024 and 2023, the Company recognized an unrealized loss of $141,636 and $400,921 for the change in fair value of the notes and is included in the Consolidated Statements of Operations and Comprehensive Loss. The Company believes accounting for the convertible notes at fair value better aligns the measurement methodologies of assets and liabilities, which may mitigate certain earnings volatility.

Derivative Liabilities and Earnout Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants and  earnout shares to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company classifies as liabilities any contracts that (i) require net-cash settlement (including a requirement to net- cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).

 

At the merger closing, the Company assumed 515,000 private placement warrants and 16,184,612 public warrants. On June 3, 2024, the Company permanently reduced the exercise price of such warrants from $11.50 per share to an exercise price of $7.80 per share. The purpose of this reduced exercise price was to potentially raise proceeds received from the exercise of such warrants, if any, for working capital and general corporate purposes. As of September 30, 2024, there were 515,000 private placement warrants and 16,159,012 public warrants outstanding. See Note 12– Private Placement and Public Warrants for more information.

 

Upon consummation of the merger, the Company evaluated the warrants and concluded that they did not meet the criteria to be classified within the stockholders’ deficit. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The initial estimated fair value of the warrants was measured using a Monte Carlo simulation. The subsequent estimated fair value of the public warrants is based on the listed price in an active market for such warrants while the fair value of the private placement warrants continues to be measured using a Monte Carlo simulation with the key inputs being directly or indirectly observable public warrants listed price. Since the public and private warrants meet the definition of a derivative, the Company recorded the public and private warrants as liabilities on the consolidated balance sheet at fair value upon the merger closing, with subsequent changes in the fair value recognized in the consolidated statements of operations at each reporting date.

 

At the closing of the merger, the Airship AI securityholders that hold shares of common stock of Airship AI, Airship AI options, Airship AI earnout warrants or Airship AI SARs have the contingent right to receive up to 5.0 million additional shares of common stock, subject to certain contingencies.  These earnout shares have been categorized into two components: (i) the vested shares that are associated with stockholders with vested equity at the closing of the merger that will be earned upon achievement of the earnout milestones and (ii) the unvested shares associated with stockholders with unvested equity at the closing of the merger that will be earned over the remaining service period with the Company on their unvested equity shares and upon achievement of the earnout milestones.

 

The earnout shares associated with vested shares are recognized as derivative liabilities in accordance with ASC 815-40, as the events that determine the number of earnout shares required to be released or issued, as the case may be, include events that were not solely indexed to the fair value of common stock of the Company. The earnout shares were measured at the merger closing and subsequently measured at each reporting date until settled or when they met the criteria for equity classification. Accordingly, the Company recognizes the earnout shares as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The earnout shares were valued using a Monte Carlo analysis.

 

At the closing of the merger, the unvested earnout shares were considered to be equity instruments and valued at approximately $2,675,000. This amount will be recognized as stock-based compensation going forward over the five-year vesting period.

 

Derivative warrant and earnout shares liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of significant current assets or require the creation of current liabilities.

Stock-Based Compensation

The Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted stock, stock appreciation rights, incentive stock options, nonqualified stock options, unvested earnout shares and warrants to purchase shares of common stock at the fair market value at the time of grant. Stock-based compensation cost is measured by the Company at the grant date and the fair value of the award is recognized as an expense, over the requisite service period which is generally the vesting period. The Company adjusts stock-based compensation for changes to the estimate of expected equity award forfeitures based on actual forfeiture experience. The effect of adjusting the forfeiture rate is recognized in the period the forfeiture estimate is changed.

Income Taxes

Income taxes are accounted for using the liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The Company’s ability to realize deferred tax assets depends upon future taxable income, as well as the limitations discussed below. For financial reporting purposes, a deferred tax asset must be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized prior to expiration. The Company considers historical and future taxable income, future reversals of existing taxable temporary differences, taxable income in prior carryback years, and ongoing tax planning strategies in assessing the need for valuation.

Comprehensive Gain Comprehensive gain is defined as the change in equity of a business during a period from non-owner sources. There was other comprehensive gain of $354 and loss of $2,410 related foreign exchange translation for the three months ended September 30, 2024 and 2023, respectively. There was other comprehensive gain of $9,338 and gain of $40,141 related foreign exchange translation for the nine months ended September 30, 2024 and 2023, respectively.
Going Concern Assessment

The Company applies Accounting Standards Codification 205-40 (“ASC 205-40”), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which the Financial Accounting Standards Board (“FASB”) issued to provide guidance on determining when and how reporting companies must disclose going concern uncertainties in their consolidated financial statements. ASC 205-40 requires management to perform assessments of an entity’s ability to continue as a going concern within one year of the date of issuance of the entity’s consolidated financial statements (or within one year after the date on which the consolidated financial statements are available to be issued, when applicable). Further, a company must provide certain disclosures if there is “substantial doubt about the entity’s ability to continue as a going concern” and management plans to alleviate the going concern. In November 2024, the Company analyzed its cash requirements and operations at least through November 2025 and has determined that, based upon the Company’s current available cash and operations, the Company has no substantial doubt about its ability to continue as a going concern.

Use of Estimates

In preparing these consolidated financial statements in conformity with GAAP, management is required to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates and assumptions included in the Company’s consolidated financial statements relate to the calculation of revenue recognition, stock-based compensation, valuation of common stock, valuation of senior secured convertible notes, warrant liability, earnout share liabilities, accruals for potential liabilities including income taxes, valuation of deferred tax assets and valuation assumptions related to share-based compensation.

Income (Loss) Per Share

Basic income (loss) per share is based upon the net income (loss) for the three and nine months ended September 30, 2024 and 2023 divided by the weighted average shares of common stock outstanding. Diluted net income per share is determined using the weighted average number of common shares and potential common shares (representing the dilutive effect of stock options, warrants, convertible notes payable and stock appreciation rights) outstanding during the period using the treasury stock method for the three months ended September 30, 2024. Common stock equivalents for the three months ended September 30, 2023 and the nine months ended September 30, 2024 and 2023 are not included in the calculation of diluted earnings (loss) per share given the Company incurred a loss and they are anti-dilutive. See Note 15—Earnings per share.

Reportable Segments

The Financial Accounting Standards Board, or FASB, Accounting Standard Codification, or ASC, Topic 280, Segment Reporting, requires that an enterprise report selected information about reportable segments in its financial reports issued to its stockholders. Management monitors the revenue and expense components of the various products and services the Company offers, but operations are managed and financial performance is evaluated on a corporation-wide basis in comparison to a business plan which is developed each year. Accordingly, all operations are considered by management to be one operating segment and one reportable segment as contained in the Consolidated Statements of Operations and Comprehensive Loss to the consolidated financial statements.

Recent Accounting Pronouncements

All recent accounting pronouncements issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

v3.24.3
Organization (Tables)
9 Months Ended
Sep. 30, 2024
Organization  
Schedule of fair value transactions

 

 

Liability as of

 

 

Liability as of

 

 

 

September 30, 2024

 

 

December 31, 2023

 

 

 

 

 

 

 

 

Earnout liability

 

$6,229,390

 

 

$5,133,428

 

Senior Secured Convertible Promissory Notes

 

 

1,793,360

 

 

 

2,825,366

 

Warrant liability (Public Warrants)

 

 

3,393,393

 

 

 

646,428

 

Warrant liability (Private Warrants)

 

 

108,150

 

 

 

21,557

 

Total liabilities measured at fair value

 

$11,524,293

 

 

$8,626,779

 

 

 

 

 

 

 

 

 

 

Other loss related to instruments recorded at fair value during the nine months ended September 30, 2024 and 2023

 

$(4,071,156)

 

$(400,921)
v3.24.3
Stockholders Deficit (Tables)
9 Months Ended
Sep. 30, 2024
STOCKHOLDERS' DEFICIT:  
Schedule of stock incentive plans

 

 

Options

 

 

Weighted Average

 

 

 

Shares

 

 

Exercise Price

 

Outstanding as of December 31, 2023

 

 

4,664,589

 

 

$0.55

 

Granted

 

 

1,050,000

 

 

 

3.74

 

Exercised

 

 

(324,448)

 

 

(0.60)

Forfeited

 

 

(300,000)

 

 

(6.85)

Outstanding as of September 30. 2024

 

 

5,090,141

 

 

$0.83

 

Schedule information of stock options outstanding and exercisable

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

Average

 

 

Weighted

 

 

 

 

 

Average

 

 

Remaining Life

 

Range of

 

 

Number

 

 

Remaining Life

 

 

Average

 

 

Number

 

 

Exercise Price

 

 

In Years - Vested

 

Exercise Prices

 

 

Outstanding

 

 

In Years

 

 

Exercise Price

 

 

Exercisable

 

 

Exercisable

 

 

and Exercisable

 

$

0.12

 

 

 

2,495,803

 

 

 

3.59

 

 

$0.12

 

 

 

2,495,803

 

 

$0.12

 

 

 

3.59

 

 

0.57

 

 

 

922,963

 

 

 

3.77

 

 

 

0.57

 

 

 

922,963

 

 

 

0.57

 

 

 

3.77

 

1.49-1.65

 

 

 

1,096,562

 

 

 

7.67

 

 

 

1.64

 

 

 

505,178

 

 

 

1.64

 

 

 

7.67

 

 

1.90

 

 

 

49,813

 

 

 

3.23

 

 

 

1.90

 

 

 

33,148

 

 

 

1.90

 

 

 

3.23

 

 

2.86

 

 

 

525,000

 

 

 

9.88

 

 

 

2.86

 

 

 

32,813

 

 

 

2.86

 

 

 

9.88

 

 

 

 

 

 

5,090,141

 

 

 

5.14

 

 

$0.83

 

 

 

3,989,905

 

 

$0.45

 

 

 

5.14

 

Schedule of significant weighted-average assumptions

Assumptions

 

9/30/2024

 

 

6/30/2024

 

 

3/31/2024

 

Estimated stock price

 

$2.86

 

 

$7.61

 

 

$1.49-$6.59

 

Exercise price

 

$2.86

 

 

$7.61

 

 

$1.49-$6.59

 

Dividend yield

 

 

0%

 

 

0%

 

 

0%

Expected life

 

4 years

 

 

4 years

 

 

5-10 years

 

Expected volatility

 

 

69%

 

 

69%

 

 

69%

Risk free interest rate

 

 

3.77%

 

 

4.68%

 

 

4.23%
Summary of warrants outstanding

 

 

September 30, 2024

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Exercise

 

 

 

Shares

 

 

Price

 

Outstanding January 1, 2024

 

 

19,443,314

 

 

$10.16

 

Issued

 

 

3,454,033

 

 

 

2.72

 

Exercised

 

 

(162,967)

 

 

(4.92)

Forfeited

 

 

(51,967)

 

 

(3.70)

Expired

 

 

-

 

 

 

-

 

Outstanding at September 30, 2024

 

 

22,682,413

 

 

$6.34

 

Summary of warrants outstanding and exercisable

 

 

 

September 30, 2024

 

 

 

 

Weighted

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

Average

 

 

 

 

 

Average

 

Number of

 

 

Remaining

 

 

Exercise

 

 

Shares

 

 

Exercise

 

Warrants

 

 

Life ( In Years)

 

 

Price

 

 

Exercisable

 

 

Price

 

 

2,689,902

 

 

 

3.47

 

 

$1.77

 

 

 

2,689,902

 

 

$1.77

 

 

220,000

 

 

 

5.00

 

 

 

2.36

 

 

 

220,000

 

 

 

2.36

 

 

2,882,283

 

 

 

4.92

 

 

 

2.65

 

 

 

2,882,283

 

 

 

2.65

 

 

216,216

 

 

 

4.92

 

 

 

3.47

 

 

 

216,216

 

 

 

3.47

 

 

16,674,012

 

 

 

4.04

 

 

 

7.80

 

 

 

16,674,012

 

 

 

7.80

 

 

22,682,413

 

 

 

4.08

 

 

$6.34

 

 

 

22,682,413

 

 

$6.34

 

Schedule of warrants weighted average assumptions

Assumptions

 

 

 

Dividend yield

 

 

0%

Stock price

 

$2.72

 

Exercise price

 

$2.72

 

Expected life

 

4 years

 

Expected volatility

 

 

69%

Risk free interest rate

 

 

3.77%
v3.24.3
Commitments, Contingencies and Legal Proceedings (Tables)
9 Months Ended
Sep. 30, 2024
COMMITMENTS AND CONTINGENCIES (Note 9)  
Schedule of minimum future lease payments

Years Ended September 30,

 

2025

 

$327,308

 

2026

 

 

367,606

 

2027

 

 

378,646

 

2028

 

 

32,333

 

Total remaining payments

 

 

1,105,893

 

Less Imputed Interest

 

 

(119,840)

Total lease liability

 

$986,053

 

v3.24.3
Reverse Recapitalization (Tables)
9 Months Ended
Sep. 30, 2024
Reverse Recapitalization  
Schedule of Reverse Recapitalization

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Accumulated

 

 

 

Shares

 

 

Par Amount

 

 

Common Stock

 

 

Paid in Capital

 

 

Deficit

 

SPAC Financing

 

 

8,891,718

 

 

$0.0001

 

 

$889

 

 

$8,315,186

 

 

$-

 

Transaction expenses (1)

 

 

532,986

 

 

 

0.0001

 

 

 

53

 

 

 

(6,651,674)

 

 

(894,662)
Earnout liability

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4,470,918)

 

 

(22,638,859)
Warrants liability

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,009,105)

 

 

-

 

Reverse capitalization on December 21, 2023 (1)

 

 

9,424,704

 

 

 

 

 

 

$942

 

 

$(4,816,511)

 

$(23,533,521)
Schedule of revision of prior period financial information

 

 

As of December 31, 2023

 

 

 

As Reported

 

 

Adjustment

 

 

As Revised

 

Prepaid expenses and other

 

$

913,030

 

 

$

(894,662

)

 

$

18,368

 

Total current assets

 

 

5,693,577

 

 

 

(894,662

)

 

 

4,798,915

 

Total assets

 

 

6,982,575

 

 

 

(894,662

)

 

 

6,087,913

 

Accumulated deficit

 

 

(16,582,038

)

 

 

(894,662

)

 

 

(17,476,700

)

Total stockholders' deficit

 

 

(16,592,565

)

 

 

(894,662

)

 

 

(17,487,227

)

v3.24.3
Private Placement and Public Warrants (Tables)
9 Months Ended
Sep. 30, 2024
Private Placement and Public Warrants  
Schedule of the Public and Private Warrants outstanding

 

 

Number of Shares

 

 

Exercise Price

 

 

Expiration Date

 

Fair Value

 

Public Warrants

 

 

16,159,012

 

 

$7.80

 

 

December 21, 2028

 

$3,393,393

 

Private Warrants

 

 

515,000

 

 

$7.80

 

 

December 21, 2028

 

$108,150

 

v3.24.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2024
Fair Value Measurements  
Schedule of Assets and Liabilities that are Measured at Fair value on a Recurring Basis

 

 

 

 

September 30, 2024

 

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Liabilities-

 

 

 

 

 

 

 

 

 

 

 

 

Earnout liability

 

$2,875,000

 

 

$-

 

 

$3,354,390

 

 

$6,229,390

 

Senior Secured Convertible Promissory Notes

 

 

-

 

 

 

-

 

 

 

1,793,360

 

 

 

1,793,360

 

Warrant liability (Public Warrants)

 

 

3,393,393

 

 

 

-

 

 

 

-

 

 

 

3,393,393

 

Warrant liability (Private Warrants)

 

 

-

 

 

 

108,150

 

 

 

-

 

 

 

108,150

 

Total liabilities measured at fair value

 

$6,268,393

 

 

$108,150

 

 

$5,147,750

 

 

$11,524,293

 

 

 

December 31, 2023

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Earnout liability

 

$

-

 

 

$

-

 

 

$

5,133,428

 

 

$

5,133,428

 

Senior Secured Convertible Promissory Notes

 

 

-

 

 

 

-

 

 

 

2,825,366

 

 

 

2,825,366

 

Warrant liability (Public Warrants)

 

 

646,428

 

 

 

-

 

 

 

-

 

 

 

646,428

 

Warrant liability (Private Warrants)

 

 

-

 

 

 

21,557

 

 

 

-

 

 

 

21,557

 

Total liabilities measured at fair value

 

$

646,428

 

 

$

21,557

 

 

$

7,958,794

 

 

$

8,626,779

 

Schedule of the liabilities measured at fair value

 

 

September 30,

2024

 

 

December 31,

2023

 

Stock price

 

$2.30

 

 

$1.70

 

Risk-free interest rate

 

 

3.58%

 

 

3.84%
Expected term (in years)

 

 

4.3

 

 

 

5

 

Expected volatility

 

 

60.4%

 

 

75.9%
Dividend yield

 

 

0%

 

 

0%

 

 

September 30,

2024

 

 

December 31,

2023

 

Stock price

 

$2.30

 

 

 

1.70

 

Effective discount rate

 

 

12.28%

 

 

12.95%

Expected term (in years)

 

 

0.73

 

 

0.48 to 0.75

 

Expected volatility

 

 

55.0%

 

 

62.5%

Dividend yield

 

 

0%

 

 

0%
Schedule of the estimated fair value of the Senior Secured Convertible Promissory Notes

 

 

Level 3

 

 

 

Beginning Balance

 

 

Unrealized and

 

 

Conversions /

 

 

Transfers out

 

 

Ending Balance as of

 

 

 

January 1, 2024

 

 

Realized Loss

 

 

Settlements (a)

 

 

of Level 3

 

 

September 30, 2024

 

Liabilities-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnout liability

 

$5,133,428

 

 

$1,620,962

 

 

$-

 

 

$(3,400,000)

 

$3,354,390

 

Senior Secured Convertible Promissory Notes

 

 

2,825,366

 

 

 

735,227

 

 

 

(1,767,233)

 

 

-

 

 

 

1,793,360

 

 

 

$7,958,794

 

 

$2,356,189

 

 

$(1,767,233)

 

$(3,400,000)

 

$5,147,750

 

v3.24.3
Earnings per Share (Tables)
9 Months Ended
Sep. 30, 2024
Earnings per Share  
Schedule of basic and diluted net income (loss) per share attributable to common stock

 

 

September 30, 2024,

 

 

September 30, 2023,

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Three Months Ended

 

 

Nine Months Ended

 

Net Income (loss)

 

$6,213,956

 

 

$(7,288,520)

 

$(1,666,607)

 

$(6,482,062)

Less: interest expense and gain on remeasurement of

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

convertible debt

 

 

(236,724)

 

 

-

 

 

 

-

 

 

 

-

 

Net income (loss) - Diluted

 

$5,977,232

 

 

$(7,288,520)

 

$(1,666,607)

 

$(6,482,062)

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

24,696,425

 

 

 

23,609,189

 

 

 

22,812,048

 

 

 

22,812,048

 

Add: dilutive effect of convertible debt, stock options, SARs, vested earnout shares and warrants

 

 

10,749,269

 

 

 

-

 

 

 

-

 

 

 

-

 

Diluted

 

 

35,445,694

 

 

 

23,609,189

 

 

 

22,812,048

 

 

 

22,812,048

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$0.25

 

 

$(0.31)

 

$(0.07)

 

$(0.28)

Diluted

 

$0.17

 

 

$(0.31)

 

$(0.07)

 

$(0.28)
Schedule of the Outstanding stock options

 

 

September 30,

2024

 

 

September 30,

2023

 

Public Warrants

 

 

16,159,012

 

 

 

-

 

Private Warrants

 

 

515,000

 

 

 

-

 

Convertible debt

 

 

-

 

 

 

367,000

 

Warrants

 

 

216,216

 

 

 

-

 

Outstanding stock options

 

 

525,000

 

 

 

-

 

 

 

 

17,415,228

 

 

 

367,000

 

v3.24.3
Organization (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Organization    
Earnout liability $ 6,229,390 $ 5,133,428
Senior Secured Convertible Promissory Notes 1,793,360 2,825,366
Warrant liability (Public Warrants) 3,393,393 646,428
Warrant liability (Private Warrants) 108,150 21,557
Total liabilities measured at fair value 11,524,293 8,626,779
Other expense related to instruments recorded at fair value $ (4,071,156) $ (400,921)
v3.24.3
Organization (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
9 Months Ended
Sep. 03, 2024
Sep. 30, 2024
Sep. 27, 2024
Feb. 02, 2024
Organization        
Private placement warrants shares outstanding   515,000    
Public warrants shares outstanding   16,184,612    
Warrants exercise price   $ 11.50    
Stock option exercise price $ 2.775      
Exercise price   $ 7.80    
Net proceeds $ 7.3      
Offering price $ 8.0      
Number of private placement warrants   515,000    
Number of Public Warrants   16,159,012    
Stock options outstanding 2,882,883      
Warrants to Purchase Common Stock by each founders 2,882,883 216,216 220,000 189,334
Warrants exercise price $ 2.65 $ 6.34    
v3.24.3
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Federal depository insurance coverage amount $ 250,000   $ 250,000    
Short term deferred revenue $ 3,326,543   $ 3,326,543   $ 4,008,654
Private placement warrants shares outstanding 515,000   515,000    
Public warrants shares outstanding 16,159,012   16,159,012    
Deferred revenue carry forward $ 8,970,780   $ 8,970,780    
Long term deferred revenue 3,585,344   3,585,344   4,962,126
Accounts receivable 1,121,862   1,121,862   $ 1,648,904
Equity instruments 2,675,000   2,675,000    
Impairment losses     0 $ 0  
Research and Development expenses 1,073,735 $ 688,798 2,471,872 2,028,081  
Advertising and marketing costs 41,107 2,587 130,428 55,916  
Contingent $ 5,000,000.0   $ 5,000,000.0    
Exercise price, maximum $ 11.50   $ 11.50    
Exercise price, minimum $ 7.80   $ 7.80    
Recognized an unrealized loss     $ 141,636 400,921  
Private placement warrants 515,000   515,000    
Public Warrants 16,184,612   16,184,612    
Other comprehensive gain (loss) $ 354 2,410 $ 9,338 $ 40,141  
One Customer [Member] | Revenue [Member]          
Concentration Risk, Percentage     63.00% 49.00%  
One Customer [Member] | Account Receivable [Member]          
Concentration Risk, Percentage     21.00%   51.00%
Two Customer [Member] | Revenue [Member]          
Concentration Risk, Percentage       16.00%  
Two Customer [Member] | Account Receivable [Member]          
Concentration Risk, Percentage     20.00%   26.00%
Three Customer [Member] | Account Receivable [Member]          
Concentration Risk, Percentage     16.00%   17.00%
Four Customer [Member] | Account Receivable [Member]          
Concentration Risk, Percentage     12.00%    
Five Customer [Member] | Account Receivable [Member]          
Concentration Risk, Percentage     11.00%    
Multi-year support contracts          
Recognized revenue 1,042,008 1,413,548 $ 3,083,464 $ 3,536,003  
One year support contracts          
Recognized revenue $ 95,120 $ 60,367 $ 234,717 $ 141,582  
v3.24.3
Advances due to and from Founders (Details Narrative) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 27, 2024
Dec. 31, 2023
Exercise price $ 7.80    
Master Loan Agreement      
Interest Rate   6.00%  
Proceeds from advances   $ 284,478  
Advance from founders   $ 11,913  
Exercise price   $ 2.36  
Additionl funding for the agreement   $ 1,500,000  
Founder [Member]      
Advanced to company     $ 600,000
Airship AI [Member]      
Proceeds from advances $ 2,100,000   1,350,000
Advance from founders 1,750,000   1,750,000
Repaid $ 2,100,000   $ 200,000
v3.24.3
Revenues (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Short term deferred revenue $ 3,326,543   $ 3,326,543   $ 4,008,654
Net revenues 2,867,649 $ 2,384,356 19,843,695 $ 8,092,971  
Deferred revenue carry forward 8,970,780   8,970,780    
Long term deferred revenue 3,585,344   $ 3,585,344   4,962,126
2024     15.00%    
2025     85.00%    
Deferred Revenue Recognized     $ 6,900,000    
Revenue          
Short term deferred revenue 3,326,543   3,326,543   4,008,654
Net revenues     16,500,000.0    
Deferred revenue carry forward 8,970,780   8,970,780    
Long term deferred revenue 3,585,344   3,585,344   $ 4,962,126
Deferred revenue recognized $ 933,675   3,061,613    
Transferred at Point in Time [Member]          
Net revenues     16,500,000 4,400,000  
Transferred over Time [Member]          
Net revenues     $ 3,300,000 $ 3,700,000  
v3.24.3
Notes Payable and Line of Credit (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 05, 2024
Oct. 03, 2023
Mar. 18, 2024
Feb. 02, 2024
Jun. 22, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Sep. 13, 2024
Sep. 03, 2024
Jun. 22, 2024
Convertible promissory note           $ 141,636   $ 400,921          
Prepaid expenses           $ 16,366 $ 2,722 $ 22,922 $ 7,425        
Stock options outstanding                       2,882,883  
Common stock shares issued           26,954,871   26,954,871   22,812,048     232,360
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited     51,967                    
Common stock value           $ 2,692   $ 2,692   $ 2,281      
Platinum Capital Partner, Inc.                          
Interest Rate       6.00%                  
Common shares issued 169,204     189,334                  
Convertible promissory note   $ 600,000   $ 2,000,000 $ 2,000,000                
Stock options outstanding                     86,198    
Accounts payable amount               1,793,360   $ 2,825,366      
Common stock shares issued         232,360                
Warant Received     137,367                    
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited     51,967                    
Promissory notes with a face value $ 600,000                        
Common stock value $ 835,610                        
Loss on debt conversion           $ 234,459   393,253          
Conversion price       $ 2                  
Exercise price   $ 2.65   $ 3                  
Platinum Capital Partner, Inc.One                          
Convertible promissory note         $ 2,000,000     $ 500,000          
Extension fees         1,008,400                
Prepaid expenses         $ 487,000                
Common stock shares issued         232,360 219,763   219,763          
Loss on debt conversion               $ 200,338          
Conversion price         $ 2                
Exercise price         $ 3                
v3.24.3
Stockholders Deficit (Details)
9 Months Ended
Sep. 30, 2024
$ / shares
shares
STOCKHOLDERS' DEFICIT:  
Number of shares, Options Outstanding, Beginning | shares 4,664,589
Number of shares, Options Outstanding, granted | shares 1,050,000
Number of shares, Options Outstanding, exercised | shares (324,448)
Number of shares, Options Outstanding, forfeited | shares (300,000)
Number of shares, Options Outstanding, Ending Balance | shares 5,090,141
Weighted average exercise price, option outstanding, Beginning Balance | $ / shares $ 0.55
Warrants, weighted average exercise price, options granted | $ / shares 3.74
Warrants,Weighted average exercise price, Options exercised | $ / shares (0.60)
Warrants,Weighted average exercise price, Options cancelled/forfeited | $ / shares (6.85)
Weighted average exercise price, option outstanding, Ending Balance | $ / shares $ 0.83
v3.24.3
Stockholders Deficit (Details 1) - $ / shares
9 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Number of shares, Options Outstanding 5,090,141 4,664,589
Weighted average exercise price, option outstanding $ 0.83 $ 0.55
Number of shares, Options exercisable 3,989,905  
Weighted average exercise price, option exercisable $ 0.45  
Weighted average remaining life in years- vested and exercisable 5 years 1 month 20 days  
Weighted average remaining life in years- vested and exercisable 4 years 29 days  
Weighted average remaining life in years- Options Outstanding 5 months 4 days  
Exercise Prices 0.12    
Number of shares, Options Outstanding 2,495,803  
Weighted average exercise price, option outstanding $ 0.12  
Number of shares, Options exercisable 2,495,803  
Weighted average exercise price, option exercisable $ 0.12  
Weighted average remaining life in years- vested and exercisable 3 months 17 days  
Weighted average remaining life in years- Options Outstanding 3 months 17 days  
Exercise Prices 0.57    
Number of shares, Options Outstanding 922,963  
Weighted average exercise price, option outstanding $ 0.57  
Number of shares, Options exercisable 922,963  
Weighted average exercise price, option exercisable $ 0.57  
Weighted average remaining life in years- vested and exercisable 3 months 23 days  
Weighted average remaining life in years- Options Outstanding 3 months 23 days  
Exercise Prices 1.49-1.65    
Number of shares, Options Outstanding 1,096,562  
Weighted average exercise price, option outstanding $ 1.64  
Number of shares, Options exercisable 505,178  
Weighted average exercise price, option exercisable $ 1.64  
Weighted average remaining life in years- vested and exercisable 7 months 20 days  
Weighted average remaining life in years- Options Outstanding 7 months 20 days  
Exercise Prices 1.90    
Number of shares, Options Outstanding 49,813  
Weighted average exercise price, option outstanding $ 1.90  
Number of shares, Options exercisable 33,148  
Weighted average exercise price, option exercisable $ 1.90  
Weighted average remaining life in years- vested and exercisable 3 months 7 days  
Weighted average remaining life in years- Options Outstanding 3 months 7 days  
Exercise Prices 2.86    
Number of shares, Options Outstanding 525,000  
Weighted average exercise price, option outstanding $ 2.86  
Number of shares, Options exercisable 32,813  
Weighted average exercise price, option exercisable $ 2.86  
Weighted average remaining life in years- vested and exercisable 9 months 26 days  
Weighted average remaining life in years- Options Outstanding 9 months 26 days  
v3.24.3
Stockholders Deficit (Details 2) - $ / shares
3 Months Ended 6 Months Ended 9 Months Ended
Mar. 31, 2024
Jun. 30, 2024
Sep. 30, 2024
STOCKHOLDERS' DEFICIT:      
Dividend yield 0.00% 0.00% 0.00%
Estimated stock price, minimum $ 1.49    
Estimated stock price   $ 7.61 $ 2.86
Estimated stock price, maximum 6.59    
Exercise price, minimum 1.49    
Exercise price   $ 7.61 $ 2.86
Exercise price, maximum $ 6.59    
Expected life, minimum 5 years    
Expected life   4 months 4 months
Expected life, maximum 10 years    
Expected Volatility 69.00% 69.00% 69.00%
Risk free interest rate 4.23% 4.68% 3.77%
v3.24.3
Stockholders Deficit (Details 3)
9 Months Ended
Sep. 30, 2024
$ / shares
shares
STOCKHOLDERS' DEFICIT:  
Warrants outstanding , Beginning | shares 19,443,314
Warrants issued | shares 3,454,033
Warrants Exercised | shares (162,967)
Warrants Forfeited | shares (51,967)
Warrants outstanding , ending | shares 22,682,413
Weighted average exercise price, option outstanding, Beginning Balance $ 10.16
Warrants, weighted average exercise price, Issued 2.72
Warrants, weighted average exercise price, Exercised (4.92)
Warrants, weighted average exercise price, Forfeited (3.70)
Warrants, weighted average exercise price, Expired 0
Weighted average exercise price, option outstanding, Ending Balance $ 6.34
v3.24.3
Stockholders Deficit (Details 4) - $ / shares
9 Months Ended
Sep. 30, 2024
Sep. 03, 2024
Number of Warrants 22,682,413  
Weighted average exercise price, Warrants $ 6.34 $ 2.65
Number of shares, Warrants exercisable 22,682,413  
Weighted average exercise price, Warrants exercisable $ 6.34  
Weighted average remaining life in years- vested and exercisable 4 years 29 days  
Warrants 1 [Member]    
Number of Warrants 220,000  
Weighted average exercise price, Warrants $ 2.36  
Number of shares, Warrants exercisable 220,000  
Weighted average exercise price, Warrants exercisable $ 2.36  
Weighted average remaining life in years- vested and exercisable 5 years  
Warrants 2 [Member]    
Number of Warrants 2,882,283  
Weighted average exercise price, Warrants $ 2.65  
Number of shares, Warrants exercisable 2,882,283  
Weighted average exercise price, Warrants exercisable $ 2.65  
Weighted average remaining life in years- vested and exercisable 4 years 11 months 1 day  
Warrants 3 [Member]    
Number of Warrants 216,216  
Weighted average exercise price, Warrants $ 3.47  
Number of shares, Warrants exercisable 216,216  
Weighted average exercise price, Warrants exercisable $ 3.47  
Weighted average remaining life in years- vested and exercisable 4 years 11 months 1 day  
Warrants 4 [Member]    
Number of Warrants 16,674,012  
Weighted average exercise price, Warrants $ 7.80  
Number of shares, Warrants exercisable 16,674,012  
Weighted average exercise price, Warrants exercisable $ 7.80  
Weighted average remaining life in years- vested and exercisable 4 years 15 days  
Warrants [Member]    
Number of Warrants 2,689,902  
Weighted average exercise price, Warrants $ 1.77  
Number of shares, Warrants exercisable 2,689,902  
Weighted average exercise price, Warrants exercisable $ 1.77  
Weighted average remaining life in years- vested and exercisable 3 years 5 months 19 days  
v3.24.3
Stockholders Deficit (Details 5) - $ / shares
3 Months Ended 6 Months Ended 9 Months Ended
Mar. 31, 2024
Jun. 30, 2024
Sep. 30, 2024
Dividend yield 0.00% 0.00% 0.00%
Estimated stock price   $ 7.61 $ 2.86
Exercise price   $ 7.61 $ 2.86
Expected life   4 months 4 months
Expected Volatility 69.00% 69.00% 69.00%
Risk free interest rate 4.23% 4.68% 3.77%
Warrant To Purchase Of Common Stock [Member]      
Dividend yield     0.00%
Estimated stock price     $ 2.72
Exercise price     $ 2.72
Expected life     4 months
Expected Volatility     69.00%
Risk free interest rate     3.77%
v3.24.3
Stockholders Deficit (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 05, 2024
Mar. 18, 2024
Jun. 22, 2023
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 27, 2024
Sep. 13, 2024
Sep. 03, 2024
Jun. 22, 2024
May 16, 2024
Feb. 02, 2024
Dec. 31, 2023
Number of shares, Options Outstanding, exercised                   (525,000)                
Number of shares, Options Outstanding, forfeited                   (300,000)                
Purchase shares of common stock                   324,448                
Convertible promissory note       $ 141,636           $ 400,921                
Warrants Exercised                   (162,967)                
Stock based compensation expense       $ 273,170 $ 261,636 $ 268,989   $ 136,709 $ 136,709                  
Stock options outstanding                           2,882,883        
Stock option exercise price                           $ 2.775        
Common stock exercise price per share       $ 0.60           $ 0.60                
Common stock shares issued       26,954,871           26,954,871         232,360     22,812,048
Warrants, weighted average exercise price, Exercised                   $ (4.92)                
Common stock shares par value       $ 0.0001           $ 0.0001                
Common stock shares issued       200,000,000           200,000,000                
Common stock shares, outstanding       26,954,871           26,954,871               22,812,048
Aggregate intrinsic value       $ 5,090,141           $ 5,090,141                
Preferred stock, shares authorized       5,000,000           5,000,000               5,000,000
Common forfeited shares   51,967                                
Common shares received   137,367                                
Additional stock based compensation                   $ 205,879                
Unrecognized Stock based compensation                   $ 1,962,124                
Costs are expected to be recognized over a period                   3 months 15 days                
Common Stock, Shares Authorized       205,000,000           205,000,000                
Warrants to Purchase Common Stock by each founders       216,216           216,216   220,000   2,882,883     189,334  
Warrants exercise price       $ 3.47           $ 3.47   $ 2.36   $ 2.65     $ 3  
Weighted average exercise price, Warrants       6.34           $ 6.34       $ 2.65        
Common Stock [Member] | Invester [Member]                                    
Secured convertible promissory note issued $ 250,000                                  
converted a senior secured convertible shares of common stock 70,502                 25,600                
Proceed from warrants                   $ 294,030                
Weighted average exercise price, Warrants       $ 11.49           $ 11.49                
Common Stock [Member] | Investor 1 [Member]                                    
Common stock shares issued                               50,000   15,000
Secured convertible promissory note issued $ 350,000                                  
converted a senior secured convertible shares of common stock 98,702                                  
Stock Incentive Plan                                    
Purchase shares of common stock                   324,448                
Purchase shares of common stock, amount                   $ 196,173                
Convertible promissory note     $ 2,000,000             500,000                
Stock based compensation expense       $ 139,409     $ 206,495     $ 420,824 $ 479,913              
Stock options outstanding                         86,198 2,882,883        
Stock option exercise price       $ 0.83           $ 0.83     $ 2.65 $ 2.775        
Common stock exercise price per share       $ 0.60           $ 0.60                
Common stock shares issued       219,763           219,763                
Vested warrants Shares       5,090,141           5,090,141                
Aggregate intrinsic value       $ 7,781,223           $ 7,781,223                
Common Stock SARs outstanding       1,758,000           1,758,000               1,758,000
Seven Employee [Member]                                    
Purchase shares of common stock                   1,050,000                
Common stock exercise price per share       $ 3.74           $ 3.74                
Five Employee [Member]                                    
Purchase shares of common stock                   300,000                
Common stock exercise price per share       $ 6.85           $ 6.85                
v3.24.3
Employee 401(k) Plan (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Employee 401(k) Plan        
Contributions expense $ 52,456 $ 44,973 $ 153,254 $ 138,532
Description     The plan provides for a 3.5% match on up to 6% of deferred salary  
v3.24.3
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
May 08, 2023
Mar. 31, 2024
Jun. 30, 2024
Sep. 30, 2024
Sep. 27, 2024
Dec. 31, 2023
Sep. 03, 2024
Estimated stock price     $ 7.61 $ 2.86      
Expected Volatility   69.00% 69.00% 69.00%      
Risk free interest rate   4.23% 4.68% 3.77%      
Owed by related party           $ 60,000,000  
Exercise price       $ 7.80      
Weighted average exercise price, Warrants       $ 6.34     $ 2.65
Mr Huang And Mr Xu [Member]              
Estimated stock price $ 1.89            
Interest Rate         6.00%    
Expected Volatility 39.40%            
Risk free interest rate 3.41%            
Owed by related party $ 213,611,500            
Advance from related party       $ 1,750,000   1,750,000  
Warrants to purchase 1,344,951            
Proceeds from advances         $ 284,478    
Payments for advances of related party       2,100,000   200,000  
Advance received from related party       $ 2,100,000   $ 1,350,000  
Advance from founders         $ 11,913    
Exercise price         $ 2.36    
Additionl funding for the agreement         $ 1,500,000    
Weighted average exercise price, Warrants $ 1.77            
v3.24.3
Commitments Contingencies and Legal Proceedings (Details)
Sep. 30, 2024
USD ($)
COMMITMENTS AND CONTINGENCIES (Note 9)  
2025 $ 327,308
2026 367,606
2027 378,646
2028 32,333
Total remaining payments 1,105,893
Less Imputed Interest (119,840)
Total lease liability $ 986,053
v3.24.3
Commitments Contingencies and Legal Proceedings (Details Narrative)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 13, 2023
USD ($)
ft²
Feb. 29, 2024
USD ($)
Sep. 30, 2024
USD ($)
$ / shares
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
$ / shares
Sep. 30, 2023
USD ($)
Feb. 09, 2024
ft²
Dec. 31, 2023
USD ($)
$ / shares
Area of lease agreement | ft² 15,567           3,621  
Monthly payment increases in percentage 3.00%              
Operating lease liabilities     $ 986,053   $ 986,053     $ 1,118,578
Right of use assets     929,890   929,890     1,104,804
Lease costs for the leases     88,428 $ 162,414 $ 265,283 $ 487,242    
Weighted average discount rate         7.00%      
Lease obligations- current liabilities     $ 267,660   $ 267,660     $ 174,876
Common stock exercise price per shares | $ / shares     $ 0.0001   $ 0.0001     $ 0.0001
Net monthly payment $ 25,000 $ 6,488            
Lease expires date Oct. 31, 2027 Feb. 28, 2025            
Employment Agreement [Member]                
Base salary         $ 250,000      
Common stock exercise price per shares | $ / shares     $ 1.49   $ 1.49      
v3.24.3
Income Taxes (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Income Taxes    
Provision for income taxes $ 0 $ 0
Effective tax rate 0.00% 0.00%
v3.24.3
Reverse Recapitalization (Details) - USD ($)
Sep. 30, 2024
Jun. 22, 2024
Dec. 31, 2023
Issued shares of common stock, value $ 2,692   $ 2,281
Common stock shares issued 26,954,871 232,360 22,812,048
Common stock exercise price per shares $ 0.0001   $ 0.0001
Common Stocks [Member]      
Issued shares of common stock, value $ 942    
Common stock shares issued 9,424,704    
Common Stocks [Member] | SPAC Financing [Member]      
Issued shares of common stock, value $ 889    
Common stock shares issued 8,891,718    
Common stock exercise price per shares $ 0.0001    
Common Stocks [Member] | Transaction expenses [Member]      
Issued shares of common stock, value $ 53    
Common stock shares issued 532,986    
Common stock exercise price per shares $ 0.0001    
Additional Paid In Capitals [Member]      
Issued shares of common stock, value $ 4,816,511    
Additional Paid In Capitals [Member] | SPAC Financing [Member]      
Issued shares of common stock, value 8,315,186    
Additional Paid In Capitals [Member] | Transaction expenses [Member]      
Issued shares of common stock, value 6,651,674    
Additional Paid In Capitals [Member] | Earnout liability [Member]      
Issued shares of common stock, value 4,470,918    
Additional Paid In Capitals [Member] | Warrants liability [Member]      
Issued shares of common stock, value 2,009,105    
Accumulated Deficits [Member]      
Issued shares of common stock, value 23,533,521    
Accumulated Deficits [Member] | SPAC Financing [Member]      
Issued shares of common stock, value 0    
Accumulated Deficits [Member] | Transaction expenses [Member]      
Issued shares of common stock, value 894,662    
Accumulated Deficits [Member] | Earnout liability [Member]      
Issued shares of common stock, value 22,638,859    
Accumulated Deficits [Member] | Warrants liability [Member]      
Issued shares of common stock, value $ 0    
v3.24.3
Reverse Recapitalization (Details 1) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Total assets $ 9,096,370     $ 6,087,913        
Accumulated deficit (24,765,218)     (17,476,700)        
Total stockholders' deficit $ (12,920,583) $ (27,966,537) $ (48,050,609) (17,487,227) $ (12,226,689) $ (10,721,782) $ (9,933,878) $ (8,358,411)
As Reported [Member]                
Prepaid expenses and other       913,030        
Total current assets       5,693,577        
Total assets       6,982,575        
Accumulated deficit       (16,582,038)        
Total stockholders' deficit       (16,592,565)        
Adjustment [Member]                
Prepaid expenses and other       894,662        
Total current assets       894,662        
Total assets       894,662        
Accumulated deficit       (894,662)        
Total stockholders' deficit       (894,662)        
As Revised [Member]                
Prepaid expenses and other       18,368        
Total current assets       4,798,915        
Total assets       6,087,913        
Accumulated deficit       (17,476,700)        
Total stockholders' deficit       $ (17,487,227)        
v3.24.3
Reverse Recapitalization (Details Narrative)
$ in Millions
9 Months Ended
Sep. 30, 2024
USD ($)
Reverse Recapitalization  
Net proceeds $ 2.8
Net of transaction costs $ 6.6
v3.24.3
Private Placement and Public Warrants (Details) - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 03, 2024
Dec. 31, 2023
Weighted average exercise price, Warrants $ 6.34 $ 2.65  
Warrant, Outstanding (in Shares) 22,682,413   19,443,314
Private Placement [Member]      
Weighted average exercise price, Warrants $ 7.80    
Warrant, Expiration date Dec. 21, 2028    
Warrant, Outstanding (in Shares) 515,000    
Warrant, Initial Fair Value $ 108,150    
Public Warrant [Member]      
Weighted average exercise price, Warrants $ 7.80    
Warrant, Expiration date Dec. 21, 2028    
Warrant, Outstanding (in Shares) 16,159,012    
Warrant, Initial Fair Value $ 3,393,393    
v3.24.3
Private Placement and Public Warrants (Details Narrative)
9 Months Ended
Sep. 30, 2024
$ / shares
shares
Warrant outstanding (in Shares) 16,159,012
Private placement warrants shares outstanding 515,000
Public warrants shares outstanding 16,184,612
Warrants exercise price | $ / shares $ 11.50
Exercise price | $ / shares $ 7.80
Public Warrant and Private Warrant [Member]  
Warrant outstanding (in Shares) 16,159,012
Private placement warrants shares outstanding 515,000
Warrant received (in Shares) 515,000
Public warrants shares outstanding 16,184,612
Warrants exercise price | $ / shares $ 11.50
Exercise price | $ / shares $ 7.80
v3.24.3
Earnout Liability (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Earnout liability decreased       $ 5,133,428
Vested Earnout Shares are included 1,250,000 1,250,000    
Closing trading price $ 2,875,000 $ 2,875,000    
Initial fair value of earnout liability   2,675,223   $ 27,109,777
Estimated fair value of the earnout liability   6,229,390    
Change in fair value of the earnout liability   $ 5,511,961 $ 1,095,962  
Earnout Shares receival   5,000,000    
Stock-based compensation expense 133,761 $ 401,283    
Unrecognized compensation cost $ 2,273,941 $ 2,273,941    
Weighted average period over   4 months 7 days    
25 Percent Earnout Shares [Member]        
Earnout Shares description   25% of the earnout shares if, for the period starting on the closing date and ending on the last day of the full calendar quarter immediately following the first anniversary of the closing date, (1) company revenue (as defined in the merger agreement) is at least $39 million, or (2) the aggregate value of new contract awards with federal law enforcement agencies has grown by at least 100% as compared to the year-over-year amount for the twelve-month period ending on the date of the merger agreement (the “First Operating Performance Milestone”)    
75 Percent Earnout Shares [Member]        
Earnout Shares description   75% of the earnout shares if, for the period starting on the closing date and ending on the last day of the full calendar quarter immediately following the third anniversary of the closing date, company revenue is at least $100 million    
50 Percent Earnout Shares [Member]        
Earnout Shares description   50% of the earnout shares if, at any time during the period starting on the closing date and ending on the fifth anniversary of the closing date, over any twenty (20) trading days within any thirty (30) trading day period the volume weighted average price (“VWAP”) of the common stock is greater than or equal to $12.50 per share; and    
50 Percent One Earnout Shares [Member]        
Earnout Shares description   50% of the earnout shares if, at any time during the period starting on the closing date and ending on the fifth anniversary of the closing date, over any twenty (20) trading days within any thirty (30) trading day period the VWAP of the common stock is greater than or equal to $15.00 per share    
v3.24.3
Fair Value Measurements (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Earnout liability $ 6,229,390 $ 5,133,428
Senior Secured Convertible Promissory Notes 1,793,360 2,825,366
Warrant liability (Public Warrants) 3,393,393 646,428
Warrant liability (Public Warrants) 3,393,393 646,428
Warrant liability (Private Warrants) 108,150 21,557
Warrant liability (Private Warrants) 108,150 21,557
Total liabilities measured at fair value 11,524,293 8,626,779
Fair Value Inputs Level 1 [Member]    
Earnout liability 2,875,000 0
Senior Secured Convertible Promissory Notes 0 0
Warrant liability (Public Warrants) 3,393,393 646,428
Warrant liability (Private Warrants) 0 0
Total liabilities measured at fair value 6,268,393 646,428
Fair Value Inputs Level 2 [Member]    
Earnout liability 0 0
Senior Secured Convertible Promissory Notes 0 0
Warrant liability (Public Warrants) 0 0
Warrant liability (Private Warrants) 108,150 21,557
Total liabilities measured at fair value 108,150 21,557
Fair Value Inputs Level 3 [Member]    
Earnout liability 3,354,390 5,133,428
Senior Secured Convertible Promissory Notes 1,793,360 2,825,366
Warrant liability (Public Warrants) 0 0
Warrant liability (Private Warrants) 0 0
Total liabilities measured at fair value $ 5,147,750 $ 7,958,794
v3.24.3
Fair Value Measurements (Details 1) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 21, 2023
Dec. 31, 2023
Expected term (in years) 8 months 23 days    
Expected term (in years), minimum   5 months 23 days  
Monte Carlo Simulation [Member]      
Stock price $ 2.30   $ 1.70
Expected term (in years), maximum   9 months  
Dividend yield $ 0   $ 0
Expected volatility $ 55,000.0   $ 62,500
Risk-free interest rate 12.28%   12.95%
Monte Carlo Model One [Member]      
Stock price $ 2.30   $ 1.70
Expected term (in years) 4 years 3 months 18 days 5 years  
Dividend yield $ 0   $ 0
Expected volatility $ 60,400   $ 75,900
Risk-free interest rate 3.58%   3.84%
v3.24.3
Fair Value Measurements (Details 2)
9 Months Ended
Sep. 30, 2024
USD ($)
Fair value Of Liabilities measured , beginning $ 7,958,794
Unrealized and Realized Loss 2,356,189
Conversions Settlements (1,767,233)
Transfers out (3,400,000)
Fair value Of Liabilities measured , ending 5,147,750
Fair Value Inputs Level 3 [Member] | Earnout liability [Member]  
Fair value Of Liabilities measured , beginning 5,133,428
Unrealized and Realized Loss 1,620,962
Conversions Settlements 0
Transfers out (3,400,000)
Fair value Of Liabilities measured , ending 3,354,390
Fair Value Inputs Level 3 [Member] | Senior Secured Convertible Promissory Notes [Member]  
Fair value Of Liabilities measured , beginning 2,825,366
Unrealized and Realized Loss 735,227
Conversions Settlements (1,767,233)
Transfers out 0
Fair value Of Liabilities measured , ending $ 1,793,360
v3.24.3
Fair Value Measurements (Details Narrative)
Sep. 30, 2024
USD ($)
shares
Fair Value Measurements  
Vested Earnout Shares are included | shares 1,250,000
Closing trading price | $ $ 2,875,000
v3.24.3
Earnings per Share (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Earnings per Share                
Net Income (loss) $ 6,213,956 $ 18,461,995 $ (31,964,469) $ (1,666,607) $ 3,103,279 $ (1,712,176) $ (7,288,520) $ (6,482,062)
Less: interest expense and remeasurement of convertible debt (236,724)     0     0 0
Net income (loss) - Diluted $ 5,977,232     $ (1,666,607)     $ (7,288,520) $ (6,482,062)
Weighted average shares outstanding basic 24,696,425     22,812,048     23,609,189 22,812,048
Add: dilutive effect of stock options, SARs and Airship warrants 10,749,269     0     0 0
Weighted average shares outstanding diluted 35,445,694     22,812,048     23,609,189 22,812,048
Income (loss) per share basic $ 0.25     $ (0.07)     $ (0.31) $ (0.28)
Income (loss) per share Diluted $ 0.17     $ (0.07)     $ (0.31) $ (0.28)
v3.24.3
Earnings per Share (Details 1) - shares
Sep. 30, 2024
Sep. 30, 2023
Earnings per Share    
Public Warrants 16,159,012 0
Private Warrants 515,000 0
Convertible debt 0 367,000
Warrants 216,216 0
Outstanding stock options 525,000 0
Diluted shares outstanding 17,415,228 367,000
v3.24.3
Earnings per Share (Details Narrative)
Sep. 30, 2024
shares
Earnings per Share  
Vested Earnout Shares are included 1,250,000
Earnout Shares are excluded 3,750,000
v3.24.3
Subsequent Events (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Nov. 13, 2024
Nov. 11, 2024
Sep. 30, 2024
Sep. 30, 2024
Convertible promissory note     $ 141,636 $ 400,921
Subsequent Event        
Convertible promissory note $ 219,763 $ 109,881    

Airship AI (NASDAQ:AISPW)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Airship AI Charts.
Airship AI (NASDAQ:AISPW)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Airship AI Charts.